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ABSTRACT 
Titanium (Ti) and its alloys have many properties and behaviour characteristics 
which make them a suitable group of materials to be used for biomedical 
implants. Ti implant materials are used in both indwelling sites such as parts of 
joint replacements or in sites that penetrate the epithelium such as dental implants. 
In both contexts, device failure which is often associated with chronic 
inflammation is a significant problem. For indwelling devices, the build-up of 
particles and implant derived ions in the peri-implant tissues has been identified to 
significantly have impact on inflammation and clinical outcomes. For skin or 
mucosa penetrating Ti implants, little consideration is given to the potential role 
that Ti has in particulate or ionic form in modifying or indeed initiating 
inflammatory responses.  
In the current thesis, state of the art elemental detection methods were adopted to 
firstly probe tissues surrounding Ti implants where wear processes would not be 
expected. The discovery of Ti distributions in forms indicative of corrosion 
processes suggests that indeed Ti should be considered as a potential modifier of 
the peri-implant physiological processes. Subsequent analysis of inflamed peri-
implant tissues from indwelling, percutaneous and transmucosal sites 
demonstrated the presence of Ti in all samples studied. Characterisation of the Ti 
speciation preceded electrochemical simulations which confirmed that all Ti that 
had been observed in the tissues could be accounted for by crevice corrosion 
processes.  
Neutrophils are the predominant acute inflammatory cells in percutaneous and 
transmucosal peri-implant sites. Therefore, an array of neutrophil immune 
responses (phagocytosis, respiratory burst, NETosis, cytokine secretion and 
chemotaxis) were studied following stimulation with Ti in forms identified in the 
peri-implant tissues. Finally, the modification of neutrophil immune responses to 
known periodontal pathogens following Ti exposures was explored. The findings 
strongly indicated that neutrophil responses can be modified by Ti species found 
in peri-implant sites and further work is needed to identify the role that ‘free Ti’ 
has on implant outcomes. 
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
 
1.1 Titanium (Ti) and Ti alloys as biomaterials 
 
Titanium (Ti) is a transitional metal with silver colour, possessing an atomic 
number of 22 and atomic weight of 47.9 (McQuillan, 1970). Ti is generally 
considered as one of the most biocompatible metallic materials used for 
biomedical applications (Williams, 1987). However, the term ‘biocompatibility’ is 
often loosely used by the biomaterials community and the general population and 
is frequently ill-defined. Biocompatibility is best considered as a state of mutual 
coexistence between the biomaterial and the physiological environment such that 
neither has an undesirable effect on the other (Tang & Eaton, 1995). However, a 
material may be biocompatible in one form in a specific environment but elicit an 
unfavourable response when presented in a different form or placed into a 
different environment (Williams, 1994). Therefore, biocompatibility of a material 
must be contextualised to a specific application (Brunette, 2001).  
 
Ti has been successfully used in a wide variety of surgical applications including 
orthopaedics (Cook et al., 1988), maxillofacial (Williams, 1981), craniofacial 
(Albrektsson et al., 1983), cardiovascular and neurosurgery (Sunny & Sharma, 
1991) rehabilitation purposes. Ti is a suitable substrate for a variety of 
manufacturing routes including casting, sintering or machining (lathing, milling, 
threading) which are all currently used for the manufacture of Ti medical devices 
(Brunette, 2001). Alongside the versatility in processing Ti, it has favourable 
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mechanical properties including a high tensile strength, high toughness, low 
elastic modulus and low density of 4.54 (g/cm
3
) (Elias et al., 2008). These 
characteristics of Ti confer a light weight to fabricated devices (Elias et al., 2008) 
and suitable chemical properties including corrosion resistance and thermal 
stability (Albrektsson et al., 1981) which ensure that they are also highly damage 
tolerant (Hallam et al., 2004). In addition, Ti was the first metallic biomaterial 
which was demonstrated to have the ability to osseointegrate (Brånemark, 1977). 
Osseointegration is a time dependent process and is defined as the dynamic 
interaction of living bone with an implanted biomaterial which occurs with the 
absence of an interposing soft tissue layer (Brånemark et al., 1985). A further 
favourable property of Ti for biomedical applications includes that it is relatively 
radiolucent (Mudali et al., 2003) enabling patients with indwelling Ti implant(s) 
to be examined with Magnetic Resonance Imaging (MRI) (Hettige & Norris, 
2012). As a consequence Ti is being increasingly used as a biomedical material. 
 
1.1.1 Classification of biomedical Ti 
  
The American Society for Testing and Materials (ASTM) International recognizes 
31 grades of Ti and Ti alloys of which 23 are classified as biomedical materials 
(Brunnette, 2001). Biomedical Ti is used in either commercially pure (Cp) forms 
or alloyed with elements such as aluminium (Al), vanadium (V) or niobium (Nb) 
(Elias et al., 2008) in order to modify the mechanical and surface properties. CpTi 
is itself not completely pure, containing metallic impurities of which iron (Fe) is 
the most common and which can modify the mechanical and chemical material 
properties. The two most commonly used biomedical forms of Ti include CpTi 
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and the alloy Ti-6Al-4V (Elias et al., 2008). Both grades are paramagnetic, have 
low electrical and thermal conductivity and a significantly higher strength to 
weight ratio in comparison to other competing metallic implant materials such as 
stainless steel or Cobalt-Chromium-Molybdenum (Co-Cr-Mo) (Elias et al., 2008).  
 
1.1.2 CpTi (unalloyed) biomedical implants 
 
CpTi is classified by ASTM as Grades I-IV which are suitable for the 
manufacture of long term craniofacial and dental devices and for which the 
mechanical demands are considered less than for orthopaedic applications (Elias 
et al., 2008). Grades I-IV are distinguished by their varying degrees of tensile 
strength which is influenced by the oxygen content (itself dictated by the impurity 
level). Grade I is the most ductile (lowest tensile strength of 240 MPa with an 
oxygen content of 0.18%) and Grade IV the least ductile (highest tensile strength 
of 550 MPa with an oxygen content of 0.40%).  
 
1.1.3 Ti-6Al-4V alloyed biomedical implants 
 
Ti-6Al-4V is the ASTM Grade V alloy and was originally developed for 
aerospace applications but has historically been the most attractive for indwelling 
(orthopaedic) implant applications because of its high tensile strength of 910 MPa 
(Elias et al., 2008). The alloy is less commonly used in dental applications but is 
extensively used for craniofacial fixation devices (Neumann, 2009) following 
trauma or elective surgeries for fracture stabilisation.  
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1.1.4 Biological and biomechanical differences between CpTi (unalloyed) and 
Ti-6Al-4V alloyed implants 
 
Differences between the biological responses to CpTi (unalloyed) and Ti-6Al-4V 
alloyed implants have been observed in in-vivo studies. Following osseous 
insertion into rabbit bone, it was observed that the CpTi implants had higher 
removal torque values than the Ti-6Al-4V alloyed implants and a significantly 
increased number of bone contacts were observed (Johansson et al., 1998 & Elias 
et al., 2008). It has subsequently been proposed that the increased elasticity of 
CpTi results in more evenly shared loading between bone and the implant (Wang 
et al., 2007) thus leading to a lower incidence of bone degradation (Niinomi, 
2003). However, CpTi implants possess lower shear strengths (240-550 MPa) 
than Ti-6Al-4V and are therefore largely precluded in orthopedic applications 
(Elias et al., 2008). The corrosion resistance of Ti-6Al-4V implants is also lower 
and therefore for permanent implant applications, the alloy has been proposed to 
have toxic effects on host tissues but to date this has largely been associated with 
the release of Al and V ions (Mudali et al., 2003 & Elias et al., 2008). For this 
reason, Al- and V- free alloys including Ti-6Al-7Nb (ASTM F1295), Ti-13Nb-
13Zr (ASTM F1713) and Ti-12Mo-6Zr (ASTM F1813) have been introduced 
(Elias et al., 2008). It is important to note that the potential toxicity of Ti itself is 
rarely considered. 
 
1.2 The Ti surface 
 
Ti is a highly reactive metal and its stability in physiological environments and 
the biological response to it are conferred by the presence of a resilient surface 
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oxide layer (Kasemo, 1983). Cellular responses to Ti, including the highly 
favourable phenomenon of osseointegration are determined by the interaction 
with the Ti oxide surface which is extremely thin at a thickness of 5-20 nm 
(Schroeder et al., 1981). Disruption of this oxide surface either mechanically or 
chemically leads to rapid reformation (re-passivation) of the surface (Kasemo, 
1983) wherever moisture and oxygen are present due to the strong affinity of Ti 
for oxygen (Joshi & Eley, 1988). It is important to recognise that the formation of 
such a robust oxide layer on Ti implants accounts for the perceived benign nature 
of Ti as a biomaterial (Sunny & Sharma, 1991 & Olmedo et al., 2008). 
 
The chemical composition and structure of the surface oxide film is complex and 
can be highly heterogeneous. Simplistically, it can be considered as comprising of 
three layers where the first layer adjacent to metallic Ti is TiO, the intermediary 
layer is Ti2O3, and the third layer, which is in contact with the external 
environment, displays the passive oxide (TiO2) film (Gemelli et al., 2007). The 
composition, structure and morphological variability of biomedical Ti surfaces 
have been shown to impact on the surface hydrophobicity (influencing protein 
interactions) (Rae, 1978 & Varmanu et al., 2008), cellular adhesion and 
proliferation (Sunny & Sharma, 1991) and corrosion resistance properties (Koike 
& Fujii, 2001). 
 
1.2.1 The composition of the surface oxide layer (TiO2) on Ti implants 
 
The passive surface exhibits TiO2 which is a naturally occurring, highly insoluble 
(Driscoll et al., 1997), thermally stable Ti compound found in minerals as rutile, 
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anatase, brookite as well as in iron-containing ilmenite (Jolivet et al., 2010). 
Although they share the same chemistry, each form of TiO2 has a distinctive 
structure due to its atomic co-ordination (Hedenborg, 1988 & Rahman et al., 
2002). In nature, ilmenite is the most common form of TiO2 (Duan et al., 2010 & 
Iavicoli et al., 2011) however, the passive film formed on biomedical Ti has been 
characterised as composed of mainly rutile and anatase polymorphs (Effah et al., 
1995 & Olmedo et al., 2008). Structurally, the Ti atoms in rutile and anatase are 
surrounded octahedrally in a distorted structure by six oxygen atoms (Figure 1.1) 
(Jolivet et al., 2010).  
 
Figure 1.1 Crystal structure representations of (a) rutile and (b) anatase 
polymorphs of TiO2 (Jolivet et al., 2010) 
 
  
 
 
 
 
 
 
Both rutile and anatase polymorphs of TiO2 possess tetragonal symmetry and 
have similar physical properties although their stability differs (Iavicoli et al., 
2011). Rutile has been assumed to be the most thermodynamically stable form 
because of its significantly naturally increased occurrence as compared with 
anatase (Iavicoli et al., 2011).  
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1.3 Ti prosthesis failure 
 
Despite the extensive use of Ti implant devices which have revolutionised 
treatment options in dentistry and many surgical disciplines (Albretktsson, 1983), 
failure of the device and its management remains, the key clinical concern. 
Several people worldwide annually undergo revision procedures, for maintenance 
or replacement of a Ti prosthesis. Complications are predominately biological 
(Ratner, 2001) which have raised concerns regarding the biocompatibility of Ti as 
an implant material (Li et al., 2010). Biological complications are frequently ill-
defined but include pathological inflammatory changes in the tissues surrounding 
a functional Ti implant. In dentistry, adverse biological responses associated with 
implants are termed as peri-implant disease (Albretktsson & Isidor, 1994).  
 
1.3.1 Peri-implant disease 
 
Peri-implant disease encompasses two distinct entities. Establishment of a 
reversible inflammatory lesion in the peri-implant mucosa is referred to as ‘peri-
implant mucositis’ (Albrektsson & Isidor, 1994 & Klokkevold & Newman, 2000). 
However, this lesion may spread in an ‘apical’ direction to involve bone, 
compromising osseointegration, with varying degrees of bone loss and is referred 
to as ‘peri-implantitis’ (Albrektsson & Isidor, 1994 & Klokkevold & Newman, 
2000). Bone loss associated with peri-implantitis is typically circumferential and 
the shape of the bony defects appears to be influenced by the macroscopic shape 
of the implant. Peri-implantitis, like most inflammatory diseases, exhibits 
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discontinuous progression so that episodes of disease progression are interspersed 
with periods of quiescence (Klinge et al., 2005).  
 
1.3.2 Prevalence of dental peri-implant disease 
 
According to the 6
th
 European workshop on periodontology, it is estimated that 
around 80% subjects with Ti dental implants suffer from peri-implant mucositis 
and up to 46% subjects suffer from peri-implantitis (Lindhe & Meyle, 2008). 
Mucositis and peri-implantitis are likened to gingivitis and periodontitis 
respectively (Mombelli et al., 1987). However, the extent and composition of the 
inflammatory infiltrate (ICT) into the lesion has been demonstrated to differ 
suggesting the mediators of the inflammation may also be different (Meffert, 
1996). 
 
1.3.3 Failure of skin penetrating Ti implants  
 
It is estimated that around 25,000 percutaneous Ti implants require revision 
procedures annually worldwide (Ratner, 2001) which have raised concerns 
regarding the use of Ti in skin accessible systems. One such system where 
complications are frequent are Bone Anchored Hearing Aids (BAHA) used for the 
treatment of unilateral sensorineural hearing impairment (Wazen et al., 2008). 
BAHA’s are dependent on a Ti implant which is inserted into the outer table of 
the post-auricular skull and connected via a modular percutaneous CpTi abutment 
to a sound processor (Addison et al., 2012). It is reported that ~33% patients 
suffer from peri-implant skin inflammation and ~3% extrude the prosthesis (Grant 
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et al., 2010) following chronic peri-implant inflammation. The prevalence of 
adverse complications manifested for Ti skin penetrating devices are similar to 
those for Ti indwelling prostheses (Ratner, 2001). 
 
1.3.4 Failure of orthopaedic Ti implants 
 
Ti and Ti alloys are extensively used in orthopaedic surgery as indwelling devices 
forming components of hip and knee joints (Sargeant & Goswami, 2007). It is 
estimated that over 300,000 patients with indwelling Ti prostheses undergo 
revision annually worldwide due to implant associated complications (Ratner, 
2001). Symptoms associated with failing Ti devices include significant pain; 
clinical swelling and implant mobility are often detected (Hallam et al., 2004). 
Radiographic imaging can reveal cortical hypertrophy associated with intra-
osseous Ti which has been described as resembling osteoid osteoma (Figure 1.2) 
(MDA, 2002 & Hallam et al., 2004).  
 
Figure 1.2 Radiographs of a Ti hip replacement. Left: 2 days after 
implantation. Right: 2 years after implantation showing femoral loosening, 
thickening of the femoral cortices, similar to osteoid osteoma (Hallam et al., 
2004) 
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Clinical signs associated with failing indwelling Ti prostheses include 
architectural modification of the tissues (Agins et al., 1988 & Black et al., 1990); 
discoloration of the surrounding bone and fibrous tissues known as metallosis 
(Scales, 1991); and inflammation of the surrounding tissues (Hallam et al., 2004). 
The current understanding of adverse inflammatory reactions surrounding 
orthopaedic indwelling Ti prostheses is that implant failure is multifactorial 
(Hallab & Jacobs, 2009) but failure is usually aseptic (Hallam et al., 2004). One of 
the major factors implicated is the presence of wear and/or corrosion processes 
(Mudali et al., 2003) leading to the accumulation of metal debris in the 
surrounding tissues. Therefore, considering Ti as a biologically inactive and 
physiological inert material in the human body is a false assumption (Warheit, 
1997). The release of metal debris is itself complex and is mediated by 
mechanisms ranging from obvious wear processes to crevice corrosion and bio-
corrosion. The combination of mechanisms which contribute to the release of Ti 
ions and particles (Ingham & Fischer, 2000 & Hallab et al., 2004) into the peri-
prosthetic environment determine the characteristics of the metal release and are 
influenced by physiochemical processes which may be specific to a particular 
physiological environment (Sargeant & Goswami, 2007). 
  
1.4 Aetiology of the failure of skin and mucosal penetrating Ti implants 
 
The current understanding of the aetiology of skin and mucosal penetrating 
devices suggests multifactorial mechanisms, implicating both the presence of a 
bacterial biofilm (Fransson, 2009) and a dysregulated host-response (Flatebø et 
al., 2006). 
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1.4.1 The role and composition of microflora in the peri-implant milieu 
 
The current understanding is that the presence of a biofilm on the implant surface 
is necessary for peri-implant ‘mucositis’ and ‘implantitis’ to occur (Berglundh et 
al., 1992 & Meffert, 1996). This cause and effect relationship is similar to that 
observed between bacterial plaque and periodontal inflammation (Bundy et al., 
1980) in which plaque components express virulence factors which stimulate an 
array of inflammatory responses within the host that directly disturb tissue 
homeostasis (Amano, 2003). Similar to periodontal disease, the microbial flora 
comprises a multitude of microorganisms and a single causative pathogen for 
peri-implantitis cannot be identified (Socransky et al., 1998 & Haffajee et al., 
2008). Early microbial colonisation studies of the ‘pristine’ peri-implant pocket 
identified that similar proportions of coccoid cells, motile rods and spirochetes 
become established within one to three weeks of implant insertion (Ponteriero et 
al., 1994 & Quirynen et al., 2006). The biofilm composition on the implant 
surfaces subsequently increases in complexity with time and is modified in the 
presence of peri-implant disease. Studies on Ti dental implants, after 6 years of 
service life associated with probing depths greater than 6 mm found higher 
percentages of both anaerobic gram positive and negative bacteria (George et al., 
1995 & Renvert et al., 2007). Some of the pathogens dominating inflamed Ti 
implant sites identified using DNA probe analysis include gram positive 
Staphylococci species (Bundy et al., 1980 & Rams & Feik, 1990) and 
Actinobacillus actinomycetemcomitans (Leonhardt et al., 1993); and/or gram 
negative bacteria as Fusobacterium nucleatum (FN) (Mombelli et al., 1995), 
Porphyromonas gingivalis and Bacterioides forsythus (Becker et al., 1990). 
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1.4.2 The host response role in the progression of peri-implant disease and 
the impact of Ti implant derivatives 
 
In common with periodontal disease, the host response is also implicated in 
determining an individual’s susceptibility to the progression of peri-implant 
disease. The host-response can significantly influence the nature or magnitude of 
tissue destruction and inflammation. To date, studies have focused on the 
response(s) to periodontal pathogens, however, factors intrinsic to the implant 
environment including the potential release of Ti ions or particles which may act 
to stimulate or modulate the host response contributing in progression of the peri-
implant disease are less well understood (Cobelli et al., 2011).  
 
A limited number of studies have documented the potential cellular and molecular 
consequences of Ti ions and particles. Investigations have studied cell viability, 
differentiation and proliferation on variety of cell types with a variety of stimuli 
(Table 1.1). Ti particles have been reported to cause increased production of pro-
inflammatory and pro-osteoclastogenic cytokines including interleukins such as 
IL-1α/β, IL-6, IL-8, IL-12; interferons such as IFN-α/γ, tumour necrosis factor-
alpha (TNF-α); receptor activator of nuclear factor kappa-B ligand (RANKL) 
(Tuan et al., 2008) and many more which have been addressed to mediate 
enhanced bone resorption, contributing to peri-implant disease progression 
(Iavicoli et al., 2011). However, the mechanisms by which Ti particulate debris 
mediate such biological responses remain incompletely addressed (Iavicoli et al., 
2011).  
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Table 1.1 Documented toxicological effects of Ti particles (Listed in 
alphabetical chronological order) 
 
Ti Species Cell Type Reference 
TiO2 (anatase) Human bronchial cells 
(BEAS-2B) 
Bhattacharya et al., 2009 
Ti(iv) ions Human osteoclasts and 
osteoblasts 
Cadosch et al., 2009 
TiO2 (unspecified) Human dendritic cells Chan et al., 2009 
Ti(iv) ions Wistar rats osteoblasts Choi et al., 2005 
TiO2 (anatase) Rat osteosarcoma Di Virgilio et al., 2010 
TiO2 (anatase) Chinese hamster ovary Dodd & Jha, 2009 
TiO2 (anatase & rutile) Human bronchial cells 
(BEAS-2B) 
Falck et al., 2009 
TiO2 (anatase) Human neutrophils Goncalves et al., 2010 
TiO2 (anatase) Human bronchial cells 
(BEAS-2B) 
Gurr et al., 2005 
TiO2 (anatase) Murine alveolar 
macrophages 
Hamilton et al., 2009 
TiO2 (unspecified) Rat macrophages Hirayama et al., 2011 
TiO2 (anatase & rutile) Human bronchial 
epithelial cells 
Hussain et al., 2009 
TiO2 (anatase & rutile) Mouse fibroblasts Jin et al., 2008 
TiO2 (unspecified) Fish neutrophils Jovanovic et al., 2011 
TiO2 (unspecified) Human lymphocytes Kang et al., 2009 
TiO2 (anatase & rutile) Human neutrophils Kumazawa et al., 2002 
TiO2 (anatase & rutile) Human fibroblasts Lai et al., 2008 
TiO2 (anatase & rutile) Human mesagial L’Azou et al., 2008 
TiO2 (unspecified) Human osteoblast-like 
cells (SaOS2) 
Li et al., 2010 
TiO2 (anatase & rutile) Mouse neuronal cells Liu et al., 2010 
Metallic Ti Rat brain microglia Long et al., 2007 
TiO2 (unspecified) Human mesenchymal 
stem cells (hMSCs)  
Okafor et al., 2006 
TiO2 (anatase & rutile) Male Wistar rats Olmedo et al., 2008 
TiO2 (rutile) Rat whole blood Onuma et al., 2009 
TiO2 (rutile) Human bronchial cells 
(BEAS-2B) 
Park et al., 2008 
TiO2 (unspecified) Human aortic endothelial 
cells (HAECs) 
Peng et al., 2010 
TiO2 (unspecified) Human muscle cells Peters et al., 2004 
Metallic Ti Rat osteoblasts Pioletti et al., 1999 
TiO2 (unspecified) Hamster embryo cells  Rahman et al., 2002 
TiO2 (unspecified) Mouse fibroblasts Renwick et al., 2001 
TiO2 (anatase & rutile) Human fibroblasts Rothen-Rutishauser et 
al., 2008 
TiO2 (anatase) Human monocytes, Sayes et al., 2006 
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macrophages and 
dendritic cells 
TiO2 (anatase) Human dendritic cells  Schanen et al., 2009 
TiO2 (anatase) Human macrophages 
(THB-1) 
Soto et al., 2007 
TiO2 (anatase & rutile) Human epithelial cells Stearns et al., 2001 
TiO2 (unspecified) Hamster ovary cells Uchino et al., 2002 
TiO2 (unspecified) Human mesenchymal 
stem cells (hMSCs) and 
lymph cells 
Wang et al., 2007 & 
2009 
 
The current understanding is that Ti particles can alter cell function and phenotype 
with effects regulated by particle size (Choi et al., 2005 & Cobelli et al., 2011). In 
particular, nanoparticles with dimensions <100 nm, have been shown to interact 
differently with various proteins and subsequently with cells when compared with 
larger sized particles (Liu and Webster, 2006). Further studies have demonstrated 
that nanoparticles bind to serum proteins which enables the transport of Ti debris 
into surrounding tissues and to organs far from the implant site (Rubio et al., 
2008). In-vivo studies measuring Ti debris accumulation in sites distant from the 
implant including the kidneys, livers, lungs, spleens and lymph nodes (Rubio et 
al., 2008) revealed Ti localised within these organs and the concentrations 
significantly increased with implantation time. Using energy filtered transmission 
electron microscopy (EFTEM) and mass spectrometry (MS), it has been 
demonstrated that Ti possesses a strong affinity for phosphorous containing 
molecules (Chan et al., 2009). This could have particular relevance to 
euchromatin in the nucleus, ribosomes in the cytoplasm, and phospholipids in the 
cell membrane (Carvalho et al., 2007). It has been suggested that the attachment 
of Ti to phosphorylated intercellular proteins and phospholipids (corresponding to 
the active functional states of enzymes or signalling proteins) could alter cellular 
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and metabolic functions of the cell such as migration and protein secretion 
(Carvalho et al., 2007 & Chan et al., 2009). 
 
1.5 Role of neutrophils in inflammation 
 
Amongst the innate immune cells; neutrophils have been significantly associated 
with the progression of periodontitis (Kantarci et al., 2003) and are found in high 
numbers in mucosa and skin penetrating implant sites (Holgers, 2000). When 
compared with chronic periodontitis, neutrophils are proportionally found in 
increased numbers in peri-implant disease sites (Klinge et al., 2005 & Teronen et 
al., 1997). Initially neutrophils are attracted to the inflamed site following a 
chemotactic gradient from the blood with the aim of infiltrating the tissue and 
phagocytosing the pathogen or foreign material, to prevent its spread (Witko-
Sarsat et al., 2000). The process involves margination, tethering and rolling, 
adhesion and finally transmigration (Witko-Sarsat et al., 2000). Bacterial products 
such as lipopolysaccharides (LPS) (Edwards, 1994); formyl peptides (Amulic et 
al., 2012); and endogenous signals such as pro-inflammatory cytokines released 
by other immune cells are known chemoattractants (Tuan et al., 2008 & Kumar & 
Sharma, 2010).  
 
Neutrophils constitute ~40-60% of the white blood cell (WBC) population and are 
considered as the first line of defence in the inflammatory response providing a 
relatively non-specific response (Segal, 2005). These cells are also known as 
polymorphonuclear leukocytes (PMNL) due to their multi-lobed (3-5 lobes) 
nuclei (Metchnikoff, 1905) and their cytosol is densely populated with four 
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different types of granules containing cytotoxic contents such as hydrolytic 
enzymes, defensins, proteolytic enzymes and antimicrobial proteins (AMP’s) 
(Hampton et al., 1998) which are released upon microbial challenge to kill the 
internalised microorganism (Borregaard & Cowland, 1997) and/or in the process 
of eliminating foreign stimuli such as cellular debris (Cicchetti et al., 2002).  
 
1.5.1 Neutrophil activation 
 
An abundance of neutrophils (5 x 10
10
 cells/day) circulate in the blood of normal 
healthy individuals and the cells are short lived (~12 hr in circulation), and are not 
present in normal healthy tissue sites (Edwards, 1994). During an inflammatory 
response, neutrophils leave the blood volume and infiltrate the site of tissue injury 
or infection (Stevens et al., 2002). Following migration to the site, the activated 
cells execute a variety of specialised tasks including phagocytosis, degranulation 
and secretion of variety of pro-inflammatory cytokines (Metchinikoff, 1893 & 
Wright et al., 2010). Neutrophils have significant antimicrobial activity through 
the secretion of reactive oxygen species (ROS) (Larsson et al., 2003) and/or 
through degranulation releasing antimicrobial agents such as neutrophil elastase 
(NE) into the extracellular space (Parsonage et al., 2008). A variety of cell surface 
receptors including pattern recognition receptors (PRRs) including toll like 
receptors (TLRs) and Fc-γ receptors (Fc-γR) for the Fc region antibodies, and 
receptors for C3b, an opsonising molecule of the complement system have been 
identified as routes by which neutrophils can target and internalise a pathogen 
within a vacuole called the phagosome (Figure 1.3) (Garcia-Garcia, 2005). Once 
formed, the phagosomes can fuse with endosomes and lysosomes which contain 
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active lipases and proteases to produce phagolysosome (Figure 1.3) (Tapper, 
1996). 
 
Figure 1.3 Schematic representations of neutrophil phagosome and 
phagolysosome formation (Tapper, 1996) 
  
  
 
 
 
 
 
 
 
 
 
 
 
1.5.2 Neutrophil killing mechanism 
 
Following engulfment of the foreign material, the neutrophil generates 
antimicrobial agents to combat its spread (Hampton et al., 1998). The 
antimicrobial activity is via two routes involving either oxidative or non-oxidative 
mediated killing mechanisms (Hampton et al., 1998). The release of proteases and 
AMPs within neutrophil granules is known as the non-oxidative killing 
mechanism (Hampton et al., 1998). The process occurs by fusing of the granule 
with the phagosome leading to exposure of the engulfed body to antimicrobial 
peptides and enzymes (Hampton et al., 1998). In addition, an oxidative killing 
mechanism known as oxidative burst (Griffiths & Lunec, 1988) involves the 
generation of ROS (Larsson et al., 2003). Such species are chemically reactive 
18 
 
molecules and free radicals such as singlet oxygen, superoxides, peroxides, 
hydroxyl radical (
.
OH) and hypochlorous acid (HOCl) are generated as by-
products from cellular metabolism of oxygen (Nathan, 2006). ROS are capable of 
oxidizing various types of molecules including nucleic acids (Park et al., 1992), 
lipids (Battino et al., 1999) and proteins (Roberfroid & Calderon, 1995) and if 
released into the extracellular space, can damage components of the connective 
tissue leading to destruction of tissues such as alveolar bone and the periodontium 
(Moseley et al., 1997). The release of ROS can also cause activation of other cells 
such as osteoclasts and evidence has shown that ROS are capable of both 
increasing osteoclast numbers and osteoclasts activity (Garrett et al., 1990 & 
Pioletti et al., 1999).  
 
1.5.3 Extracellular killing mechanism 
 
Neutrophils are also capable of mediating extracellular killing mechanism by 
actively protruding fragile fibril complexes called Neutrophil Extracellular Traps 
(NETs) into the extracellular matrix (Brinkmann et al., 2004). NETs are web-like 
strands of decondensed chromatin packaged with antimicrobial components such 
as NE and myeloperoxidase (MPO) (Brinkmann & Zychlinsky, 2007) secreted to 
trap and kill micro-organisms extracellulary (Remijsen et al., 2010 & Menegazzi 
et al., 2012). Recent studies over the past years have implicated NETs to play an 
important role in immune defence (Beiter et al., 2006 & Buchananan et al., 2006). 
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1.6 Neutrophil responses to Ti particles  
 
Surprisingly, despite the significant presence of neutrophils at peri-implant 
disease sites, there have been limited studies to evaluate the potential effects of Ti 
particles exposure on neutrophil responses (Table 1.1) (Kumazawa et al., 2002, 
Goncalves et al., 2010, & Jovanovic et al., 2011). However, the evidence that has 
been reported strongly suggests that should these species be present in the peri-
implant tissues, they can significantly affect neutrophil function. In-vitro studies 
have demonstrated that TiO2 of up to 3 µm diameter can be phagocytised by 
mammalian neutrophils (Kumazawa et al., 2002) and stimulate respiratory burst 
release (Jovanovic et al., 2011). Neutrophils exposed to nano TiO2 (0-100 µg/mL) 
have been reported to induce phosphorylation of p38 Mitogen Activated Protein 
Kinase (MAPK) and Extracellular signal Regulated Kinases-½ (ERK-1/2) 
(Goncalves et al., 2010). In addition, TiO2 exposure (≥20 µg/mL) has been shown 
to significantly inhibit neutrophil apoptosis in a concentration dependent manner 
and stimulate IL-8 cytokine release (Goncalves et al., 2010). Moreover, NET 
release which is associated with the neutrophil respiratory burst process has been 
demonstrated in TiO2 stimulated fish neutrophils (Jovanovic et al., 2011).  
 
1.7 Summary and aims 
 
Clinical concern remains regarding the performance of biomedical Ti implants 
largely due to the development of chronic inflammation in the peri-implant tissues 
necessitating removal or revision of the device (Hallab & Jacobs, 2009). The 
perceived biocompatibility of Ti is conferred by a resilient surface oxide film 
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(Kasemo, 1983). However, the composition, structure and morphology of the 
layer have been shown to be sensitive to the alloy type and the environment into 
which it is placed (Williams, 1994). The failure of indwelling Ti devices is often 
aseptic (Caicedo et al., 2010) and associated with the generation of micron and 
nano sized implant debris released into the peri-implant tissues (Choi et al., 2005 
& Hallab & Jacobs, 2009). In common with orthopaedic devices, chronic 
inflammation in peri-implant tissues surrounding skin and/or mucosal penetrating 
Ti implants is of significant concern. To date all research into chronic 
inflammation associated with these devices has implicated implant surface 
microflora (section 1.4.1) and the host response (section 1.4.2) in the pathogenesis 
of peri-implant disease. Although, it is strongly hypothesized, but it is not known 
whether Ti implant derivatives are formed or whether they can contribute to 
pathophysiology of the inflammation present surrounding skin or mucosal 
penetrating Ti implants. However, Ti products identified or hypothesised to be 
released into these environments have been previously shown to be pro-
inflammatory and have been studied in-vitro (Table 1.1). Very few studies have 
focused on cell types which are identified to be of primary importance in the 
progression of the inflammation surrounding Ti skin or mucosal penetrating 
implants, such as human neutrophils. The current evidence suggests that should 
such Ti implant derivatives be present, they are likely to have an impact on 
neutrophil phagocytosis, ROS and NET generation mechanisms. 
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The overall objectives of this thesis are to: 
 
 Identify whether Ti is found in soft tissues surrounding percutaneous/trans-
mucosal implants.  
 
 Identify whether Ti species found in tissues can be accounted for release by 
mechanically assisted crevice corrosion (MACC) mechanism. 
 
 Study the responses of human neutrophils to representative Ti stimuli identified 
from the peri-implant tissues in terms of ROS production, NET formation and 
chemotaxis. 
 
 Study how Ti implant derivatives may disrupt or modify responses of 
neutrophils to known peri-implant pathogens. 
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CHAPTER 2 
 
MATERIALS AND METHODS  
 
 
2.1 Raw materials 
 
3 mm wide strips of 5 µm (TI2279) and 50 µm thick (TI2276) commercially pure 
titanium (CpTi) foils [Carbon (C) 200 ppm, Nitrogen (N) 120 ppm, Iron 
(Fe) 1500 ppm and Oxygen (O) 1500 ppm] were purchased from Advent 
Materials, Oxford, UK. Titanium chloride (TiCl3) solution (14010) was purchased 
from Sigma-Aldrich, UK. Ultra-pure silica plates (Spectrosil 2000) were ordered 
from HeraeusQuarzglas GmbH & Co., Hanau, Germany. Polyimide films 
(PC500FILM-0500) were purchased from Kapton, Dupont, Wilmington, NC, 
USA. Vacutainer (GRI454247) and lithium heparin coated tubes (171 U/mL) 
(GRI454008) were purchased from Greiner, Bio-one Ltd, Stonehouse, UK. 
Needles (SN2170) and syringes (BS-120527) were purchased from Terumo 
Europe, Leuven, Belgium. Percoll 1.13 g/mL (17-0891-01) was purchased from 
GE Healthcare, Buckinghamshire, UK. Distilled sterile water (10977-023) was 
purchased from Versol, Somerset, UK. Sodium chloride (NaCl) (S9625) was from 
Sigma-Aldrich, UK. Trypan blue (T8154) was purchased from Sigma-Aldrich, 
UK. Bovine Serum Albumin (BSA) (A4530) was purchased from Sigma-Aldrich, 
UK. 96-well white plates (15041) were purchased from Immunolon2, Chantilly, 
USA. 30% hydrogen peroxide (H2O2) (H1009) was purchased from Sigma-
Aldrich, UK. Mannitol Salt Agar (MSA) (CM0085), Tryptone Soya Agar 
(CM0131) and Tryptone Soya Broth (CM0129) were purchased from 
ThermoFisher Scientific, Oxford, UK. Petri dishes (101VR20) were from Sterilin, 
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Newport, UK. Formaldehyde (P6148) was from Sigma-Aldrich, UK. Vigam 
liquid (5 mg/mL IgG) (2620102) was purchased from Bio Products Laboratory, 
Hertfordshire, UK. Fusobacterium Nucleatum (FN) (ATCC 10953) in freeze dried 
format was supplied by LGC Standards, Germany. Crystal violet (C0775) was 
purchased from Sigma-Aldrich, UK. RPMI-1640 (R2405) was obtained from 
Sigma-Aldrich, UK. SYTOX
®
 Green nucleic acid stain (S7020) was purchased 
from Invitrogen, Paisley, UK. 96-well black plates (3340) were ordered from 
Corning, Lowell, MA, USA. Micrococcal nuclease (MNase) (LS004797) was 
from Worthington Biochemical Corporation, Lakewood, NJ, USA. Ti discs Grade 
II, IV and V (Ø 14 mm٭1 mm) (143238-954) were purchased from Titanium 
Products Ltd, England. Silicon carbide (SiC) abrasive paper (40800005) from 
P320 through P500, P800, P1200, P2400 to P4000 grit were purchased from 
Struers, UK. Transparent 24-well sterile plates (CLS3527) were purchased from 
Corning Costar, Dorset, UK. RPMI-1640 with ultraglutamine-1, Foetal Calf 
Serum (FCS) and penicillin (1000 U/mL)/streptomycin (10,000 μg/mL) (BE12-
702F/U1) were obtained from Lonza Wokingham Ltd, Berkshire, UK. Interferon-
alpha (IFN-α) (500 pg/mL) (I4784) was purchased from Sigma-Aldrich, UK. 
Transparent 6 (CC010) and 12 (BC311) well cell culture plastic plates were 
purchased from Appleton Woods (Birmingham, UK). All the other reagents were 
obtained from Sigma-Aldrich Chemical Company, Poole, UK and solvents from 
Fisher, Loughborough, UK unless otherwise stated. Furthermore, range of Ti 
powders utilised within the study (Table 2.1) were purchased from Sigma-Aldrich 
or Alfa-Aesar, UK. 
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2.2 Ti stimuli preparation and storage 
 
The dispersions of Ti stimuli (Table 2.1) were prepared in either phosphate 
buffered saline (PBS) (Appendix I) or in RPMI-1640 and stored at 4 °C until 
used. 0.1 g of each respective Ti powder was weighed out and dispersed in 10 mL 
of PBS or RPMI-1640 resulting in 2000 ppm Ti dispersion. A set of serial 
dilutions was performed by transferring 1 mL of the higher Ti concentration 
dispersion to 9 mL of PBS or RPMI-1640 resulting in 200, 20 and 2 ppm Ti 
dispersions respectively. Prepared dispersions were then autoclaved and prior to 
being used were sonicated using an electric sonicator (Clifton MU-22, Progen 
Scientific, London, UK) at 25 °C for 15 mins.  
 
Table 2.1 Ti stimuli used in this study 
 
Ti stimuli Application Particle 
size 
Supplier 
(Product Code) 
Anatase Chemiluminescence, MNase 
and ELISA assays 
~30 nm Alfa-Aesar 
(039953) 
Rutile Chemiluminescence, MNase, 
TEM, chemotaxis and ELISA 
assays 
~50 nm Sigma-Aldrich 
(1317802) 
 
Mix oxide 
(anatase-rutile) 
Chemiluminescence, MNase 
and ELISA assays 
~66 nm Sigma-Aldrich 
(13463677) 
Anatase mesh TEM and EDX analysis <45 nm Sigma-Aldrich 
(248576) 
Peroxy Chemiluminescence assays Unknown Produced in 
house (section 
2.2.1) 
Metallic Chemiluminescence, MNase, 
chemotaxis and ELISA assays  
~5 µm Prepared in house 
(section 2.2.2)  
 
Metallic Chemiluminescence, MNase 
and ELISA assays 
~20 µm Alfa-Aesar 
(744032) 
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2.2.1 Ti peroxy (Ti stimuli produced in house) 
 
Ti peroxy compounds are yellow powders prepared by exposing the surfaces of 
mirror-like Grade IV Ti discs to physiological saline (0.9% NaCl solution) and 
10% H2O2 (H1009; Sigma-Aldrich, UK). Ti Grade IV identical disc specimens (Ø 
14 mm٭1 mm, Titanium Products Limited, England) were ground in distilled 
water using sequential grades of SiC abrasive paper from P320 through P500, 
P800, P1200, P2400 to P4000 grit (Struers, UK). All specimens were polished 
with MD-Chem polishing cloth using OP-S colloidal silica suspension (Struers, 
UK) prior to thorough cleaning in acetone, ethanol and distilled water using 
ultrasonic agitation for 10 mins at each stage. All the samples were then dried in 
an oil and water free air stream prior to treatment. The prepared mirror-like Ti 
discs specimens were immersed in 3 mL of physiological saline and exposed to 
10% H2O2 in a 30 mL universal tube which was covered with a cap and sealed 
with parafilm in order to prevent any evaporation. These were then incubated at 
37 °C and shaken every day on A500 orbital mixer (Denley, England) for 1 hr 
daily. In addition, the physiological saline was replenished every week and the 
colour of the surface of the samples after immersion was visually examined and 
recorded with optical camera. After 4 weeks of immersion, the Ti precipitate 
yellow in colour is formed on the surface of the Ti discs which is easily separated 
and then dispersions in PBS similarly to other Ti stimuli were prepared (section 
2.2) for ex-vivo chemiluminescence assays (section 5.4.3).  
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2.2.2 Preparation of ~5 µm metallic Ti dispersions (Ti stimuli prepared in 
house) 
 
Metallic Ti dispersions of concentrations 2000, 200, 20 and 2 ppm in PBS or 
RPMI-1640 were prepared using ~20 µm particles (section 2.2). Particles ranging 
between 2.5 µm and 5 µm were separated using 5 and 2.5 µm pore size filters 
(Appleton Woods, UK) and the collected particles were then dispersed in PBS or 
RPMI-1640 (section 2.2). The prepared dispersions were then autoclaved and 
prior to being used were sonicated using an electric sonicator (Clifton MU-22, 
Progen Scietific, London, UK) at 25 °C for 15 mins.  
 
The purity of sourced Ti oxide powders was verified using Raman spectroscopy 
(Appendix III) and the particulate sizes and morphology following dispersions 
were studied in section 5.4.1. 
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CHAPTER 3  
 
DETECTION OF TITANIUM IN TISSUES ASSOCIATED 
WITH IMPLANTS NOT SUBJECTED TO SIGNIFICANT 
WEAR 
 
 
3.1 PREFACE 
 
Significant limitations exist in current methods used to detect implant derived 
metals in peri-implant tissues and therefore the stability of implant surfaces in 
physiological environments may be being over-estimated. Using a beyond-state-
of-the-art technique –namely micro-focus synchrotron X-ray spectroscopy, the 
distribution and chemical speciation of Ti in peri-implant tissues was studied. The 
Ti implant component of Bone Anchored Hearing Aids (BAHA) was used as a 
model system to explore whether commercially pure Ti implant surfaces could 
deteriorate releasing Ti into the surrounding tissues in the absence of wear. 
Measurements of explanted inflamed tissues taken from around BAHA implants 
demonstrated a heterogeneous distribution of Ti debris in oxide states such as 
anatase and rutile and in Ti-metallic and intermediary forms. The abundance of 
oxide species suggests that corrosion processes are operative. Basic haematoxylin 
and eosin (H & E) histology of the studied tissues confirmed the distribution of Ti 
to be non-exclusively associated with PMNL infiltrates suggesting that 
interactions of such cells with the Ti debris may be of interest when considering 
the biological consequences of ‘free Ti’ in these tissues. 
 
Published in: Addison et al. (2012). Do 'passive' medical titanium surfaces 
deteriorate in service in the absence of wear? R. Soc. Interface, 9, 3161-3164. 
Included in: Highlights of the Diamond Light Source 2012/2013.
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3.2 INTRODUCTION 
 
3.2.1 Stability of passive Ti-oxide surfaces 
  
Accumulation of Ti in the soft tissues that surround indwelling implants subjected 
to obvious wear processes (e.g. articulating joints used in orthopaedic 
rehabilitations) is well documented (Ektessabi et al., 1994, Doorn et al., 1998, 
Coen et al., 2003, Kasai et al., 2003, Sargeant & Goswami, 2007 & Jacobs et al., 
2011). However, to date there is little evidence that demonstrates the presence of 
implant derived Ti in the tissues or in fluids surrounding skin or mucosa 
penetrating devices such as dental implants or craniofacial anchorage devices 
where wear processes are minimal (Ektessabi et al., 1994 & Uo et al., 2007). 
These implants are assumed to have Ti oxide surfaces which are highly stable in 
the environment into which they are placed, but studies have reported elevated 
serum and urine Ti levels in both animals (Bianco et al., 1996 & Sarmieno-
González et al., 2008) and humans (Bölükbaş et al., 2013) which have been 
implanted with such devices. The question that arises is whether there is actually 
only minimal Ti release into the surrounding tissues or whether the current 
detection methods and experimental approaches lack the required sensitivity to 
determine the presence of Ti. 
 
3.2.2 Detection of peri-implant Ti 
 
A variety of imaging/detection methods are available to probe tissues for the 
presence of metal ions and/or particles (Punshon et al., 2005 & McRae et al., 
2009). The optimal approach for the identification of metal ions in tissues will 
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provide high sensitivity and specificity for the element of interest and will enable 
spatial correlation of the element with the underlying structures (Lobnski et al., 
2006 & Ortega et al., 2009). Histology is the first experimental approach to study 
the microscopic anatomy of cells and tissues (Willmott, 2011) and has previously 
been used to explore peri-implant tissues (Lalor et al., 1991 & Lang et al., 1994). 
Studies using simple staining methods such as haematoxylin and eosin (H & E) 
have reported metal particle associations (assumed to be Ti) with multi-nucleated 
cells including neutrophils, macrophages and also with T and B lymphocytes 
(Lalor et al., 1991). Light microscopy and basic histology provides some insight 
into the presence of implant debris but fails to provide the necessary chemical and 
spatial characterisation to elucidate both the mechanism of metal release and the 
biological consequences. Combining these histological techniques with scanning 
electron microscopy (SEM) (Maloney et al., 1993 & Ichinose et al., 2003) and 
transmission electron microscopy (TEM) (Wu et al., 2005) has provided insight 
into the morphology of particulate debris but has provided little information on 
the presence of Ti in ionic forms (Ferguson et al., 1960 & Koike & Fujii, 2001). 
Quantification of Ti concentrations in peri-implant tissues and in distant organs 
can be performed using Mass Spectrometry (MS) (Griffin & Schnitzer, 2011) and 
the technique takes into account both particulate and soluble Ti (Wang et al., 
2007). Most MS studies on tissues associated with Ti implants that have been 
reported have used Inductively Couple Plasma techniques (ICP-MS) which have 
confirmed the presence of elemental Ti in concentrations of up to 100 ppm (Rubio 
et al., 2008, Sarmieno-González et al., 2008 & Bölükbaşı et al., 2013). However, 
ICP-MS provides a measurement of elemental concentration averaged across the 
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tissue bulk and may significantly underestimate local concentrations of an element 
should it be heterogeneously distributed (Griffin & Schnitzer, 2011). Moreover, 
ICP-MS techniques are sensitive to polyatom effects whereby failure for atoms to 
dissociate in the plasma field can lead to over or underestimations (Bradford & 
Cook, 1997). This is a particular problem for Ti whose common isotope mass is 
47 (Barbalace, 2006) and therefore is difficult to differentiate from a common and 
biologically relevant polyatom, P-O whose combined mass (P (31) and O (16)) is 
equivalent (Barbalace, 2006). Therefore, both MS and EM techniques have 
limitations in detection ability and cannot relate a characterised Ti distribution to 
the cellular and subcellular structures with a wide field of view (Griffin & 
Schnitzer, 2011). Furthermore, the specimen preparation requirements for these 
techniques is either destructive or can modify the location of Ti in the tissues 
before or during the test (Hanlon et al., 1992 & Doorn et al., 1998). 
 
3.2.3 X-ray microscopy 
 
X-ray microscopy offers a possible solution to achieve highly sensitive imaging 
for metallic elements on a micron and submicron scale within peri-implant tissues 
that are preserved close to their natural hydrated state (Ektessabi, 1998, Carvalho 
et al., 2007 & McRae et al., 2009). X-ray microscopy is advantageous as it is 
highly specific for an element and works by probing a sample with ionising 
radiation (Newville, 2006). X-rays of energy greater than the atom’s ionising 
potential will cause ejection of one or more electrons from a quantum core level 
through a phenomenon known as the photoelectric effect (Figure 3.1) (Newville, 
2006). The removal of an electron destabilises the atom and consequently an 
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electron from a higher orbit drops into the lower orbit. As the electron drops, 
energy is released in the form of a photon which has a characteristic energy and 
this photon and its specific energy can subsequently be detected (Newville, 2006). 
 
Figure 3.1 Photoelectric effect of an X-ray absorbed and a core level electron 
is prompted out of an atom (Newville, 2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The primary limitation of X-ray microscopy using laboratory sources is a lack of 
lateral resolution (inability to focus the X-ray beam) and a low X-ray flux, so that 
detailed mapping of a sample where elemental concentrations are dilute is often 
not possible (Willmott, 2011). However, these limitations can be surmounted with 
the use of synchrotron X-ray sources. 
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3.2.4 Synchrotron sources 
 
Synchrotron facilities produce X-rays up to ten thousand billion times brighter 
than the X-rays produced by a conventional hospital source (McRae et al., 2009). 
Such X-rays allow sensitive detection of trace levels of elements in samples in a 
natural hydrated state and through considerable advances in optics can provide 
spatial resolutions of <50 nm (Petibois & Guidi, 2008 & McRae et al., 2009).  
 
3.2.4.1 Generation of synchrotron radiation (SR) 
 
A synchrotron consists of an evacuated storage ring into which high energy 
electrons are injected (Willmott, 2011). The electrons are then accelerated to just 
below the speed of light (Figure 3.2) (Willmott, 2011). The electrons travel in 
straight lines and so in order that they can follow the curvature of the storage ring, 
an array of bending magnets is used to modify their trajectory. As the electron 
passes through the magnetic field their velocity is changed which results in the 
emission of photons which range in wavelength from X-rays to microwaves. It is 
these photons which are considered the Synchrotron Light and which are then 
guided through sophisticated optics to an experimental end-station to probe a 
sample. Although the brilliance of the light emitted from bending magnets far 
exceeds that of laboratory X-ray sources (McRae et al., 2009), further orders of 
magnitude of increase in brilliance can be achieved by the use of insertion devices 
(ID) (Willmott, 2011) and it is these levels of brightness that are often required to 
detect ultra-trace concentrations of an element. IDs are positioned between 
bending magnets on straight sections of the storage ring and employ sets of 
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permanent magnets to produce magnetic fields that point alternatively in 
perpendicular directions to each other (Willmott, 2011). IDs are found in two 
forms and can be distinguished by the degree to which the direction of the 
electrons is moved away from a straight path (Willmott, 2011). Wigglers cause 
large angular excursions from which the emitted radiation cones of each ‘wiggle’ 
do not overlap and the intensities are added. The radiation is enhanced by a factor 
of 2N where N is the number of magnetic periods in the ID and the radiation 
produced is both of a high power and a broad spectrum (Willmott, 2011). In 
contrast, Undulators cause gentler electron excursions creating spectra consisting 
of regularly separated narrow bands of highly intense radiation (Willmott, 2011). 
 
Figure 3.2 Schematic representation of a synchrotron source (Willmott, 2011) 
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3.2.4.2 Use of synchrotron radiation for imaging biological samples 
 
In the past two decades there has been increased use of SR for the microanalysis 
and mapping of elemental distributions in biological samples (Chen et al., 1999, 
Ektessabi, 1998, Bacquart et al., 2007, Carvalho et al., 2007, Petibois & Guid, 
2008, Ortega et al., 2010 & Hart et al., 2012). Related to the objectives of this 
thesis a multi-disciplinary team recently used SR to study tissues surrounding 
failing Co-Cr-Mo implants used for total hip replacements (Hart et al., 2012). SR 
techniques enabled identification of particle sizes, chemical compositions and 
localisation of implant elements with inflammatory cells (Hart et al., 2012). 
Studies utilising SR to study Ti associated with implants have been limited to 
measurements on bulk tissues with a relatively low resolution (Uo et al., 2007). Ti 
however, is a particularly interesting element to study using X-ray methods as it 
has well characterised X-ray absorption behaviours enabling simple separation of 
different Ti-O co-ordinations (Mountjoy et al., 1999) and hence identification of 
the chemical speciation of Ti within the sample. 
 
3.2.5 I-18 beamline, the Diamond Light source 
 
The Diamond Light source is the United Kingdom’s (UK) 3rd generation, 3 GeV 
synchrotron facility and the I-18 beamline which takes light from an ID has been 
developed as a world-leading micro-focus spectroscopy instrument with an 
accessible X-ray energy range from 2.0 to 20.7 KeV. The I-18 beamline is able to 
analyse heterogeneous materials and is capable of exciting the K-edges of 
elements from P to Mo and the L3-edges from Sr to Pu. To date the instrument has 
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been applied in multiple fields of science including cultural heritage, geology and 
biomedicine (Mosselmans et al., 2009). The I-18 optics takes advantage of the 
high brightness of the Diamond lattice combined with a 27 mm period undulator 
providing an energy tunable X-ray microbeam to perform micro-X-ray 
fluorescence (XRF) (section 3.2.6) and micro-X-ray absorption spectroscopy 
(XAS) (section 3.2.7) measurements with an average spot size of around 3 µm at 
the sample (Mosselmans et al., 2009). As part of the beamline commissioning and 
exploration of its capabilities, Ti debris was identified in thin sections (6 µm) of 
oral epithelium taken from adjacent to Ti dental implants which had been in-situ 
for 3 months (Mosselmans et al., 2009). 
 
3.2.6 X-ray Fluorescence (XRF) for mapping elements within biological 
samples 
 
XRF is a highly sensitive technique for multi-elemental and quantitative imaging 
(Punson et al., 2005, Lobinski et al., 2006 & Ortega et al., 2009). XRF is achieved 
by focussing an X-ray beam onto the sample whereby the incident X-ray photon 
knocks out electrons from the inner shells of all elements with lower ionising 
energies than the energy of the incident X-rays (Punson et al., 2005 & Ortega et 
al., 2009). In doing so an electron hole is created which is immediately filled by a 
higher orbit electron which drops into the lower shell and simultaneously emits a 
fluorescence photon which is then detected for imaging using a detector (Punson 
et al., 2005 & Ortega et al., 2009). The number of fluorescence photons can be 
quantified in order to provide a surrogate measure of concentration and can be 
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further calibrated against standards to provide absolute elemental concentrations 
(Punson et al., 2005, Lobinski et al., 2006 & McRae et al., 2009).  
 
3.2.7 X-ray Absorption Spectroscopy (XAS) 
 
Measurement of X-ray absorption spectra is referred to as X-ray absorption 
spectroscopy (XAS) and can provide information on the organisation of atoms 
and chemical bonds surrounding the absorbing atom in all of the possible 
environmental states that it may be in i.e. a solid, liquid, and/or gas (Ortega et al., 
2009 & Willmott, 2011). XAS relies on repeatedly scanning the sample with a 
monochromatic beam with the energies increasing from just below to just above 
the absorption energy for the element under investigation (Ortega et al., 2009). 
XAS can be performed in a fluorescence mode or by transmission through the 
sample (Kruger et al., 1990) and the technique is typically divided into two parts, 
namely X-ray absorption near edge structure (XANES) and extended X-ray 
absorption fine structure (EXAFS) (Figure 3.3) (Kruger et al., 1990, Punson et al., 
2005, Petibois & Guidi, 2008 & Willmott, 2011). The principle of EXAFS which 
provides information regarding the metal atom site ligation (Willmott, 2011) is 
not discussed in detail as the technique is not employed within this investigation. 
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Figure 3.3 Schematic representations of XANES and EXAFS regions 
(Willmott, 2011)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.8 XANES 
 
XANES is a highly sensitive detection method for the oxidation state, 
coordination environment and bonding characteristics of a specific element 
(Ektessabi, 1998 & Baccquart et al., 2007). In combination with a micro-focussed 
beam it can be used to probe subcellular compartments thereby avoiding cell 
fractionation and other preparation steps that might modify the chemical species 
(Ektessabi et al., 2005 & Baccquart et al., 2007). A XANES spectrum is typically 
divided into three regions, namely the pre-edge, edge and above the edge region 
(Figure 3.4) (Ravel & Newville, 2005 & Weng et al., 2005). The pre-edge area is 
sensitive to the local structure surrounding the element of interest and its 
oxidation state and the edge energy position is a specific characteristic of the 
absorbing atom, again dependent on its oxidation state (Baccquart et al., 2007).  
 
 
 
38 
 
Figure 3.4 Schematic representations of XANES regions of a metallic Ti 
spectrum 
 
XANES = Pre-edge + Edge + Above the Edge 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.8.1 XANES studies on Ti 
 
Previous XANES studies for Ti (K-edge) have focused on the pre-edge area of the 
spectrum as the pre-edge heights/intensities and positions vary considerably 
between common Ti species (Farges et al., 1996 & Mountjoy et al., 1999). Three 
different coordination states of Ti have been characterised including tetrahedral 
(four-fold), square-pyramid (five-fold) and octahedral (six-fold) (Figure 3.5) 
(Farges et al., 1996 & Mountjoy et al., 1999). The height/intensity of the pre-edge 
peak decreases sequentially from a tetrahedral coordination to square pyramid to 
octahedral fold due to the increasing centrosymmetry (Figure 3.5) (Farges et al., 
1996 & Mountjoy et al., 1999). Furthermore, the pre-edge features are modified 
by Ti-O bond length, coordination and bond angles (Farges et al., 1996 & 
Mountjoy et al., 1999). All these features are considered as fingerprints for 
qualitatively identifying Ti coordination states in unknown samples. 
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Anatase and rutile which are reported as the main polymorphs of the passive 
oxide layer formed on Ti implants (Effah et al., 1995) belong to tetrahedral 
coordination (Iavicoli et al., 2011) but have differing arrangement of the Ti atoms 
(Figure 1.1) (Jolivet et al., 2010) which consequently results in differing pre-edge 
peak heights/intensities (Mountjoy et al., 1999 & Farges et al., 1996) (Figure 3.5).  
 
Figure 3.5 Ti K-edge XANES spectra of (a) tetrahedral (b) square pyramid 
and (c) octahedral coordination states (Farges et al., 1996) 
 
 
 
 
Previous studies investigating the structure of TiO2 nanoparticles by probing the 
Ti K-edge and studying XANES have revealed severe distortions in the Ti 
environments when compared to bulk particles (Chen et al., 1999). The distorted 
Ti sites have been associated with distortions in the TiO2 lattice located on the 
surface of the particles (Chen et al., 1999). As the particles decrease in size the 
surface atoms have proportionally greater influence on the spectra when compared 
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with the bulk (Chen et al., 1999). Therefore, the presence of distorted Ti sites in 
spectra from an unknown sample can possibly provide additional information on 
particle size (Chen et al., 1999). 
 
The objective of the current investigation was to apply this beyond-state-of-the-art 
instrumentation to identify whether there is a detectable Ti distribution in the soft 
tissues which surround Ti implants that are not subjected to significant wear 
processes.  
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3.3 METHODS 
 
3.3.1 Model system selection 
 
Ti cranial anchorage implants were selected as a model system to study whether 
passive Ti surfaces can deteriorate in the absence of wear. Epithelial tissues from 
surrounding Ti implants used as part of Bone Anchored Hearing Aids (BAHA) 
were studied. The BAHA offers an ideal model system to test the experimental 
null hypothesis that there is no discernible Ti distribution in tissues surrounding 
implants not subjected to wear. The system is useful to study as all implants are 
placed in anatomically the same site; the implants are fabricated from Grade IV 
CpTi in common with most dental implants but in contrast with dental implants 
there is little geometrical variability with only the abutment component provided 
in different lengths. The implants are provided by a single manufacturer (Cochlear 
Ltd, Sydney, Australia). Furthermore, the abutments are pre-connected and 
torqued by the manufacturer prior to surgical insertion removing the risk of 
introduction of Ti from abutment insertion at a later stage. The Ti implants are 
percutaneous but surrounded by a relatively thick soft tissue cuff which prevents 
the surface(s) from being exposed to wear processes from foreign objects (as 
dental implants which may be brushed during oral hygiene measures). Finally, 
tissue from around these implants is readily available from surgical debulking 
procedures during palliative treatments of chronically inflamed implants.  
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3.3.2 Tissue excision and preparation 
 
Peri-implant inflamed skin tissue was obtained from six consented competent 
adults undergoing scheduled revision surgery associated with a BAHA at 
University Hospital Birmingham NHS Foundation Trust (Ethical approval REC 
08/H1203/128). The inflamed tissue was surgically retrieved from around the 
percutaneous Grade IV CpTi implants (BAHA, Cochlear Ltd, Sydney, Australia) 
using a full thickness circumferential excision. Skin was retrieved from around 
implants that remained firm and well osseointegrated but associated with a 
hypertrophic reaction surrounding the Ti implant that necessitated skin reduction 
surgery. The implants were present for between 2 and 6 years prior to revision 
surgery. During tissue excision, metallic contamination was prevented and tissue 
sections were immediately orientated and snap-frozen prior to cryo-preparation. 
Sequential frozen sections of 4-6 µm thickness were cut using tungsten carbide 
knives and were mounted on ultra-pure fused silica plates (<10 ppb Ti) (Spectrosil 
2000, Heraeus Quarzglas GmbH & Co., Hanau, Germany); desiccated, then 
covered with 25 µm kapton film (Kapton, Dupont, Wilmington, NC, USA) and 
sealed peripherally with epoxy resin. Alternating sections were fixed and H & E 
stained to provide a histological reference for each experimental section. In 
addition, supplementary tissue sections which had not been exposed to Ti were 
prepared in an identical manner as a control in order to determine if any 
contamination had occurred during sample preparation.      
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3.3.3 Ti reference standards preparation and calibration 
 
In addition to the explanted human tissue samples, spectra were also collected in 
transmission mode from Ti standards, including Ti foil (metallic) and several 
containing Ti4+ ions in different coordination environments: cristobalite (four-
fold), Na2TiSiO5 (five-fold); and anatase, rutile and CaTiSiO5 (all six-fold).  
 
3.3.4 XRF measurements 
 
Using the micro-focus capability of I-18 beamline (Diamond Light Source, UK) 
each experimental tissue section (section 3.3.2) was initially fluorescence mapped 
with an incident beam of 5.7 KeV at a 50 µm resolution to identify areas of 
interest. Fluorescence data were collected using a four element Si drift detector 
(Oxford Instruments, Oxford, UK). The beam was then focused to give a spot size 
5 µm (height) by 3.4 µm (width) and the sample was mounted at a 45° angle to 
the incident beam, thus resulting in a resolution of 5 µm by 5 µm. The 
measurements were undertaken in reflection mode at room temperature. The 
fluorescence intensity under the Kα and Kβ emission peaks were integrated to 
give the total number of counts. 
 
3.3.5 XANES measurements 
 
To determine Ti speciation from regions where Ti was detected, Ti K-edge 
XANES spectra were acquired for specimens (section 3.3.2) in fluorescence mode 
at room temperature. Measurements were taken using Si (111) crystal 
monochromator giving an energy range 4950 to 5050 eV with a 9 element Ge 
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detector. The beam size was maintained at 5 µm (H) x 5 µm (V) at the sample 
allowing accurate localisation on discrete particles/groups of small particles. 
Spectra acquired were compared with Ti standards of known coordination (section 
3.3.3). 
 
3.3.6 Data analysis 
 
XANES data analysis was carried out using ATHENA (version 0.8.061, 2001-
2009). All data was normalised by selecting two points which had the best fit in 
pre-edge and post-edge regions (Figure 3.6). Consistency in normalising the data 
was maintained throughout to avoid fluctuations in the acquired results. Reference 
standards (section 3.3.3) were compared with experimental measurements (section 
3.3.2) acquired using ATHENA to determine Ti speciation. 
 
Figure 3.6 Normalisation of XANES spectra using Athena (Version 0.8.061, 
2001-2009) (a) a typical raw data plot (b) selection of pre-edge and post-edge 
range for normalisation and (c) normalised data plot 
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3.4 RESULTS 
 
3.4.1 SR-XRF mapping of inflamed peri-implant (BAHA) tissues 
 
Synchrotron X-ray fluorescence mapping of thin (4-6 μm) sections of the 
inflamed skin tissue recovered from adjacent to percutaneous CpTi implants 
demonstrated a widespread scattered distribution of Ti in all tissue sections 
studied (6 patients and 1-3 sections from each patient) (Figure 3.7). The Ti 
distribution was heterogeneous in both the size of the particles (areas of 
fluorescence intensity) of Ti observed and in their chemical speciation. Areas of 
Ti concentration varied in size from 5 μm (highest resolution of detection) to 150 
μm.  
 
Figure 3.7 An X-ray fluorescence map (5300 × 2000 µm) of the associated 
distribution of Ti in peri-implant soft tissue (6 µm thickness) taken at greater 
than 25 µm from a CpTi BAHA. Legend refers to increasing Ti fluorescence 
values 
 
 
 
Orientation of the tissue prior to snap-freezing allowed the Ti distribution to be 
co-ordinated relative to the adjacent Ti implant surface which demonstrated that 
the Ti was scattered radially outwards from the tissue-implant interface to 
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distances > 2000 μm (Figure 3.7). Tissue sections immediately adjacent to those 
mapped for Ti fluorescence and stained with H & E and were observed with 
optical microscopy (Figure 3.8). No obvious relationship between the Ti maps and 
the underlying cell types and tissue architecture were observed. However, PMNLs 
were seen in a zone close to the implant surface where an abundance of Ti had 
been demonstrated (Figure 3.8).  
 
Figure 3.8 An optical micrograph of the H & E stained tissue section taken 
from immediately adjacent to a section mapped for Ti using X-ray 
fluorescence as presented in Figure 3.7. A mixed inflammatory infiltrate 
including the presence of PMNLs was seen adjacent to the implant surface 
with densely packed plasma cells at a greater distance from the Ti surface  
 
 
No Ti was detected by X-ray fluorescence mapping performed on the control 
tissue, which had no known Ti exposure and had been collected, stored and 
prepared according to an identical experimental protocol. 
 
3.4.2 Calibration of Ti standards 
 
XANES spectra were acquired in transmission mode for all Ti reference standards. 
Spectra were calibrated to the inflection point of Ti at 4960 eV. Ti oxides as rutile 
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and anatase have three well resolved pre-edge features at ~4968.7 eV, 4971.5 eV 
and 4974.2 eV. Ti as metallic form exhibits one well resolved pre-edge peak of 
higher intensity at around 4966 eV (Figure 3.9).  
 
Figure 3.9 Normalised Ti K-edge XANES spectra pre-edge features acquired 
in transmission mode of high purity (99.9 %) Ti standards in forms of oxide 
and metallic species 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.3 XANES spectra of inflamed Ti peri-implant soft tissues 
 
Comparison of the XANES spectra of the Ti standards with spectra taken from 
areas of high, medium and low relative Ti fluorescence intensity, as identified by 
XRF mapping, revealed that the Ti was present in a number of forms. Metallic 
particles were detected only in small quantities and there was a considerable 
quantity of Ti species exhibiting six-fold coordination states analogous to anatase 
and rutile (Ti oxide species) (Figures 3.10 & 3.11). Furthermore, spectra 
resembling Ti-peroxo complexes and intermediary between oxide and metallic 
states were frequently encountered. 
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Figure 3.10 A representative plot showing a normalised Ti K-edge XANES 
spectra for BAHA tissues (BAHA 1 and 2) compared with anatase and rutile 
(Ti-oxide) reference standards 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11 Normalised Ti K-edge XANES spectra above edge features for 
BAHA tissues (BAHA 3-5) compared with Ti metallic and rutile (oxide) 
reference standards suggesting combination of both metallic and oxide states 
 
 
 
 
 
 
 
 
Over 30 XANES spectra were acquired from areas of high, medium and low Ti 
fluorescence intensity from peri-BAHA tissues. The majority of XANES spectra 
acquired suggested that Ti was present as Ti-oxide with predominance for a rutile 
state and intermediary species (mixed oxide and/or oxide-metallic) were observed. 
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3.5 DISCUSSION 
 
Previously investigators have used microscopy, optical spectroscopy and MS 
techniques to confirm the existence of Ti in peri-prosthetic orthopaedic soft 
tissues (Hallab et al., 2004, Kasai et al., 2003, Sargeant & Goswami, 2005 & 
Baldwin & Hunt, 2006). The techniques have limited resolution or an inability to 
relate the quantity, size and chemical speciation of Ti to cellular and sub-cellular 
structures that would be required to inform biological investigations (McRae et 
al., 2009).  
 
Accordingly, synchrotron X-ray micro-focus spectroscopy was used in the current 
investigation and conferred the ability to detect trace distributions of Ti in thin 
tissue sections at a high resolution (section 3.4) (Mosselmans et al., 2009). The 
observation of Ti in all of the tissue sections probed apart from the control tissues 
was confirmatory that the implant surfaces were deteriorating in service. A small 
number of tissue sections of thin thickness (4-6 µm) were prepared from relatively 
large tissue blocks from 6 different patients. Multiple tissue sections from each 
patient were prepared and the sections for XRF mapping (which is a limited 
resource) were randomly selected with Ti discovered in all without any pre-
screening methods being applied. Given the small tissue volumes probed it is 
highly unlikely that the findings were therefore fortuitous and it can also be safely 
extrapolated that the Ti is likely to be found in a 3 dimensional distribution around 
the implant itself.  
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For the first time, a scattered and heterogeneous distribution of Ti in inflamed 
tissues taken from around failing skin-penetrating Ti implants has been observed 
(Figure 3.7). The tissue taken was adjacent to a CpTi device that was not exposed 
to obvious macroscopic wear or loading in service. Furthermore, the location of 
the distributed Ti was deep with respect to the skin surface which suggests that 
wear processes were unlikely to be a major contributor. Debris from implant 
insertion is also highly unlikely to lead to the observed widespread distribution of 
fine fragments of both oxide and metal forms of Ti that were observed. The 
predominance of oxide forms (section 3.4.3) is strongly suggestive that chemical 
or physiochemical mechanisms underpin metal release.  
 
In the absence of obvious macroscopic wear or loading processes, we propose that 
the Ti in the tissue results from micro-motion and localized corrosion in surface 
crevices (Griess, 1968). This is supported by previous observations of 
systemically distributed Ti that has been detected in serum in ionic states (Kasai et 
al., 2003) and bound to proteins (Vamanu et al., 2008) and that implant debris in 
the form of nanoparticles ranging from 10-50 nm has been localised with 
inflammatory cells in tissues surrounding implants (Broggini et al., 2006). 
Localised corrosion which is mechanically assisted will lead to transient 
depassivation of the Ti surface oxide layer resulting in the burst release of Ti ions 
(Mudali et al., 2003). These will either bind to biomolecules or rapidly oxidise 
and where oxidation occurs insoluble particles will be formed. In the absence of 
wear, only small numbers of Ti ions are likely to be generated at any one instance 
so that following oxidation the insoluble particle formed is likely to be of a nano-
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scale. The current methodology did not permit size discrimination to the nano-
scale but chemical evidence derived from the XANES spectra was strongly 
indicative of the formation of oxidised particles on this scale (Uo et al., 2007). 
 
The results provide primary evidence that the expected passive surface of skin-
penetrating Ti implants can deteriorate in clinical service, leading to the 
accumulation of Ti debris in the surrounding tissue. The quantities, size and 
speciation of Ti debris reflect stimuli that have previously been demonstrated to 
be pro-inflammatory in nature (Iavicoli et al., 2011). In the current study, the 
tissues were examined close to their native state and referenced against 
histological images taken from immediately adjacent section taken during cryo-
preparation (section 3.4.1). Measurements on H & E stained specimens 
themselves were avoided because of the risk of moving Ti through the tissue 
section during staining or due to the risk of modifying the chemical state of any Ti 
that may be present. The tissues sections cannot therefore be explicitly correlated 
with the XRF maps but were indicative that some of the Ti distribution was found 
in close proximity to PMNLs which were found in abundance in regions close to 
the implant surface. These findings suggest that PMNL interactions with Ti 
implant debris may be of significance in the pathogenesis of chronic peri-implant 
inflammation.  
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3.6 CONCLUSION 
 
For the first time synchrotron micro-focus XRF and XAS measurements have 
been successfully performed on tissues surrounding Ti implants. A chemically 
and geographically heterogeneous distribution of Ti has been demonstrated to be 
associated with Ti implants that are not subjected to significant wear. The results 
challenge previous assumptions of the chemical stability of “passive” biomedical 
Ti oxide surfaces and given findings from the orthopaedic literature highlight that 
implant metal debris must be considered as a potential factor in the failure of skin 
penetrating Ti implants. The results highlight the need to understand both the 
physical and the chemical mechanisms leading to the generation and dispersal of 
Ti species in the tissue surrounding implants and then their subsequent potential to 
exacerbate inflammation. Similar processes are likely to contribute to the failure 
of other metal implants in soft tissues where macroscopic wear is not traditionally 
considered to be a risk. 
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CHAPTER 4  
 
ACCOUNTING FOR THE TITANIUM SPECIES 
OBSERVED IN PERI-IMPLANT TISSUES 
 
 
4.1 PREFACE 
 
In Chapter 3, it was demonstrated that a heterogeneous distribution of Ti can be 
detected in inflamed peri-implant soft tissues surrounding percutaneous Ti 
devices. It is essential for both the purposes of improving biomedical materials 
and for informing appropriate biological modelling of the consequences of the 
released Ti, that the mechanisms underpinning the generation of such debris are 
understood. The mechanism or mechanisms will dictate the morphological and 
chemical characteristics of Ti implant derivatives and the release process itself 
may have biological consequences (e.g. through the generation of localised 
acidity). A preliminary electrochemical investigation was undertaken using a Ti 
artificial pit model in various media, including physiologically representative, in 
order to identify whether the species observed in a range of peri-implant 
environments can be generated by a non-tribological (non-wear) process. In 
addition, a further preliminary investigation was undertaken to identify whether 
cellular products could further modify Ti when it is in particulate form in the peri-
implant soft tissues. It was demonstrated that all Ti species observed in peri-
implant soft tissues can be accounted for its release by crevice corrosion 
processes. In addition, the capacity of human neutrophils to chemically modify Ti 
nanoparticles was suggested. 
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4.2 INTRODUCTION 
 
4.2.1 Corrosion of biomedical Ti 
 
It is acknowledged that in certain conditions all metals are susceptible to corrosion 
(Shreir et al., 1993) but for Ti and Ti alloys such conditions are not predicted in 
physiological environments (Hansen, 2008). Therefore, when Ti has been detected 
in fluids and tissues (Bölükbaş et al., 2013), wear processes are normally 
attributed (Mudali et al., 2003). However, a small body of evidence exists which 
demonstrates Ti binding to biomolecules and the accumulation of Ti in structures 
and organs and for this to occur Ti must at some point have been in ionic state, in 
solution (Beck, 1973). This has been further supported by the findings of Chapter 
3 which demonstrate a significant distribution of oxide particles which again can 
only have formed from the oxidation of Ti
3+
 or Ti
4+
 released from the Ti surface 
(Vicentini et al., 1975). 
 
Corrosion encompasses groups of chemical phenomena which results in the 
progressive dissolution of a metal in an environment via electrochemical reactions 
(Kruger, 1979 & Mudali et al., 2003). These electrochemical reactions occur at 
the surface of the implant which acts as an anode and where the metallic 
components are oxidised to their ionic forms and any dissolved oxygen is reduced 
to hydroxyl ions (Kruger, 1979). Prolonged hydrolysis and dissolution of a 
metallic biomaterial leads to build up of metal ions and compounds including 
chloride products which consequently reduce the pH and can prevent re-
passivation of metal surface leading to prolongation of the process (Kruger, 1979 
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& Geringer et al., 2005). Corrosion processes pertinent to current implant alloys 
include crevice, galvanic, intergranular, stress-corrosion cracking, corrosion 
fatigue and fretting corrosion (Mudali et al., 2003 & Sargeant & Goswami, 2007). 
The consequences of these processes include mechanical deterioration of the 
implant and the generation of particulate debris and ions ranging from nano- to 
macro- scale which are then released into the peri-prosthetic milieu (Hallam et al., 
2004). For biomedical Ti alloys corrosion is not expected to occur at temperatures 
under 65 °C (He et al., 2002 & Thomas et al., 2004). However, corrosion of 
explanted devices has been demonstrated (Figure 4.1) (Hallam et al., 2004 & 
Thomas et al., 2004). 
 
Figure 4.1 Photograph of a Ti femoral stem post-implantation (2-5 yrs) 
indicating gross corrosion (left) and pH examinations (right) (Hallam et al., 
2004) 
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The corrosion susceptibility of Ti implant materials may be modified by organic 
species present particularly in inflamed tissue sites (Huang & Lee, 2005). 
Hypochlorous acid (HOCl) and hydrogen peroxide (H2O2) which are products of 
inflammation are known to accelerate the electrochemical reactivity of Ti (Hench, 
1975 & Tengvall et al., 1989). In-vitro studies have documented that peroxide 
species can complex with Ti and the products have been shown to diffuse through 
cement to the bone contributing in progression of the implant inflammatory 
response (Tengvall et al., 1989). Furthermore, inorganic species such as sodium 
fluoride (NaF) found in dentifrices can also reduce the corrosion resistance of Ti 
and are particularly pertinent to implants in oral environments (Noguchi et al., 
2008). 
 
4.2.2 Pitting corrosion of Ti implants 
 
Pitting corrosion of Ti implant surfaces has been documented (Dugdale & Cotton, 
1964 & Beck, 1973) but such evidence has subsequently been heavily scrutinised. 
Pitting refers to the formation of holes or pits on the metal surface (Mudali et al., 
2003) but in the context of Ti is known to result from presence of impurity 
inclusions (usually ferrous) or geometrical defects on the passive film (Thomas et 
al., 2004). True pitting corrosion is often a severe form of localised corrosion 
attack which contributes to extensive surface damage and release of significant 
amounts of metal ions (Mudali et al., 2003) and is rarely reported with Ti implant 
materials (Shreir et al., 1993).  
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4.2.3 Crevice corrosion of Ti implants 
 
In contrast to pitting corrosion, crevice corrosion is implicated as occurring in-
vivo and differs due to the generation of specific local chemistry which is 
confined spatially to within the crevice (Mudali et al., 2003). In crevices, a 
volume of solution can stagnate leading to local acidification and a build-up of 
chloride (Cl
-
) and hydroxyl (OH
-
) ions from the extracellular fluid gap 
contributing to dissolution of the metal (Thomas et al., 2004). Numerous 
parameters including increase in temperature, aggressive solution chemistry and a 
decrease in pH have been reported to influence crevice corrosion initiation of Ti in 
Cl, fluoride (F), halide and sulphate solutions (He et al., 2002). Nonetheless, Ti 
remains an electrochemically extremely passive material and studies utilising 
electrochemical impedance spectroscopy (EIS) and X-ray photoelectron 
spectroscopy have reported crevice corrosion of Ti alloys does not occur at 
temperatures below 65 °C (Menini et al., 2005).  
 
4.2.4 Mechanically assisted crevice corrosion (MACC) of Ti implants 
 
It has been theorised that crevice corrosion is unlikely to be significant for Ti 
implant materials (Shreir et al., 1993). However, the likelihood for crevice 
corrosion to occur is significantly increased by the presence of micro-motion 
between crevice walls which initiates surface depassivation (Hallam et al., 2004). 
Mechanically Assisted Crevice Corrosion (MACC) can occur on several scales –
between modular implant components, between implant surfaces and cement or 
bone or between micron sized surface irregularities (Mudali et al., 2003). 
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Movement in a wide range of 1-100 μm have been identified as initiators of 
MACC which is also referred to as fretting corrosion within the literature 
(Duisabeau et al., 2004 & Geringer et al., 2005). When related to clinical 
outcomes MACC has been extensively attributed to orthopaedic total joint 
prosthesis failure (Hallab & Jacobs, 2003 & Sargeant & Goswami, 2007). Cyclic 
loads imposed on cemented Ti hip implants, bone-plates and screws are known to 
cause micro-displacements which result in disruption of the Ti oxide implant 
surface leading to exposure of the base metal and consequently resulting in 
dissolution of the metal (Duisabeau et al., 2004 & Hallam et al., 2004). The 
process is associated with crevice acidification and hence a corrosive medium is 
generated which then further accelerates the corrosive behaviour (Hallam et al., 
2004). 
 
4.2.5 Studying crevice corrosion of Ti implant materials 
 
Artificial crevices or pits are widely used to study geometrical and chemical 
parameters of crevice corrosion (Isaacs, 1995). An artificial pit comprises of a 
metal wire or foil embedded in an inert resin and where anodic dissolution of the 
metal to a certain depth can be induced (Figure 4.2) (Isaacs, 1995). Build-up of 
high concentrations of cations within the pit leads to acidification which then 
induces stable pit growth (Galvele et al, 1990). The artificial pits may also provide 
information regarding the effect of salt films within the pits and information on 
the chemistry of species formed within the pit (Issacs, 1995).  
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Figure 4.2 Schematic diagram of an artificial pit (Issacs, 1995) 
 
 
 
 
 
4.2.6 Understanding the Ti pit chemistry  
 
Localised corrosion studies are difficult since they are associated with wet 
environments and measurements beyond basic electrochemistry are difficult to 
perform (Thomas et al., 2004). Therefore, experimental crevice corrosion of Ti 
has only been minimally reported (He et al., 2002). Ti can actively transform from 
an active to passive state by air, water and or other reagents to restore the metal or 
alloy’s most common and stable oxidation state of Ti4+ (Menini et al., 2005). To 
date, investigations have attempted to mimic the physiological environment and 
have established Ti is susceptible to corrosion in aqueous solutions containing 
bromide, chloride, and iodide ions (Beck, 1973, He et al., 2002 & Noguchi et al., 
2008). A preliminary investigation examined the dissolution of the passive state of 
Ti implant materials in physiological Ringer’s solution (Souto & Burstein, 1996) 
and reported that at ambient temperatures, the passivity of the metal is 
destabilised by the presence of an aqueous chloride environment and a decrease in 
pH. In addition, the instability of the passive Ti oxide surface dictates the 
behaviour of metal dissolution products produced (Ektessabi et al., 1997). It is 
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therefore likely that surface roughness, crevices, complex geometries and internal 
line angles, and restriction of the flow of species as well as strain and stress all 
may contribute to corrosion which is not proportional to the surface area of the 
implant (Menini et al., 2005).  
 
4.2.7 Experimental objectives 
 
The corrosion of Ti is clearly highly complex and is influenced by a wide number 
of parameters (Thomas et al., 2004). The objectives of this study are therefore 
limited to identifying whether the same implant debris that is observed in the 
tissues surrounding Ti implants can be formed by (mechanically assisted) crevice 
corrosion simulated using an artificial pit model and measure with identical X-ray 
characterisation techniques. The susceptibility of Ti to modification by organic 
species generated during inflammation will be explored by exposing characterised 
Ti-oxide species to human neutrophils and measuring potential modifications 
(which can be hypothesised to occur in tissues) spectroscopically. 
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4.3 METHODS 
 
4.3.1 Tissue excision and preparation 
 
To study peri-implant Ti distributions in tissues associated with both CpTi and Ti-
6Al-4V alloys which have also likely been exposed to different degrees of 
corrosion, three tissue types were obtained. Peri-implant inflamed epithelial tissue 
sections were obtained from consented adults (Ethical approval REC 
08/H1203/128) undergoing scheduled removal or revision surgery for a failing: 
 
(a) CpTi prostheses Grade IV. Epithelial tissue from surrounding BAHA implants 
in service for between 2-6 years (n=6). 
 
(b) CpTi prostheses Grade IV. Oral mucosa from surrounding a Straumann RN 
SLA active dental implant in service for 6 months and 6 years (n=2). 
 
(c) Ti-6Al-4V prostheses Grade V. Mixed connective tissue taken from adjacent 
to an intra-medullary stem (tibia) as part of a total knee replacement. 7 and 9 years 
of clinical service (n=2).  
 
During tissue excision, metallic contamination was prevented and tissue sections 
were immediately orientated and snap-frozen prior to cryo-preparation. Sequential 
frozen sections of 4-6 µm thickness were cut with Tungsten Carbide blades and 
mounted on ultra-pure fused silica plates (<10 ppb Ti) (Spectrosil 2000, 
HeraeusQuarzglas GmbH & Co., Hanau, Germany), covered with 25 µm kapton 
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film (Kapton, Dupont, Wilmington, NC, USA) and sealed peripherally with epoxy 
resin. Alternating sections were fixed and H & E stained to provide histological 
reference for each experimental section. In addition, supplementary tissue sections 
which had not been exposed to Ti were prepared in an identical manner as control 
to determine if any contamination occurred during sample preparation.  
 
4.3.2 Characterisation of Ti within peri-implant tissues 
 
XRF mapping was performed using the micro-focus capability of I-18 beamline 
(Diamond Light Source, UK) in accordance with the methodology described in 
section 3.3.4. XANES measurements were taken at high, intermediate and low 
fluorescence values for Ti, identified by XRF mapping, using Si (111) crystal 
monochromator giving an energy range 4950 to 5050 eV with a 9 element Ge 
detector.  
 
4.3.3 Ti reference standard preparation for XANES measurements 
 
Ti standards were prepared as previously described (section 3.3.3). Further TiCl 
solution standards (Table 4.1) were made under inert gas and transferred into a 
Telfon cell under inert gas pressure for the period of the measurement. To prevent 
oxidation of the solution, solution standards were prepared 1 hr prior to 
measurements taken and both inlet and outlet tubes after transferring were 
immediately sealed. Spectra from the reference standards were measured 
simultaneously with sample spectra, where the reference standard is placed 
between the transmitted and third ion chamber.  
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Table 4.1 Ti solution standards 
 
Compound State Oxidation 
State 
Solution 
Composition 
Environment 
TiCl4 Liquid  4 9 mM TiCl4 in 0.55 M 
HCl 
N2 
BSA Liquid 4 9 mM TiCl4 in 0.55 M 
BSA 
Air 
Ringers 
solution
*
 
Liquid 4 9 mM TiCl4 in 0.55 M 
Ringers Solution 
Air 
 
*
Ringers solution were prepared by adding 8.5 g of NaCl, 8.5 g of KCl, 0.25 g of 
CaCl2 and 0.22 g of NaHCO3 to 1 L of distilled water. The solution was prepared 
1 hr prior to electrochemical measurements or alternatively stored in 4 °C until 
use. 
 
4.3.4 Setup of an electrochemical cell  
 
3 mm wide strips of CpTi foil (50 µm thick) were cut and degreased with acetone 
before being sandwiched between Kapton adhesive tape with epoxy adhesive 
(Araldite) and attached to a polyvinyl chloride (PVC) reservoir The 
electrochemical cell comprised of 20 mL of 1M HCl solution and an Ag/AgCl 
reference electrode and a platinum wire counter electrode. Solutions with 
controlled additions of albumin or Ringers solution were used as an alternative 
electrochemical test electrolyte were employed separately (Table 4.1). All 
potentials reported are relative to Ag/AgCl in order to monitor the potential of 
crevice electrode. A potential of 11 V was provided to promote dissolution of the 
CpTi foil to a depth approximately 3 to 4 mm and then decreased to 7 V whilst the 
pit was grown under potentiostatic conditions.  
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4.3.5 SR-XANES measurements of artificial pits  
 
Ti K-edge XANES was performed using the micro-focus capability of I-18 
beamline (Diamond Light Source, UK). Spectra were taken prior to the corrosion 
of CpTi foil (50 µm thick) in fluorescence mode with a 5 x 5 µm beam footprint. 
An optical microscope installed on the beamline enabled identification of regions 
of the artificial pit for the XANES measurements enabling measurements during 
dissolution of the CpTi foil and evaluation of any variation in species observed 
with distance from the dissolving interface to the pit mouth.  
 
4.3.6 Detection of intracellular modification of Ti nano-particles by human 
neutrophils 
 
Neutrophils were isolated (Appendix I) and re-suspended at a concentration of 
1x10
6 
cells/mL in PBS (Appendix I). 100 µL of the isolated cells were stimulated 
with 25 µL of Ti-oxide as anatase (<45 nm) at concentrations of 2000, 200, 20 
and 2 ppm (section 2.2) for 1 hr at room temperature. After 1 hr the exposed cell 
suspension was fixed with acetone and the cells were then mounted on ultra pure 
silica (Spectrosil 2000, HeraeusQuarzglas GmbH & Co., Hanau, Germany) and 
desiccated. In addition, un-exposed cells were similarly fixed and mounted and 
acted as the experimental negative control.  
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4.4 RESULTS 
 
4.4.1 Calibration of Ti standards 
 
XANES spectra were acquired in transmission mode for all Ti solid (section 
3.3.3) and Ti solution (Table 4.1) reference standards. Spectra were calibrated to 
the inflection point of Ti at 4960 eV. Ti solid reference standards as oxidized 
forms of rutile and anatase have three well resolved pre-edge features as described 
in section 3.4.2. CpTi foil (5µm) as metallic form also exhibits one well resolved 
pre-edge peak of higher intensity at around 4966 eV. In contrast to solid 
standards, the TiCl4 solution reference standard exhibited a single pre-edge peak 
at 4971.5 eV with the intensity of the peak much higher than oxide forms (Figure 
4.3). 
 
Figure 4.3 Normalised XANES Ti K-edge spectra of Ti solid standards: 5 µm 
CpTi foil, rutile, mix oxide and anatase; and Ti liquid standards -TiCl4 
 
 
 
 
 
 
 
 
 
 
 
 66 
4.4.2 SR-XRF mapping of inflamed peri-implant tissues 
 
Synchrotron X-ray fluorescence mapping of thin (4-6 μm) retrieved peri-implant 
tissues recovered from adjacent to percutaneous CpTi implants, to dental implants 
and to Ti-6Al-4V tibial stems all demonstrated Ti distributions (Figures 4.4-4.6). 
In oral epithelium, although Ti was detected in all of the sections studied the 
distribution of Ti appeared as distinct particles of <15 μm in size. In BAHA 
tissues as described in Chapter 3 a widespread distribution of Ti composed of 
different sized areas of Ti fluorescence intensity was observed. The distributions 
were consistently heterogeneous in all of the sections studied (11 sections from 6 
patients). In orthopaedic tissues, the fluorescence intensity of Ti was the highest 
and the background level of Ti between “particles” was elevated suggesting Ti in 
ionic or nano-particulate forms.  
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Figure 4.4 A X-ray fluorescence map (250 × 525 µm) of the associated 
distribution of Ti in peri-implant skin tissues (6 µm thickness) taken from 
adjacent to a CpTi BAHA. Legend refers to increasing Ti fluorescence values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increasing Ti fluorescence 
50 µm 
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Figure 4.5 An X-ray fluorescence map (150 × 150 µm) of the associated 
distribution of Ti in peri-implant mixed connective tissues (6 µm thickness) 
taken from adjacent to a Ti-6Al-4V alloy tibial stem of a total knee 
replacement. Legend refers to increasing Ti fluorescence values 
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50 µm 
 69 
Figure 4.6 An X-ray fluorescence map (50 × 200 µm) of the associated 
distribution of Ti in oral epithelial tissues (6 µm thickness) taken from 
adjacent to a CpTi dental implant. Legend refers to increasing Ti 
fluorescence values 
 
 
 
 
 
4.4.3 XANES spectra of inflamed Ti peri-implant soft tissues 
 
XANES spectra were obtained at points of high and low concentrations of Ti 
identified by the Ti XRF maps (section 4.4.2). The chemical state of Ti was 
estimated by comparing XANES spectra to those of Ti reference standards 
(Figure 4.3). Where spectra appeared to be a mix of different Ti species, iterative 
steps of changing linear combinations of Ti standards spectra were taken to 
identify the dominant species component. Approximately 50 spectra could be 
categorised and rutile was identified to be the most predominant species localised 
Increasing Ti fluorescence 
50 µm 
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within the inflamed Ti implanted soft tissues from all three tissue types (Table 4.2 
and Figures 4.7-4.11). 
 
Table 4.2 Summary of the chemical state of Ti in inflamed Ti peri-implant 
soft tissues taken from approximately 50 spectra where peak assignment and 
edge energies were discernible 
 
Tissue type Tissue location 
from the implant 
Chemical state of Ti (dominant 
species in bold) 
BAHA-skin Variable Anatase, Peroxy and Rutile 
BAHA-skin Near Metallic and Rutile 
Oral epithelium Variable Anatase, Metallic and Rutile 
Orthopaedic Distant Anatase, Metallic, Mix oxide and 
Rutile 
Orthopaedic Near Anatase and Rutile 
Orthopaedic Contacting Metallic 
 
 
Figure 4.7 Representative normalised Ti K-edge XANES spectra pre-edge 
features of BAHA tissue taken from close to the implant at high fluorescence 
intensity compared to the Ti metallic reference standard –demonstrating well 
aligned pre-edge peaks 
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Figure 4.8 Representative normalised Ti K-edge XANES spectra of oral 
epithelial tissues associated with a CpTi dental implant and compared with 
anatase, rutile and CpTi (metallic). Experimental spectra show pre-edge 
oscillations consistent with oxide and although rutile was predominant linear 
combinations of the oxide states were likely to contribute to each spectra to 
some extent 
 
 
 
 
 
 
 
 
 
Figure 4.9 Representative normalised Ti K-edge XANES spectra of mixed 
connective tissue specimens taken distant from an indwelling orthopaedic Ti-
6Al-4V implant and showing an extremely close resemblance to control 
spectra for Ti-oxide as rutile 
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Figure 4.10 Representative normalised Ti K-edge XANES spectra of mixed 
connective tissue specimens in close proximity to an indwelling orthopaedic 
Ti-6Al-4V implant and showing resemblance to control spectra for the CpTi 
metallic reference standard in terms of the pre-edge features. However, the 
edge energy and post-edge features are more indicative of an oxide state 
suggesting that the area of Ti fluorescence exhibited particles of both types 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Representative normalised Ti K-edge XANES spectra of mixed 
connective tissue specimens taken immediately adjacent to an indwelling 
orthopaedic Ti-6Al-4V implant showing resemblance to the control spectra of 
Ti-oxide as anatase or a linear combination of anatase and rutile 
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4.4.4 SR-XANES measurements of Ti speciation during simulated corrosion 
 
Before corroding the Ti foil in the artificial pit, XANES spectra were acquired in 
fluorescence mode (Figure 4.12). Due to the thickness of the 50 µm foil the 
spectra were compressed at energies above the edge due to self-absorption effects. 
A 5 µm CpTi foil was therefore substituted for the reference standard and a pre-
edge peak was clearly evident around 4967 eV.  
 
Figure 4.12 Normalised XANES Ti K-edge spectra of 5 µm CpTi foil 
standard (measured in transmission mode) and 50 µm CpTi foil in artificial 
pit (measured in fluorescence mode) 
 
 
 
 
 
 
 
 
 
During the simulated corrosion process in various environments, the 
metal/solution interface was non-uniform and exhibited considerable roughness. 
In addition, dark and bright regions inside the pit and the formation of a salt film 
at the metal solution interface were visible with optical microscopy (Figure 4.13). 
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Figure 4.13 An optical image of the Ti artificial pit grown at 7 V (Ag/AgCl) in 
1M HCl. The black solid line at the top shows the original sample edge 
position before dissolution and the oval shape shows characteristic bright and 
dark regions from which XANES measurements were taken 
 
 
 
 
 
 
 
 
 
The optical imaging allowed identification of areas of interest for a series of 
XANES measurements inside the pit including obtaining spectra from bright and 
dark regions and above the pit (pit mouth) (indicated as solid line in Figure 4.13). 
An array of heterogeneous Ti species including TiCl4, Ti as oxidized forms as 
anatase and rutile and as metallic forms were detected (Table 4.3 and Figures 
4.14-4.18).  
 
 
 
 
 
 
 
Salt Film 
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Table 4.3 Summary of the chemical state of Ti corrosion products in Ti 
artificial pit  
 
Spot Number Position Areas Chemical state of Ti 
1 and 2 Inside the Pit  Bright Metallic 
3 Inside the Pit Bright Anatase, Rutile and TiCl4 
4  Inside the Pit Bright Metallic and TiCl4 
5 Inside the Pit Bright Anatase, Rutile and TiCl4 
6-8 Inside the Pit Dark Metallic  
9 Above the Pit Bright Anatase, Rutile and 
Metallic  
10 and 11 Above the Pit Bright Anatase, Rutile and TiCl4 
 
 
Figure 4.14 A normalised XANES Ti K-edge spectra of bright spots 1 and 2 
inside the pit show similar pre-edge features to the 5 µm CpTi standard but 
post-edge features suggest a combination with oxide 
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Figure 4.15 A normalised XANES Ti K-edge spectra of bright spot 3 (region 
inside the pit) compared with anatase, rutile, TiCl4 and 5 µm CpTi standards 
suggests a linear combination of oxide and TiCl4 forms 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 A normalised Ti K-edge spectra of spot 4 (bright region inside 
the pit) exhibits pre-edge and above edge features similar to the TiCl4 
reference standard whereas the edge area was similar to 5 µm CpTi 
(metallic) 
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Figure 4.17 A normalised Ti K-edge spectra of spot 5 (bright region inside 
the pit) compared with anatase, rutile and TiCl4 reference standards. The 
pre-edge was similar to combination of TiCl4, anatase and rutile standards 
whereas the edge area was close representation of anatase and above edge 
area indicated similarity to anatase and rutile 
 
 
 
 
 
 
 
 
 
Figure 4.18 Normalised pre-edge spectra of dark regions from inside the pit 
compared with 5 µm CpTi (metallic). Furthermore, XANES measurements 
were acquired from three variable dark regions inside the pit and were 
similar to 5 µm CpTi. The intensity of the pre-edge peaks was higher than the 
metallic reference standard measured in transmission mode indicating 
evidence of non-linearity and for spectrum 6 especially resembled the 50 µm 
CpTi foil measured in fluorescence mode. These spectra are indicative of the 
generation of metallic particles from a corrosion process 
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4.4.5 SR-XANES measurements of dissolution of Ti in artificial pit containing 
albumin (BSA)  
 
A series of XANES measurements were acquired at two different time points 
whilst observing the dissolution of Ti in an electrochemical cell containing an 
albumin solution. Two consecutive XANES measurements represented as region 
1 and 2 were acquired immediately at 7 V during the dissolution process and one 
XANES measurement represented as region 3 was acquired 40 mins following 
arresting of the corrosion process. In contrast to the previously described spectra, 
Ti species were found only in oxidized forms and no metallic form debris was 
observed (Figures 4.19 & 4.20).  
 
Figure 4.19 Normalised XANES Ti K-edge spectra of regions 1 and 2 
compared with rutile and mix oxide reference standards showing a good 
approximation to rutile (Ti-oxide) 
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Figure 4.20 Normalised XANES Ti K-edge spectra of region 3 indicating a 
very close approximation to Ti-oxide as anatase 
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4.4.6 SR-XANES measurements of dissolution of Ti in artificial pit containing 
Ringers solution 
 
A XANES spectrum was acquired whilst observing the dissolution of Ti in an 
electrochemical cell containing Ringers solution and is represented as region 4 
(Figure 4.21). Similar to the XANES spectra of dissolution of Ti in solution 
containing albumin (section 4.4.5), no metallic spectra were observed with the 
closest approximation being a combination of oxide and solution species (mix 
between oxide and TiCl4).   
 
Figure 4.21 Normalised XANES Ti K-edge spectra of region 4 compared with 
mix oxide and TiCl4 reference standards 
 
 
 
 
 
 
 
 
 
4.4.7 XANES spectra of Ti stimulated neutrophils 
 
XANES spectra taken from single neutrophils which had been exposed to Ti 
oxide as anatase nanoparticles (<45nm) at 2000 and 200 ppm revealed a possible 
transformation of Ti co-ordination assumed to be occurring within or at the 
surface of the cell. The majority of spectra demonstrated a close approximation to 
 81 
the anatase (Figure 4.22a). However, when a lower concentration of nanoparticles 
was used, spectra more consistent with a rutile state were observed (Figure 4.22b). 
For neutrophils exposed to anatase at 20 and 2 ppm the spectra were too noisy to 
be classified. 
 
Figure 4.22 Normalised Ti K-edge XANES spectra taken from neutrophils 
stimulated with Ti-anatase at (a) 2000 ppm compared with anatase reference 
standard and (b) at 200 ppm compared with rutile reference standard. 
Figure 4.22b demonstrates post-edge features much more closely aligned with 
rutile 
 
(a) 
 
 
 
 
 
 
 
(b) 
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4.5 DISCUSSION 
 
The use of Ti implants and especially transmucosal and percutaneous devices was 
initially associated with extremely high clinical success rates when the considered 
outcome measures were osseointegration capability and short term function 
(Ratner, 2001). It is now acknowledged that chronic problems associated with Ti 
implants are common and extremely difficult to manage (Ratner, 2001). Most 
research focuses on the impact of microbial colonisation of Ti surfaces (Fansson, 
2009) and on possible dysregulation of host immune responses (Flatebø et al., 
2006). However, there is increasing attention on whether Ti in free (particle and 
ionic) forms in the peri-implant soft tissues can modify the inflammatory response 
(Iavicoli et al., 2011). In Chapter 3, further evidence was provided to demonstrate 
the release of Ti into peri-implant soft tissues and suggested that the processes 
leading to the Ti release are likely to be corrosion mediated (on a micro-scale) 
(Thomas et al., 2004). Two alternative routes exist to the generation of the 
observed Ti distributions associated with the skin penetrating implants studied. 
Firstly, there are tribological mechanisms including 2 and 3 body wear (Budinski, 
1991), however for skin penetrating implants and dental implants –wear processes 
that occur within the soft tissue cuff surrounding the implant are highly unlikely. 
A second alternative are biocorrosion mechanisms whereby cellular activity 
(microbial and/or eukaryotic) (Mudali et al., 2003) and extracellular contents (e.g. 
endotoxin, peroxide species and local acidification) mediate Ti release (Tengvall 
et al., 1989). It is important to note however, that biocorrosion mechanisms are 
chemically mediated (Mudali et al., 2003) and in common with crevice corrosion 
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will be exacerbated by existing disruption of the Ti oxide layer –through 
micromechanical routes (Menini et al., 2005).  
 
In this Chapter, extensive Ti distributions surrounding Ti-6Al-4V tibial stems and 
CpTi percutaneous implants was observed (section 4.4.2). Ti-6Al-4V has a lower 
corrosion resistance than CpTi (section 1.1.4) (Elias et al., 2008) however, the 
tissues probed were taken at time of revision surgery and aseptic loosening of the 
intramedullary Ti component of the device had already occurred leading to 
associated wear processes. During wear, depassivation of the Ti surface also 
occurs leading to secondary chemical reactions however; metal particulate debris 
would be expected to have dominated. Interestingly, in these mixed connective 
tissues surrounding the indwelling Ti-6Al-4V implant, the majority of debris was 
in oxide forms (Table 4.2) demonstrating that the Ti had been in ionic form at 
some stage (Beck, 1973 & Vicentini et al., 1975). A high background level of Ti 
spread throughout the tissues further suggested that Ti may still be in non-
particulate form bound to biomolecular components. The oral epithelium taken 
from around dental implants demonstrated a dispersed distribution of Ti (Figure 
4.6) and was likely to be particles. Both oxide forms and metallic debris was 
identified but again the species that dominated was Ti-oxide as rutile. The higher 
quantities of Ti observed in percutaneous implants when compared with 
transmucosal are possibly related to less of the released material being lost from 
the soft tissue crevice around the implant when compared with the gingival 
crevice. The observation of XANES spectra in all three tissue types that 
resembled species intermediary between metallic and oxide again was suggestive 
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of a corrosive process leading to the release of small particles. The mixed spectra 
gave a possible indirect indication of size effects whereby as a particle size 
reduces in the nano-scale the proportion of surface atoms (co-ordinated with 
oxygen) to core atoms which maybe as oxide or in a metallic form increases. With 
nano-sized metallic particles a spectra between oxide and metallic may be 
expected due to the relative contributions of the surface and core atoms. The 
spectroscopic findings were consistent with a corrosion process and also with 
processes leading to the generation of particles observed on a nano-scale. To 
provide supporting evidence it was important to be able to demonstrate that all the 
species observed could be generated through corrosion and to further attempt to 
identify why rutile species may dominate.  
 
A considerable advantage of synchrotron spectroscopy is the ability to undertake 
measurements in “wet” environments (Willmott, 2011). This in the current study 
allowed the chemistry of a corroding Ti crevice/pit to be studied. The high lateral 
resolution of the microfocus-beam of the I-18 beamline (Diamond Light Source) 
enabled the corrosion pit to be probed at visually distinct areas to identify regional 
variation of the Ti chemistry away from the corroding interface.  
 
In accordance with previous pitting investigations reported (Beck, 1973), 1 M 
HCl was used as an electrolyte to initiate acidification in the potential corrosion 
sites. Once initiated the aggressive electrochemical conditions were reduced 
(reducing voltage from 11 to 7 V) to reduce the diffusion rate of escaping ions 
from the pit cavity. It should be highlighted that whilst the conditions appear 
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biologically unrealistic on a microscopic scale, the same levels of acidity will be 
anticipated in crevice corrosion conditions in-vitro (Issacs, 1995). Notably, under 
these conditions it was demonstrated using XANES measurements that released 
Ti is found as TiCl4 and that with distance from the pit, Ti
4+
 becomes oxidised 
forming insoluble particles which can be observed to be co-ordinated as anatase or 
rutile or a mixture of both (Table 4.3). Furthermore, for the first time it was 
demonstrated that crevice corrosion of CpTi can lead to the generation/ release of 
Ti metallic fragments and this may further account for the occasional observation 
of Ti in this form in the oral epithelial and skin tissues studied in the current 
investigation.  
 
Electrochemical dissolution of Ti in the presence of albumin (BSA) was 
undertaken in order to closely mimic the in-vivo environment (section 4.4.5). 
Proteins including albumin are a major constituent of physiological medium and 
albumin has been demonstrated to be one of the most prevalent proteins to bind to 
metal ions (Vamanu et al., 2008). The potential influences of the protein present 
will be its adsorption to the Ti foil surface, its modification of local acidity and 
possible associations with particles and ions that are released. The XANES 
measurements acquired differed from the Cl
-
 dominated medium in section 4.4.4 
revealing an array of heterogeneous Ti species but only in oxidized forms as 
anatase and rutile and mixed speciation. No metallic traces of Ti were observed in 
pit containing albumin solution and no solution species were identifiable. This 
finding could suggest that albumin itself is mopping up some of the Ti
4+
 and in 
doing so modifying local acidity so that formation of oxide particles is promoted. 
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The findings do not however help to elucidate the seemingly preferential 
occurrence of Ti-oxide as rutile within the tissues. 
 
Ti corrosion was also studied in the presence of ringers solution (section 4.4.6). 
Components of ringers solution have previously been reported to accelerate the 
dissolution process of Ti and are representative of the physiological medium in-
vivo (Souto & Burstein, 1996). Unfortunately, due to limited experimental beam 
time, XANES measurements were only preliminary but demonstrated the 
formation of Ti-oxide species which appear intermediary between oxide states and 
the solution species, TiCl4. These findings are consistent with previous studies 
studying Ti corrosion behaviour in ringers solution which have suggested that a 
series of depassivation followed by repassivation processes occur with time 
(Souto & Burstein, 1996).  
 
These series of experiments have demonstrated the capability of crevice corrosion 
mechanisms to generate the range of Ti species which had been observed in a 
range of tissues. Importantly the heterogeneity of species observed in the pit 
simulation experiments (section 4.4.4) were consistent with the heterogeneity 
observed in the tissues (section 4.4.3) and that the Ti speciation in corroding 
crevices is heavily influenced by environmental variables such as the presence or 
absence of protein (Huang & Lee, 2005) or the different biologically relevant 
electrolytes found in physiological fluids (Shreir, 1993). However, what could not 
be explained was the predominance of Ti-oxide as rutile that was observed in the 
tissues. A preliminary experiment was undertaken to identify whether cellular 
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products or processes could potentially modify Ti once they accumulate within 
the tissues. Neutrophils were chosen as they are professional phagocytes (Dale et 
al., 2008) which have the capability of producing species such as H2O2 (Hampton 
et al., 1998) which are known to complex with Ti oxide (Tengvall et al., 1989). In 
Chapter 3, Ti-peroxy compounds were observed which gave further support to a 
hypothesis of cellular mediated modification of Ti. In the current study, high 
purity anatase nanoparticles were used to stimulate neutrophils (activity was 
monitored by enhanced chemiluminescence of controls). XANES spectra taken 
before and after exposures demonstrated that some of the Ti as anatase now 
appeared in a co-ordination more similar to rutile (section 4.4.7). As the transition 
temperatures from anatase to rutile have been reported to be >500°C (Czanderna 
et al., 1958) it is important to note that this is not an energetically favourable 
scenario. Possible mechanisms that could account for the observed spectra were 
that within the phagosome the Ti ions are generated and then re-oxidise in a rutile 
form. Alternatively, it may simply be that the anatase nanoparticles are small 
enough that their surface atoms dominate their XANES spectra. Exposure of the 
nanoparticles to cellular or extracellular contents e.g. proteins may lead to surface 
adsorption of these biomolecules and distortion of the surface Ti-O bonds leading 
to the spectral modification.  
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4.6 CONCLUSION 
 
In this chapter it has been demonstrated that a highly chemically heterogeneous 
distribution of Ti exists in peri-implant tissues and through simulations it can be 
further shown that its generation can be accounted for by crevice corrosion 
mechanisms. The speciation of Ti appears to be highly sensitive to the 
physiological environment and there is sufficient evidence to suggest that Ti 
release may be further modified within the peri-implant soft tissues. These 
findings highlight the importance to now understand the biological consequences 
of such Ti products on chronic peri-implantitis. 
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CHAPTER 5 
 
THE EFFECT OF TITANIUM IMPLANT DERIVATIVES 
ON THE NEUTROPHIL RESPIRATORY BURST 
 
 
5.1 PREFACE 
 
Enhanced chemiluminescence assays were used to determine the effect of direct 
stimulation of neutrophils with ‘Ti implant derivatives.’ Dose dependent total and 
extracellular Reactive Oxygen Species (ROS) production was measured following 
stimulation and compared against unstimulated controls. Significantly elevated 
ROS production from stimulated cells was observed with low concentrations of Ti 
implant derivatives (2 ppm). The magnitude of ROS production was influenced by 
Ti particle size and speciation. Neutrophil internalisation and subsequent 
intracellular distribution of Ti oxide nanoparticles was observed using 
Transmission Electron Microscopy (TEM) and Energy Dispersive X-ray (EDX) 
techniques. Data from neutrophil respiratory burst assays and observations of 
intra-cellularisation of Ti implant derivatives suggest that oxidative stress 
induction by such products may contribute to a pro-inflammatory state in 
susceptible patients and lead to the progression of the peri-implant inflammatory 
response. 
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5.2 INTRODUCTION 
 
5.2.1 Neutrophil respiratory burst 
 
Oxidative stress is associated with chronic inflammatory conditions (Edwards, 
1994 & Nel et al., 2006) and degenerative diseases (Ames, 1993, Floyd, 1999 & 
Kadenbach et al., 2009) which manifest due to increased cellular production of 
reactive oxygen metabolites that may be released into the extracellular 
environment (Matthews et al., 2007). Neutrophils have been recognised to play a 
vital role in inducing an oxidative stress environment and have been demonstrated 
to be important in the progression of periodontitis (Asman et al., 1985, Chapple & 
Mathews, 2007 & Wright et al., 2008). In neutrophils, oxidative stress results 
from a process known as the respiratory burst (Babior, 1984). The respiratory 
burst is associated with an increased consumption of molecular oxygen which is 
utilised by the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
enzyme complex to yield highly-reactive oxygen species (ROS) (Figure 5.1) 
(Battino et al., 1999 & Dahlgren et al., 2007).  
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Figure 5.1 Schematic representation of ROS release from neutrophils 
(Robinson, 2008) 
 
 
 
NADPH (Nicotinamide Adenine Dinucleotide Phosphate) - an enzyme complex 
used to reduce oxygen to superoxide and hydrogen peroxide 
 
SOD (Superoxide Dismutase) - catalyzes the reduction of O2
- 
to
 
H2O2  
 
Catalase reduces H2O2 to H2O 
 
MPO (Myeloperoxidase) - major constituent of the azurophil cytoplasmic 
granules which consumes H2O2 produced by the neutrophil to HOCL 
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5.2.2 The NADPH oxidase enzyme complex and its properties 
 
The NADPH oxidase consists of one membrane bound compound 
(flavocytochrome b558 comprising of gp91
phox
 and p22
phox 
subunits) and four 
cytosolic components (p47
phox
, p40
phox
, p67
phox
 and Rac) which are dormant in 
resting neutrophils. The assembly and activation of the complex is reported to 
occur on the plasma membrane, within the cytosol and on the membranes of 
specific granules (Figure 5.2) (Hampton et al., 1998 & Kobayashi et al., 1998). 
 
Figure 5.2 Possible sites for NADPH oxidase complex assembly and 
activation in human neutrophils (Dahlgren & Karlsson, 1999) 
 
 
 
 
 
 
 
 
 
 
Studies have identified that through receptor dependent or independent activation 
in neutrophils, the cytosolic proteins become phosphorylated and through an 
unknown intracellular signal translocate to the membrane bound component, 
flavocytochrome b (Hampton et al., 1998). Association of the heterodimer 
flavocytochrome b protein localised in the plasma membrane and in membranes of 
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intracellular granules leads to oxidation of glucose in the hexose monophosphate 
shunt (NADPH oxidase) causing assembly and activation of the NADPH oxidase 
enzyme complex (Borregaard et al., 1983). The electron donor, NADPH via the 
flavocytochrome b subunit in the cytosol spontaneously reduces one or two 
electrons from oxygen (O2) to generate superoxide anions (O2
-
) and H2O2 
respectively in an intracellular compartment such as the phagosome (Figure 1.3) 
(Kobayashi et al., 1998 & Dhalgren & Karlsson, 1999) or in the extracellular 
milieu (Figure 5.2) (Babior 1999).  
 
These primary products (O2
-
 and H2O2) are further recognised to be reduced by 
other cellular systems including superoxide dismutase (SOD) which catalyzes the 
reduction of O2
- 
to
 
H2O2 and/or by catalase which reduces H2O2 to H2O (Dahlgren 
& Karlsson, 1999). H2O2 produced within cells can diffuse across cell and nuclear 
membranes (Hancock, 1997 & Nathan, 2006) causing activation of pro-
inflammatory mediators which can consequently contribute to excessive 
inflammation (Chapple et al, 2007).  
 
In addition, following interactions with the cellular enzyme myeloperoxidase 
(MPO) (localised in the neutrophil azurophil granule) (Klebanoff, 2005), the 
primary products are metabolised further to form potentially toxic substances, 
such as hypochlorous acid (HOCl), chloramines and hydroxyl radicals (
.
OH) 
(Figure 5.1) (Dahlgren et al., 1999). The NADPH respiratory burst products are 
highly reactive and can be ferried to the phagosome or to the extracellular milieu 
with the aim of directly or indirectly inducing microbial death (Freitas et al., 
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2009). The activated NADPH enzyme possesses a deactivation mechanism to 
limit ROS release in inflamed sites, however failure of inactivation leads to over 
production of ROS metabolites resulting in host tissue damage (Epstein & Weiss, 
1989) (sections 1.5.2 & 5.2.3). It has been demonstrated that neutrophils from 
periodontitis patients have a deficiency in the key oxidative deactivation, due to 
reduced glutathianione (GSH), which appears to be a constitutive defect (Dias et 
al., 2013). 
 
5.2.3 Role of ROS species in host tissue destruction 
 
The toxicity of ROS to host tissues may occur directly or indirectly through 
interactions of ROS species with cellular and extracellular components (Mathews 
et al., 2007). Formation of free radicals beyond the normal threshold in the host is 
reported to exacerbate inflammatory responses (Hampton et al., 1998); induce loss 
of defence homeostasis (Chapple et al., 2007) and potentially induce apoptosis of 
other immune cells (Hildeman et al., 2003 & Park et al., 2008). Studies document 
that elevated oxygen radicals and inflammatory mediators including H2O2 and 
HOCl released into the extracellular environment contribute to peri-prosthetic 
bone loss and tissue destruction (Doorn et al., 1998). Moreover, neutrophils from 
periodontitis patients are hyperactive and hyper-reactive with respect to ROS 
release (Mathews et al., 2007) and the oxidatively stressed neutrophils direct 
superoxide into the extracellular sites (Dias et al., 2013). 
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5.2.4 The interaction of ROS with Ti implant surfaces 
 
Superoxide, singlet oxygen, H2O2, HOCl, chloramines and 
.
OH radicals which are 
all derivatives of respiratory burst products (Battino et al., 1999) have been 
demonstrated or hypothesized to interact with Ti implant surfaces. An in-vitro 
study utilising a spin trapping technique reported Ti incubated with H2O2 formed 
a yellow coloured Ti(IV)H2O2 complex (Tengavall et al., 1988 & 1989). The 
complex is reported to trap superoxide radicals therein which consequently form 
variable Ti peroxy compounds. However, the pro-inflammatory potential of such 
Ti peroxy compounds has yet to be studied. 
 
Alternatively, H2O2 and Ti may possibly yield hydroxyl radicals (
.
OH) and Ti 
hydroxide radicals via Fenton or Haber Weiss reactions (Tengvall et al., 1989) 
which could induce Nuclear Factor-kappa Beta (NF-kB) and/or DNA strand 
breaks as hydroxylation contributes to extracellular oxidative damage (Shi et al., 
1999). In addition, Ti is also reported to complex with HOCl which in the context 
of cemented orthopaedic devices has been reported to diffuse through cement to 
the bone further contributing to the progression of peri-implant inflammatory 
response (Thomas et al., 2004).  
 
5.2.5 Measurement of respiratory burst release 
 
Numerous techniques are available for the measurement of free radical release by 
professional phagocytes such as neutrophils (Table 5.1) (Curtin et al., 2002). 
Techniques for measuring the cellular production of ROS should be (a) highly 
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sensitive, (b) specific for a particular oxygen metabolite, (c) distinguish the 
cellular site of ROS release and (d) should not interfere with cellular functions, 
thus avoiding false quantification (Dahlgren et al., 1999). However, no single 
technique has been shown to be capable of satisfying all the above criteria 
(Dahlgren et al., 1999). 
 
Table 5.1 Techniques used for measuring cellular production of different 
reactive oxygen species (ROS) (Dahlgren et al., 1999) 
 
TECHNIQUE MEASURING 
PRINCIPLE 
CELLULAR 
LOCALSATION 
SENSITVITY 
Superoxide anion 
Photometry Reduction of 
cytochrome c 
Extracellular Low sensitivity 
as H2O2 may 
interfere with the 
assay 
Luminometry Isoluminol 
chemiluminescence 
Extracellular High sensitivity 
as detects O2
-
 
despite the 
requirement of 
peroxidase 
Luminometry Lucigenin 
chemiluminescence 
Extracellular High sensitivity 
but less than 
isoluminol 
Hydrogen peroxide 
Fluorometry Peroxidase dependent 
oxidation of PHPA ± 
azide 
Intracellular Low sensitivity 
Fluorometry Peroxidase dependent 
oxidation of 
scopoletin ± azide 
Extracellular Low sensitivity 
but higher than 
PHPA system  
Non-identified oxygen radical 
Luminometry Luminol 
chemiluminescence 
Intracellular and 
extracellular 
High sensitivity 
Fluorometry Oxidation of 2, 7- 
dichlorofluorescein or 
dihydrorhodamine 
Intracellular Low sensitivity 
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Enhanced chemiluminescence assays are considered the most sensitive and 
selective accurate real-time methods for low level superoxide detection especially 
during the respiratory burst (Lundqvist, 1996). Chemiluminescence assays utilise 
a luminometer (Aggarwal et al., 2004) which measures the light emitted, 
expressed in relative light units (RLU) from the oxidative end products produced 
by an in-vitro reaction between ROS and the chemiluminophores employed 
(Yamaguchi et al., 2002). The type of luminophore used for measuring ROS is 
critical as the molecular species responsible for the chemiluminescence are 
usually unknown (Yamaguchi et al., 2002). 
 
Luminol [5-amino-phthalazine-1,4(2H,3H)-dione] (Albrecht, 1928) is one of the 
most extensively used chemiluminescence probes as it can cross biological 
membranes thereby decreasing the detection limit substantially and making the 
technique very sensitive (Lundqvist, 1996). The molecular species reported for 
luminol chemiluminescence is dependent on the combined activity of NADPH 
and MPO (Stevens et al., 1978). Thus, the reagent reacts with a variety of free 
radicals including the superoxide anion, 
.
OH and H2O2 enabling the measurement 
of ROS released from the cells (extracellular activity) as well as ROS originating 
from unidentified subcellular compartments such as the phagosome (intracellular 
activity) (Briheim et al., 1984 & Dhalgren & Karlsson, 1999). HOCl is the 
principle ROS, detected by luminol, however currently there is limited 
understanding about the diffusion properties of luminol through the different 
membranes of the phagocyte (plasma membrane, granule membrane and 
phagolysosomal membrane) (Dahlgren & Karlsson, 1999). 
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In the reaction, luminol is oxidised by ROS products generated by neutrophils to 
aminodiphthalate (Gorsuch, 1969) (Figure 5.3). The aminodiphthalate produced is 
in an excited state which returns to its ground state accompanying with the 
emission of photons (hv) in the visible region of the spectrum (λ=425 nm) 
responsible for the resulting chemiluminescence (Alegria-Schaffer et al., 2009) 
(Figure 5.3).  
 
 
Figure 5.3 Simplified representation of luminol oxidation which generates 
light (hv represents photon) (Alegria-Schaffer et al., 2009) 
 
 
 
 
 
 
A further chemiluminophore is isoluminol (Lundqvist, 1996) which differs from 
luminol with respect to the position of the amino group in the phthalate ring of the 
molecule (Figure 5.4). The change in the position of the amino group does not 
change the ability of the molecule to react with ROS (Dahlgren & Karlsson, 
1999).  
 
 
 
 
 
 
 
 
 
HOCL 
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Figure 5.4 Schematic molecular representations of luminol and isoluminol 
(Yamaguchi et al., 2002) 
 
 
 
 
 
 
 
 
Isoluminol [6-aminophthalazine-1,4-(2H,3H)-dione] follows the same light 
generating mechanism as luminol (Lundqvist, 1996 & Dahlgren & Karlsson, 
1999). However, moving the amino group away from the first carbon atom in the 
aromatic ring makes the isoluminol molecule more hydrophilic and less able to 
transverse biological membranes, therefore predominately detecting extracellular 
ROS release (Figure 5.5) (Lundqvist, 1996 & Dahlgren & Karlsson, 1999). In 
addition, isoluminol shows 10-100 times weaker chemiluminescence than that of 
luminol (Yamaguchi et al., 2002) and the availability of released cellular MPO 
also hinders the isoluminol light generating reaction (Dahlgren & Karlsson, 1999). 
Accordingly, owing to the fact that isoluminol chemiluminescence signal is 
weaker, exogenous peroxidase such as horseradish peroxidase (HRP) is added to 
the measuring system to amplify the isoluminol chemiluminescence signal 
(Lundqvist, 1996). 
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Figure 5.5 Membrane permeability of luminol and isoluminol (Dahlgren & 
Karlsson, 1999) 
 
 
 
 
 
 
 
 
 
A number of studies report that Ti nanoparticles presented as oxide species cause 
oxidative stress in various cell types including osteoblasts (Pioletti et al., 1999 & 
Li et al., 2010), BEAS-2B (Park et al., 2008), fibroblasts (Bhattacharya et al., 
2009) and many more (Long et al., 2007 & Jin et al., 2011) and can lead to either 
cell apoptosis (Wang et al., 2003, Park et al., 2008 & Kang et al., 2009) or 
necrosis (Tsutsui et al., 1999 & Osano et al., 2003). However, surprisingly the 
pro-inflammatory potential of Ti of different chemical speciation and particle 
sizes representative of implant derived debris on mammalian neutrophils 
(Kumazawa et al., 2002 & Goncalves et al., 2010) is poorly researched. 
 
Colorimetric, fluorometric and chemiluminescence assays of cellular processes 
are considerably complicated by the presence of particulate stimuli which may 
interfere with light output through absorption and with chemical reactions 
involved in the light production. Despite the extensive interest in cellular 
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responses to particles, this significant issue is rarely considered. In the context of 
the current investigation, TiO2 absorbs light in a spatial range overlapping the 
emission spectra of common chemiluminophores (luminol λ=425 nm and 
isoluminol λ=526 nm) with different observations according to speciation. 
Furthermore, TiO2 may also complex with produced ROS species such as H2O2 
and O2
- 
(section 5.2.4) (Tengvall et al., 1988). As a result considerable care must 
be taken to account for the possible interference effects the stimulus has on the 
measurement. 
 
5.2.6 Neutrophil phagocytosis
 
 
In addition to the neutrophil respiratory burst, neutrophils also display increased 
consumption of O2 during phagocytosis (Baldridge & Gerard, 1933 & Sbarra & 
Karnovsky, 1959) of foreign material and/or inflammatory mediators (May & 
Machesky, 2000). Neutrophils are recognised as the main leukocytes in humans 
with the function of phagocytosis (Metchnikoff, 1893). Phagocytosis represents a 
cellular engulfment process encompassing diapedesis, pseudopod formation and 
endocytosis to form a phagosome, but this process may also lead to tissue injury 
(Hensen & Oades, 1973), if reactive species are released from the neutrophil 
during phagocytosis.  
 
Numerous authors using imaging techniques such as transmission electron 
microscopy (TEM) have reported phagocytosis of Ti metallic wear debris in 
macrophages (Xing et al., 2008 & Hirayama et al., 2011), osteoblasts (Pioletti et 
al., 1999 & Meng & Yang, 2013), bone marrow-derived mesenchymal stem cells 
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(MSCs) (Wu et al., 2011) and fibroblasts (Osano et al., 2003). Ti debris as 
nanoparticles is proposed to be rapidly phagocytosed by cells as aggregates 
forming membrane bound vesicles and/or as individual particles via pinocytosis or 
endocytosis (Shanbhag et al., 1995 & Hallab, 2009). Moreover, investigators have 
demonstrated that the uptake of Ti nanoparticles into specific immune cell 
compartments can activate pro-inflammatory and pro-osteoclastogenic cytokines 
mediators including TNF-α, RANKL, M-SCF, PGE2, IL-1, IL-6 and IL-8 (Tuan 
et al., 2008) which could potentially influence peri-implant inflammatory 
responses (Pioletti et al., 1999 & Hiryama et al., 2011). Surprisingly, to date there 
is limited evidence for the phagocytosis of Ti nanoparticles by neutrophils and the 
subsequent distribution of Ti at the subcellular level (Kumazawa et al., 2002).  
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5.3 METHODS 
 
5.3.1 Ex-vivo determination of ROS production from stimulated neutrophils 
 
Chemiluminophores including luminol and isoluminol were employed to detect 
total and extracellular ROS production by stimulated neutrophils. A 30 mM stock 
solution was produced by dissolving 0.5 g of luminol (A8511; Sigma-Aldrich, 
UK) or isoluminol (A8264; Sigma-Aldrich, UK) in 94.05 mL of 1 mM NaOH 
prior to storage at 4 °C. The working solution was then prepared by diluting 1 mL 
of the stock solution of luminol/isoluminol in 9 mL of phosphate buffered saline 
(PBS) (Appendix I) and the pH was adjusted to 7.3 using dilute NaOH or HCl. 
 
5.3.2 Stimuli used to induce ROS production in neutrophils 
 
The control (Table 5.2) and experimental stimuli (Table 2.1; section 2.2) were 
prepared by adding high purity reagents to PBS. Table 5.2 demonstrates the 
working concentration of the prepared solution and stimulation concentration 
once added to the experimental system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 104 
Table 5.2 Stimuli used to induce ROS production 
 
Stimuli 
(Acronym) 
Supplier Working 
Concentration 
Stimulation 
Concentration 
Phosphate Buffer 
Saline (PBS) 
Made in house 
(Appendix I) 
 
- 
 
- 
Ops S. Aureus  
(Ops Sa) (non-
viable) 
LGC Standards, UK 
ATCC 9144 
6x10
8
/mL in 
PBS 
MOI
1
 1:300 
F. Nucleatum  
(FN) (non-viable) 
LGC Standards, UK 
ATCC 10953 
6x10
8
/mL in 
PBS 
MOI
1
 1:100 
 1
MOI: Multiplicity of Infection 
 
5.3.3 Characterisation of Ti stimuli 
 
In order to characterise the appearance of Ti particles and to evaluate Ti 
dispersion behaviour, Ti stimuli (Table 2.1; section 2.2) were dispersed in distilled 
water at a concentration of 200 ppm which was then dripped onto 200-mesh 
copper TEM grids. Samples were then left overnight to air dry and then studied 
using TEM (JEOL 1200, Japan) at variable magnifications. 
 
5.3.4 Blocking buffer (1% PBS-BSA)  
 
10 g of Bovine Serum Albumin (BSA) (A4503; Sigma-Aldrich, UK) was 
dissolved in 1 L of PBS to yield 1% PBS-BSA. The solution was stored at -20
 
°C 
until use.  
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5.3.5 GPBS (Glucose supplemented PBS)  
 
GPBS comprised 1.8 g of glucose, 0.15 g of CaCl2 (S10070; Sigma-Aldrich, UK) 
and 1.5 mLs of MgCl2 (1M; S22093; Sigma-Aldrich, UK) were added to 1 L of 
PBS and stored at 4 °C.  
 
5.3.6 HRP (Horseradish peroxidase) 
 
HRP provided in a salt free lyophilized powder form (P8375; Sigma-Aldrich, UK) 
was prepared in PBS of stock concentration of 1 U/µL and stored at -15 °C until 
further use. 75 µL of the stock was further diluted in 675 µL of PBS for it to be 
used at 0.1 U/µL. 
 
5.3.7 Sensitivity of chemiluminescence assay 
 
An experimental concern was that there may be an underestimation of the 
magnitude of the detected light signal as the Ti stimuli prepared as dispersions in 
PBS are likely to limit light transmission by light absorption where the effects will 
be concentration dependent. Therefore, the specific light emission of 
luminol/isoluminol was studied in the absence and presence of the Ti stimuli 
dispersed in PBS at a concentration of 2000, 200, 100, 20, 10, 2 and 1 ppm using 
a calibrated spectrometer (USB400, Ocean Optics, Dunedin, USA). A blank 
cuvette was placed in the spectrometer and intensity (Counts) against light 
wavelength (nm) was recorded. To the same cuvette, 2 mL of the respective Ti 
dispersion was added and light transmission was measured five times; between 
each measurement the cuvette was agitated so that the Ti particles remain 
 106 
dispersed during the measurement process. The light emission spectra for 
luminol/isoluminol were also measured five times. Light absorbance by each 
stimulus condition was calculated as a function of the decrease in peak emission 
wavelengths of luminol (λ=425 nm) and isoluminol (λ=526 nm) respectively (Liu 
et al., 1996). 
 
Since ROS species are known to react with Ti species (section 5.2.4) further 
calibrations were performed to identify whether the generated ROS were being 
consumed by non-light generating reactions. To ascertain these reactions the Ti 
stimuli (Table 2.1; section 2.2) prepared as dispersions in PBS at a concentration 
of 2000, 200, 20 and 2 ppm were suspended in luminol/isoluminol and then were 
reacted with H202 following measurement of light output by a Tube Luminometer 
(Lumat
3
 LB 9508, Berthold Technologies, Germany). The light output was first 
read for a blank tube for 15 secs and then 1.5 mL of luminol/isoluminol was 
transferred to the same tube and read for another 15 secs. The light measurements 
were paused and 500 µL of the luminol/isoluminol was replaced with 200 µL of 
1% PBS-BSA, 10 µL of HRP and 75 µL of GPBS and read for consecutive 15 
secs. 200 µL of the Ti stimuli were added to the same tube followed by thorough 
vortexing and monitored for 30 secs. The mixing was effective so that all the Ti 
particles remained in solution during the measurement process. 15 µL of 0.1% 
H2O2 was then added to the same tube followed by thorough vortexing and light 
output was monitored for the subsequent 30 secs. The assay was repeated five 
times and the light quenching potential of the Ti stimuli was calculated by 
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recording the proportional reduction in the peak luminescence of the test sample 
(RLU). 
 
5.3.8 Enhanced chemiluminescence assay for the measurement of ROS 
production from stimulated neutrophils  
 
Neutrophils were isolated and re-suspended at a concentration of 1x10
5 
cells/mL in 
PBS as previously described using a Percoll
®
 density gradient (Appendix I). A 96- 
well white micro-plate (Immunolon2, Dynex, Chantilly, VA, USA) was pre-
blocked with 200 µL of 1% PBS-BSA per well and stored overnight at 4 °C. The 
blocking buffer was removed by washing the plate five times with sterile PBS 
using a plate washer (Bio-Tek ELx50, Vienna). All assays were performed at 37 °C 
using a luminometer (LB96, Berthold UK Ltd., Milton Keynes, UK) where light 
output was recorded for 1 sec per well in RLU. Each well contained 45 μL of 
GPBS with 30 μL of luminol (3 mmol/L), or 15 μL of HRP (0.6 µg/mL) with 60 
μL of isoluminol (3 mmol/L). 100 μL of isolated neutrophils were added and light 
output was monitored for 30 mins to set a baseline. Cells were then stimulated with 
25 μL of either heat killed Ops Sa (MOI: 300-bacteria/neutrophil) or FN (MOI: 
100-1) as positive controls and PBS as a negative control. Experimental stimuli 
included 25 μL of high purity Ti (Table 2.1; section 2.2) prepared as sonicated 
dispersions of 2000, 200, 20 and 2 ppm in PBS. All samples were run in replicates 
of five within 2 hrs of blood collection. The entire assay was conducted around 10-
20 times for each Ti species, and on each occasion neutrophils were sourced from 
different healthy volunteers. 
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5.3.9 Ex-vivo detection of Ti nanoparticles internalised by mammalian 
neutrophils 
 
Interactions between Ti nanoparticles and mammalian neutrophils were 
investigated using TEM (TEM; JEOL 1200, Japan). Neutrophils were extracted 
from healthy volunteers as previously described (Appendix I) and re-suspended at 
a concentration of 1x10
5 
cells/mL in PBS. 6 mL of the isolated cells suspended in 
PBS, were proportioned into two equal volumes of 3 mL. Cells from each group 
were stimulated with 500 µL of Ti oxide as anatase (≤45 nm) (248576; Sigma-
Aldrich, UK) dispersed in PBS (Table 2.1; section 2.2) at a concentration of 2000 
ppm. In addition, one group of the Ti stimulated cells was also exposed to 250 µL 
of cytochalasin B (cytoB; extracted from Drechslera dematioidea) at a 
concentration of 10 µg/mL in PBS which is a known phagocytosis inhibitor 
(C6762; Sigma-Aldrich, UK). Stimulated cells were left at room temperature for 1 
hr and then repeatedly washed in PBS (x10) (centrifuged between each wash step). 
Both suspensions were then fixed with 2.5% glutaraldehyde followed by 1% 
osmium tetroxide for 1 hr. Samples were then dehydrated using graded ethanol 
dilutions prepared in distilled water ranging from 50, 60, 70, 80, 90 to 100% for 10 
mins each. After ethanol treatment, cells were embedded in a propylene oxide 
resin. Ultra-thin sections (~100 nm) were cut with a diamond knife microtome 
(UC6, Leica Ltd. Co, Germany) and then transferred onto 200-mesh copper TEM 
grids, stained with 3% uranyl acetate and lead nitrate. Sections were examined at 
variable magnifications using TEM-JEOL 1200 (JEOL 1200, Japan). In addition, 
Energy Dispersive X-ray (EDX) spectroscopy analysis (JEOL 2100, Japan) was 
conducted to locate Ti nanoparticles within the acquired images. The experiment 
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was conducted twice employing the same Ti stimuli as anatase (oxide) (≤45 nm at 
2000 ppm), with neutrophils sourced from different healthy volunteers. 
 
5.3.10 Statistical analysis  
 
Statistics were performed using SPSS 20 software. The data were initially 
explored for normality using a Shapiro-Wilk test at a 95% significance level. 
Comparison between groups was made using Wilcoxon Sign Rank tests at a 95% 
significance level. 
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5.4 RESULTS 
 
5.4.1 Dispersion of Ti particles 
 
TEM images of the Ti stimuli of oxide and metallic species of varying particle 
size dispersed in distilled water (200 ppm), revealed levels of agglomeration 
(Figure 5.6) consistent with those reported in previous literature (Tamura et al., 
2002, Wang et al., 2009 & Jin et al., 2011). For all nano sized Ti stimuli, a 
mixture of agglomerated particles (Figure 5.6; Left) and mono- dispersed 
nanoparticles (Figure 5.6; Right) were observed. Agglomerated particles remained 
below 1 µm in diameter however there was inherent variability in the size and 
morphology observed (Figure 5.6). For metallic particles sourced in high purity 
forms, but separated by sieve sizes variation in size was also observed (Figure 
5.6) up to the maximum diameter reported by the manufactures (Table 2.1; section 
2.2).  
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Figure 5.6 TEM images acquired at variable magnifications revealing surface 
properties of Ti stimuli dispersed in distilled water at a concentration of 200 
ppm as agglomerates (Left) and individual particles (Right)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ti oxide: 
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5.4.2 Sensitivity of chemiluminescence ROS quantification  
 
Spectroscopic measurements were used to estimate the attenuation of the light 
signal by the Ti stimuli used (Table 2.1; section 2.2) (Lappalainen et al., 2001). In 
these methods each sample acts as a reference for itself. The effect of light 
absorption at wavelengths (λ) corresponding to the peak emission wavelengths of 
luminol (λ=425 nm) and isoluminol (λ=562 nm) by Ti stimuli is reported in Table 
5.3 and Table 5.4 respectively. 
 
Table 5.3 Percentage attenuation of light output at emission maxima of 
luminol (λ=425 nm) following interaction with Ti stimuli at concentrations of 
2000, 200, 20, 10, 2 and 1 ppm 
 
 
 
Table 5.4 Percentage attenuation of light output at emission maxima of 
isoluminol (λ=562 nm) following interaction with Ti stimuli at concentrations 
of 2000, 200, 20, 10, 2 and 1 ppm 
 
 
 
Ti (ppm) Anatase 
(~30 nm) 
Rutile 
(~50 nm) 
Oxide 
Mix 
(~66 nm) 
Metallic 
(~5 µm) 
Metallic 
(~20 µm) 
Peroxy (size 
unknown) 
2000 88 88 89 63 88 84 
200 87 74 87 42 85 53 
20 49 50 51 22 37 31 
10 24 21 27 8 11 15 
2 11 10 11 7 7 8 
1 7 7 7 1 2 2 
Ti (ppm) Anatase 
(~30 nm) 
Rutile 
(~50 nm) 
Oxide 
Mix 
(~66 nm) 
Metallic 
(~5 µm) 
Metallic 
(~20 µm) 
Peroxy (size 
unknown) 
2000 91 91 92 67 91 88 
200 90 77 91 47 90 58 
20 53 53 55 25 41 34 
10 27 24 27 9 14 16 
2 11 12 11 7 7 8 
1 7 7 7 1 2 4 
Attenuation of light output (%) following interaction with Ti stimuli 
Attenuation of light output (%) following interaction with Ti stimuli 
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For all tested Ti species a reduction in the light signal was observed and was 
concentration dependent (Tables 5.3 & 5.4). The light signal in the presence of Ti 
as oxide nanoparticles or micron-sized metallic particles at a concentration of 
2000 and 200 ppm interacting with luminol and isoluminol, was reduced by >80% 
(Table 5.3) and >90% (Table 5.4) respectively. Ti as oxide nanoparticles 
attenuated to a greater extent than micron-sized metallic particles (Tables 5.3 & 
5.4). Increasing metallic particle size resulted in increased light attenuation 
(Tables 5.3 & 5.4). Ti peroxy compound also inhibited light output; but to a lesser 
extent (Tables 5.3 & 5.4). 
 
In addition to spectroscopy, tube luminometer measurements were used to 
estimate the reduction in chemiluminescence due to potential reaction of Ti 
stimuli with ROS species (in addition to photo-activation) (section 5.2.4) 
(Tengvall et al., 1988). For all conditions a log-linear reduction of light output 
was observed with increasing concentrations of Ti stimuli (Figure 5.7).  
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Figure 5.7 Log plots of light absorbance (RLU) in (a) luminol and (b) 
isoluminol containing Ti as oxide nanoparticles or micron sized metallic 
particles dispersed in PBS at concentrations of 2000, 200, 20 and 2 ppm 
following stimulation with 0.1% H202  
 
      (a)                                                          (b) 
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         (a)                                                  (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inhibition of light output by Ti measured by the tube luminometer (Figure 5.7) is 
similar to the percentage attenuation of light signal calculated by the spectrometer 
(Tables 5.3 & 5.4). The magnitude of the detected light signal measured for 
luminol and isoluminol excitation was quenched to a greater extent by Ti as oxide 
nanoparticles in comparison with micron-sized metallic particles (Figure 5.7).  
The magnitude of the light output was reduced with increasing Ti concentrations 
in a log-linear relationship (Figure 5.7).  
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5.4.3 Ex-vivo chemiluminescence quantification of neutrophil ROS release  
 
Chemiluminescence measurements of the respiratory burst of neutrophils at 2 hr 
post stimulation sourced from 10-20 different volunteers is presented in the form 
of Box/Whisker plots indicating median, inter-quartile range, 10
th
 and 90
th
 
percentiles and outliers (Figures 5.8-5.11). The plots demonstrate the maximum 
RLU at 2 hrs against stimulus employed. Significant differences between groups 
are marked by asterisk(s) (Figures 5.8-5.11). 
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Stimulation of cells from 20 different volunteers with Ops Sa and FN (positive 
controls) resulted in significantly increased total and extracellular ROS production 
in comparison with PBS (negative control) stimulated cells (P<0.005 for each 
comparison) (Figure 5.8). Insignificant differences in total ROS release were 
observed between Ops Sa and FN stimulated cells (P=0.333). However, for 
extracellular ROS release a significantly higher magnitude of light output was 
measured for FN exposed neutrophils in comparison to Ops Sa (P=0.003) (Figure 
5.8b). 
 
Figure 5.8 Box/Whisker plots demonstrating (a) total (luminol dependent) 
and (b) extracellular (isoluminol dependent) ROS production following 
stimulation with Ops Sa and FN (positive controls) in comparison with PBS 
(negative control)  
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Significantly increased and dose-dependent total and extracellular ROS release 
resulted from neutrophil stimulation with the Ti implant derivatives employed at 
concentrations of 2000, 200, 20 and 2 ppm when compared with the PBS 
stimulated cells (P<0.05 for each comparison) (Figures 5.9 & 5.10). However, the 
exception to the above was for extracellular ROS production in response to 
stimulation with Ti oxide as anatase (~30 nm) at 2 ppm (P=0.937) (Figure 5.9). 
Data is representative of neutrophils sourced from 10-20 different volunteers. 
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Figure 5.9 Box/Whisker plots of (a) total (luminol dependent) and (b) 
extracellular (isoluminol dependent) ROS production following stimulation 
with nano sized Ti oxides as anatase (~30 nm), rutile (~50 nm) and mix oxide 
(~66 nm) dispersed in PBS of 2000, 200, 20 and 2 ppm 
 
       (a)                    (b)                                                       
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Stimulation of cells sourced from 15 different volunteers with Ti oxide as anatase 
(~30 nm) at all tested concentrations resulted in significantly lower total and 
extracellular ROS production when compared with Ops Sa (P<0.002) and FN 
(P<0.001) exposed cells (Figure 5.9). However, Ti oxide as rutile (~50 nm) at 
2000 and 200 ppm resulted in significantly increased total and extracellular ROS 
production when compared with Ops Sa (P<0.001) and FN (P<0.001) stimulated 
cells (Figure 5.9). In common with anatase (~30 nm) stimulated neutrophils, 
responses to mix oxide (~66 nm) at all tested concentrations resulted in 
significantly decreased total and extracellular ROS release when compared with 
Ops Sa (P<0.01) and FN (P<0.01) stimulated cells (Figure 5.9). 
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Stimulation of cells sourced from 12 different volunteers with Ti as metallic 
species (~5 & ~20 µm) produced lower total and extracellular ROS production 
when compared with Ops Sa and FN exposed cells and no significant difference 
in ROS production was observed between the two metallic sized Ti species 
(P>0.333) (Figure 5.10). Ti as micron sized metallic species at tested 
concentrations of 2000 and 200 ppm showed significantly reduced total and 
extracellular ROS release when compared with Ti oxides as nanoparticles 
(P<0.008 for 2000 and 200 ppm tested concentrations).  
 
Figure 5.10 Box/Whisker plots of (a) total (luminol dependent) and (b) 
extracellular (isoluminol dependent) ROS production following stimulation 
with metallic Ti as ~5 and ~20 µm sized dispersed in PBS at concentrations of 
2000 and 200 ppm  
 
      (a)                                                        (b) 
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Stimulation of cells sourced from 10 different volunteers with Ti peroxy (size 
unknown) species revealed a significant increased dose dependent total (P<0.008) 
and extracellular ROS production (P<0.003) at all tested concentrations in 
comparison with PBS stimulated cells (Figure 5.11). The magnitude of total and 
extracellular ROS production was reduced in comparison with Ops Sa (P<0.005) 
and FN (P<0.005) stimulated cells (Figure 5.11) but similar to stimulation with Ti 
oxide species as rutile (~50 nm) (P=0.285) and anatase (~30 nm) (P=0.372) for all 
tested concentrations. Significantly increased ROS production resulted following 
stimulation with Ti peroxy (size unknown) species at all tested concentrations 
when compared with Ti as mixed oxide (~66 nm) (P<0.005) and metallic species 
(~5 & 20 µm) (P<0.003).  
 
Figure 5.11 Box/Whisker plots of (a) total (luminol dependent) and (b) 
extracellular (isoluminol dependent) ROS production following stimulation 
with Ti peroxy species dispersed in PBS at concentrations of 2000, 200, 20 
and 2 ppm 
 
(a)                                                            (b) 
 
 
 
 
 
 
 
 
 
 
 
 
*** 
*** 
*** 
*** *** 
*** 
*** *** 
** 
** 
** ** 
** 
** 
** ** 
* 
* 
* 
* 
* 
* 
* * 
Significant different from PBS* 
Significant different from Ops Sa** 
Significant different from FN*** 
Stimulus
PB S 2000 200 20 2
 R
L
U
 
0
2000
4000
6000
8000
10000
12000
14000
16000
Stimulus
PB S 2000 200 20 2
 R
L
U
 
0
500
1000
1500
2000
* 
* 
 
 
 
** 
 
** 
 ** 
 ** 
 
*  
 
** 
  
 
** 
 
*** 
 
*** 
 *** 
 *** 
 
*** 
 
*** 
 *** 
 
*** 
 
 123 
5.4.4 Ti size and species specific magnitude of ROS production 
 
Median values of light output from chemiluminescence assays of the neutrophil 
respiratory burst in response to Ti implant derivatives of varying particle size and 
species are displayed in Figure 5.12. The plots demonstrate total (luminol) (Figure 
5.12; Left) and extracellular (isoluminol) (Figure 5.12; Right) chemiluminescence 
(RLU) against particle size (nm) respectively.  
 
Total ROS production measured at all tested concentrations was significantly 
increased for Ti oxide as rutile speciation with ~50 nm a particle size in 
comparison with all other tested Ti species (Figure 5.12). Extracellular ROS 
production was also higher for Ti oxide as rutile (~50 nm) measured at 2000 and 
200 ppm when compared with all other tested Ti species (Figure 5.12). However, 
stimulation with Ti oxides as anatase (~30 nm) and mixed oxide (~66 nm) 
species, similar magnitudes of total and extracellular ROS production was 
observed (Figure 5.12). Metallic species of ~5 µm and ~20 µm sizes resulted in 
the lowest magnitude of total and extracellular ROS production at tested 
concentrations of 2000 and 200 ppm (Figure 5.12). 
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Figure 5.12 Median plots presented on a log scale of (a) total (luminol) and 
(b) extracellular (isoluminol) ROS production expressed in RLU of Ti oxides 
as anatase (~30 nm), rutile (~50 nm) and mix oxide (~66 nm); and metallic 
species of ~5 µm and ~20 µm sized stimulated cells at concentrations of 2000, 
200, 20 and 2 ppm compared to particle size in nanometers (nm) 
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5.4.5 Kinetics of ROS production from stimulated neutrophils 
 
The onset of the respiratory burst and the production of ROS over time were 
observed following stimulation with Ti oxide as nanoparticles and micron sized 
metallic particles (Figure 5.13). Stimulation of the respiratory burst with Ti oxide 
nanoparticles at a concentration of 2000 ppm was rapid with peak light emission 
observed almost immediately following stimulation (Figure 5.13). The maximum 
luminol/isoluminol chemiluminescence signal for Ti oxide nanoparticle 
stimulated neutrophils at a concentration of 2000 ppm was observed at ~2000 secs 
(stimuli added at 1800 secs) followed by a rapid decay in the signal at ~3000 secs 
(Figure 5.13). In contrast, the generation of ROS species for Ti oxide 
nanoparticles stimulated cells at concentrations of 200 and 20 ppm was slower 
with the maximum luminol/isoluminol light output observed from ~2500 secs 
onwards followed by a more gradual decay (Figure 5.13).  
 
In comparison to the kinetics of the neutrophil respiratory burst by Ti oxide 
nanoparticles, the kinetics of ROS release following stimulation with Ti as 
metallic micron sized particles at a concentration of 2000 and 200 ppm was 
similar to Ops Sa and FN exposed cells (Figure 5.13). Although the magnitude of 
luminol/isoluminol chemiluminescence signal was decreased for metallic micron 
sized particles stimulated cells at a concentration of 2000 and 200 ppm, the onset 
time to peak in light output and decay in light signal followed the same pattern 
(Figure 5.13). A maximum onset of luminol/isoluminol chemiluminescence signal 
for metallic stimulated cells was observed at ~3000 secs followed by gradual 
decay in the signal until ~6000 secs (Figure 5.13).  
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Figure 5.13  Kinetics of ROS production of neutrophils following 
stimulation with Ti implant derivatives as oxide nanoparticles or micron 
sized metallic particles, Ops Sa and FN. Response is calibrated as 
chemiluminescence (RLU) vs. time (secs). Typical curves are displayed for 
each condition and scales are not common for graphs displayed 
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5.4.6 Ex-vivo phagocytosis of Ti implant derivatives by mammalian 
neutrophils 
 
The phagocytosis of Ti oxide as anatase nanoparticles (≤45 nm) at a concentration 
of 2000 ppm by neutrophils was demonstrated using TEM (Figures 5.14-5.16). 
The TEM images acquired after 1 hour Ti exposure indicated cell surface 
interaction with particles (black and white features marked in Figure 5.14) and 
cellular uptake of Ti nanoparticles as agglomerates (Figure 5.14). Membrane 
bound uptake of Ti nanoparticles was also visualised within the neutrophil (Figure 
5.14).  
 
Figure 5.14 TEM image (JEOL 1200, Japan) acquired at 10,000 
magnification of isolated neutrophil post 1 hr stimulation with Ti oxide as 
anatase (≤45 nm) dispersed in PBS at a concentration of 2000 ppm  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition, higher magnification images of Ti stimulated neutrophils revealed 
modifications of the cell membrane demonstrating the classical appearance of 
pseudopods (encircled in red) forming around agglomerations of Ti nanoparticles 
(Figure 5.15).  
Cellular up-
take of Ti (nm) 
Membrane 
bound up-take of 
Ti (nm) 
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Figure 5.15 Enlarged TEM images (JEOL 1200, Japan) acquired at 10,000 
magnification of isolated neutrophils post 1 hr stimulation with Ti oxide as 
anatase (≤45 nm) dispersed in PBS at a concentration of 2000 ppm 
 
 
 
 
 
 
 
 
 
Agglomeration of Ti nanoparticles in the cytoplasm of the neutrophil was 
observed (Figures 5.16). The presence of Ti nanoparticles as aggregates within the 
neutrophil membranes was fluorescently confirmed by EDX (Figures 5.16).  
 
Figure 5.16 TEM image (JEOL 2100, Japan) (Left) and EDX (Right) in 
fluorescence mode acquired at 10,000 magnification of an isolated neutrophil 
post 1 hr exposed to Ti oxide as anatase (≤45 nm) dispersed in PBS at 2000 
ppm identifying distribution of Ti nanoparticles as aggregates on the 
neutrophil surface   
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In contrast pre-exposure to the actin inhibitor cytoB (10 µg/mL) followed by 
stimulation with Ti oxide as anatase (<45 nm) at a concentration of 2000 ppm 
dispersed in PBS revealed no presence of membrane bound and/or cellular uptake 
of Ti nanoparticles into the neutrophil (Figure 5.17).  
  
Figure 5.17 TEM images of isolated neutrophils post 1 hr co-stimulation with 
Ti oxide as anatase (≤45 nm) dispersed in PBS at a concentration of 2000 
ppm and phagocytosis inhibitor cyto B (10 µg/mL) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 µm 1 µm 
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5.5 DISCUSSION 
 
 
Neutrophils are sensitive immune cells but not responsive to all biochemical 
stimuli (Edwards, 1994). Measurement of ROS generation and consequent 
oxidative stress are considered to be strong indicators of a toxic effect of particles 
on such cells (Jin et al., 2011). Previous studies have demonstrated that Ti as fine 
metallic particles of up to 3 µm (Tamura et al., 2002) can stimulate oxidative burst 
reactions in healthy neutrophils (Kumazawa et al., 2002). In the current study, it 
was confirmed that Ti implant derivatives representative of those forms in tissues 
as oxide nanoparticles and micron sized metallic particles and Ti peroxy species, 
all stimulated neutrophil ROS release in a concentration dependent manner 
(Figures 5.9-5.11) and that the particle size and speciation (Figure 5.12) of the Ti 
stimuli were important parameters for determining the magnitude of the response. 
These ex-vivo observations demonstrate the capacity of Ti to modify 
inflammatory responses in-vivo as the Ti stimuli of varying concentrations and 
speciation employed were representative of the heterogeneity of the Ti debris 
observed in inflamed tissues surrounding percutaneous implants (Chapters 3 & 4).  
 
Significant stimulation of total and extracellular ROS release was observed from 
all Ti challenged neutrophils at concentrations as low as 2 ppm (Figures 5.9-5.11). 
Large variations in the magnitude of ROS release were observed as a consequence 
of individual (neutrophil donor) responses which are likely to vary on a day to day 
basis. These enhanced responses (in magnitude of ROS production) suggest 
increased sensitivity of certain individuals; however this was not systemically 
evaluated. Moreover, ROS measurements were significantly underestimated due 
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to interactions of the Ti stimuli with the ROS themselves (Tengvall et al., 1988) or 
by photo-absorption of the chemiluminescence light signal (Kaida et al., 2004 & 
Zhang et al., 2004). This suggests a significantly increased potency of Ti as a 
ROS stimulator and that lower concentrations of Ti will also result in ROS 
generation. 
 
Previous studies have documented that Ti particles can alter cell function and 
phenotype with differential effects regulated by particle size (Choi et al., 2005, 
Liu & Webster, 2006, Long et al., 2007 & Lovern & Klaper, 2006). In the current 
study, it was demonstrated that Ti as oxides including anatase (~30 nm), rutile 
(~50 nm) and mix oxide (~66 nm) species all stimulated increased levels of ROS 
release in comparison with metallic particles of ~5 µm and ~20 µm sizes (Figures 
5.9 & 5.10). In addition, Ti peroxy complexes (unknown size) also resulted in 
increased ROS production when compared with metallic micron sized species 
(Figures 5.10 & 5.11). Ti peroxy species are of interest as they are a potential 
product of chemical reactions between TiO2 and H2O2 (Tengvall et al., 1988), a 
ROS product of the neutrophil respiratory burst (Figure 5.1) (Hampton et al., 
1998). These have been identified in tissues and their capacity to stimulate ROS 
production is important as it demonstrates a continuation of pro-inflammatory 
potential of Ti, following the initial interaction of TiO2 with the neutrophil 
(section 5.2.4). The dependency of the observed magnitude of ROS release on Ti 
particle size may be a consequence of differences in particle interactions with cell 
membranes; the capacity for cell internalisation; and surface interactions with 
biomolecules (Kumazawa et al., 2002 & Tamura et al., 2002). Cellular effects 
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have been shown to be more pronounced when Ti particles are smaller than the 
cell (neutrophil cell size ranges from 5-10 µm) (Kumazawa et al., 2002) enabling 
cellular internalisation of the particles via pathways including pinocytosis, 
endocytosis and/or phagocytosis with the specific pathway being dependent upon 
particle size (Tamura et al., 2002, Long et al., 2007 & Pierre, 2010). In addition to 
cellular uptake, membrane interactions of nanoparticles are likely to be more 
significant when compared with micron sized particles due to the increased 
surface area for contact and the increased surface energy of the particles (Long et 
al., 2007 & Lundqvist, 1996). It is known that the surface area of particles is a 
major determinant of cellular toxicity (Jin et al., 2011). Ti oxides as nanoparticles 
have a larger surface area and different physicochemical properties including 
higher surface energies (Long et al., 2006) than micron sized particles. It is 
proposed that in the current study, cell activation by nanoparticles is likely to have 
occurred through different pathways when compared with the larger metallic 
species. This is supported by observations of a rapid onset of the respiratory burst 
in Ti nanoparticle stimulated neutrophils when compared with cells stimulated 
with the larger particles (Figure 5.13) in combination with the observed 
magnitude of ROS release.  
 
Despite Ti oxides of similar nanoparticle sizes being employed, significant 
differences in total and extracellular ROS production were observed for rutile 
speciation (~50 nm) when compared with anatase (~30 nm) and mixed oxide (~66 
nm) species (Figure 5.9). TEM imaging demonstrated similar aggregation of the 
nanoparticles in terms of their size however there was inevitable heterogeneity in 
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the aggregate morphology (Figure 5.6). It may be postulated that rutile in-vivo 
significantly contributes to increased extracellular damage as it is one of the 
predominant Ti implant derivatives observed within inflamed tissues (Chapter 4). 
However, further studies are required to determine whether this is indeed a 
biological effect of Ti-O bond co-ordination or simply a morphological 
sensitivity. 
 
Exposure to Ti oxide as nanoparticles resulted in a more rapid activation of the 
respiratory burst by comparison with all other tested stimuli (Figure 5.13). 
Cellular internalisation with Ops Sa and FN is associated with Fc-γ and TLR-4 
receptor mediated activation respectively, leading to activation of secondary 
messengers, Protein kinase C (PKC) and NADPH oxidase assembly, and 
ultimately ROS production following phagocytosis (Huizinga et al., 1989 & 
Kawai & Akira, 2009). Particulate debris has been shown to interact with cell 
surface receptors (Dobrovolskaia & McNeil, 2007); however these interactions 
are likely to be highly variable. Furthermore, nano sized particles have been 
shown to be both phagocytosed and/or endocytosed passing directly through the 
cell membrane (section 5.4.6). The consequence of receptor mediated uptake 
(Pierre, 2010) leading to accumulation within phagosomes of the neutrophil is 
consistent with the observed rapid and increased ROS production (Figure 5.13). 
However, at increased concentrations of Ti, the particles may induce phagosomal 
destabilisation (Hussain et al., 2010). Nanoparticles endocytosed have been shown 
to have a strong binding affinity for phosphorylated proteins (Larsson et al., 2003) 
which may also account for the rapid and excessive ROS release (Goncalves & 
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Girard, 2011). In contrast, the kinetics of the respiratory burst at 200 and 20 ppm 
for oxide nanoparticles was slower and did not reduce rapidly (Figure 5.13). This 
may suggest at higher concentrations the effects on cell viability may be 
responsible for the loss of the light signal rapidly within the assay. At lower 
concentrations cell viability is improved leading to more prolonged ROS release 
(Figure 5.13). As these conditions are more likely to be observed in-vivo, one 
notable manifestation would be excessive tissue damage via a prolonged 
extracellular ROS release (Bergamini et al., 2004). 
 
In contrast, the kinetics of the neutrophil respiratory burst by micron sized 
metallic particle stimulated cells (Figure 5.13) was suggested to be independent of 
particulate uptake. It is likely that cells stimulated with micron sized particles may 
have attempted and re-attempted to perform phagocytosis but due to the size 
limitation the cells are often incapable in many cases due to complexity of the 
particle to be internalised. A negative effect of such cellular interactions has been 
reported as receptor clustering (Pierre, 2010) which may inhibit cell responses to 
critical stimuli in the extracellular environments. 
  
There is limited data on the uptake of Ti nanoparticles as agglomerates and their 
distribution within the compartments of the neutrophil (Kumazawa et al., 2002).  
TEM images acquired within this study distinguished the distribution of Ti 
nanoparticles in single cells with a detection sensitivity and resolution well suited 
to explore subcellular interactions (section 5.4.6). The findings revealed 
neutrophils extending membrane derived pseudopods to phagocytize aggregated 
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particles of the Ti oxide anatase (≤45 nm) (Figure 5.15). Furthermore, the 
nanoparticles were observed to penetrate the plasma membrane (non-membrane 
bound) and be located in the cytosol including in the region of nuclear membranes 
(Figure 5.16). The underlying mechanism of Ti nanoparticle distribution within 
the neutrophil cell compartments may be as a result of binding to proteins within 
the cell, mediated by its electrostatic properties, thus becoming entrapped 
(Jovanovic et al., 2011). Co-stimulation of neutrophils with Ti oxide in the form 
of anatase (≤45 nm) and following exposure to cyto B (phagocytosis inhibitor) 
(Honeycutt & Niedel, 1986) resulted in no cellular uptake of any Ti particles 
(Figure 5.17). Cyto B is an actin inhibitor (Honeycutt & Niedel, 1986 & Hensen 
& Oades, 1973) and accordingly the lack of observed phagosomes containing Ti 
particles was not surprising, however no uptake of Ti was observed at all (Figure 
5.17). The lack of endocytosis may be as a consequence of further effects of 
cytoB (beyond the actin cytoskeleton inhibition but was not definitively 
demonstrated in this study) (O‘Flaherty et al., 1978). 
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5.6 CONCLUSION 
 
 
The present findings suggest that Ti implant derivatives in the form of oxide 
nanoparticles and micron-sized metallic particles, and peroxy species can be 
potent inducers of the neutrophil respiratory burst. However, responses to Ti as 
oxide nanoparticles compared with micron sized metallic species suggest 
increased complexity of the cellular and subcellular interactions which have 
implications for the progression of the peri-implant inflammatory response. 
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CHAPTER 6  
 
THE IMPACT OF TITANIUM IMPLANT DERIVATIVES 
EXPOSURE ON NEUTROPHIL EXTRACELLULAR TRAP 
(NET) RELEASE FROM HUMAN NEUTROPHILS 
 
 
6.1 PREFACE 
 
This chapter investigates the potential of ‘Ti implant derivatives’ accumulated 
within peri-implant tissues to stimulate the release of Neutrophil Extracellular 
Traps (NETs) which may influence resolution of peri-implant infection and/or the 
progression of peri-implant inflammation. A MNase assay was employed for ex-
vivo fluorometric quantification of NET release from neutrophils challenged with 
nano and micron sized Ti species at concentrations of 2000 and 200 ppm and 
compared with control conditions. Fluorescence microscopy was used to visualise 
NET release and the morphology of NET structures from challenged neutrophils. 
Finally, the capacity for NET structures to adhere to Ti implant surfaces was 
studied in the presence and absence of a physiologically representative protein 
adsorbed layer. 
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6.2 INTRODUCTION 
 
6.2.1 Neutrophil Extracellular Traps (NETs) 
 
The first evidence describing the capacity of neutrophils to extrude web-like 
strands of processed chromatin fibres and granule protein complexes into the 
extracellular environment was reported in 2004 (Brinkmann et al., 2004). The 
structures were described as Neutrophil Extracellular Traps (NETs) and their 
formation represents a unique form of programmed cell death which is non-
exclusively regulated by NADPH oxidase generation of Reactive Oxygen Species 
(ROS) (Palmer et al., 2012). The entire process of NET formation has been 
termed as NETosis (Fuchs et al., 2007).   
 
The point at which NETs are released by the neutrophil is important as it ends the 
capacity of the cell to perform vital functions such as phagocytosis (Fuchs et al., 
2007) and the recruitment of immune cells (Bartneck et al., 2010). The sequence 
of events involved in NET release begins with the generation of ROS via receptor 
ligand interactions or activation of the NADPH oxidase complex via 
mitochondrial ROS generation (Fuchs et al., 2007). Subsequently, long strands of 
DNA migrate from the nucleus to the cytoplasm and mix with granular and some 
selected cytoplasmic proteins before being actively released through the plasma 
membrane into the extracellular space (Brinkmann et al., 2004 & Fuchs et al., 
2007). Following the release of NET structures, the plasma membrane ruptures 
completely (Brinkmann et al., 2004) and the cell dies (Brinkmann & Zychlinsky, 
2012). 
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6.2.2 NET morphology 
 
The composition of NETs has been characterised using a variety of methods 
including mass spectrometry (MS) (Saffarzadeh et al., 2012), proteomics (Knight, 
2012) and immunofluorescence (Bergamo, 2012). DNA has been identified as the 
major structural component and forms complexes with proteins derived from all 
three neutrophil granule types (Brinkmann & Zychlinsky, 2012). To date, proteins 
including neutrophil elastase (NE), cathepsin G and myeloperoxidase (MPO) 
(derived from azurophil granules); lactoferrin (secondary granules) and gelatinase 
(tertiary granules) have been associated with NETs (Papayannopoulos et al., 2010 
& Hakkim et al., 2011). In contrast, certain proteins such as CD63, actin and 
tubulin have been shown to be excluded (Hakkim et al., 2011). Visualisation of 
NETs using scanning electron microscopy (SEM) has identified that the DNA 
based structures have an average diameter of 15-17 nm with globular protein 
domains of approximately 25 nm (Brinkmann & Zychlinsky, 2012). However, 
these can also aggregate into larger threads with a diameter of ~50 nm 
(Brinkmann & Zychlinsky, 2012) forming netted structures of hundreds of nm in 
length and width (Clark et al., 2007).  
 
6.2.3 The function of NETs 
 
The exact function of NETs is still not fully understood, however, NETs have 
been described as contributing to both anti-inflammatory (Clark et al., 2007, 
Kessenbrock et al., 2009, Papayannopoulos & Zychlinsky, 2010 & Hakkim et al., 
2010) and pro-inflammatory processes (Brinkmann et al., 2004 & Gupta et al., 
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2005). The physiological or pathological impact of NETs is proposed to be 
dependent upon the magnitude of release and the specific NET composition which 
may consist of high or low concentrations of granular proteins (Urban et al., 
2009). 
 
6.2.3.1 Anti-infectious role of NETs 
 
The contribution of NETs to the host defence system has been identified in a 
number of pathological conditions including necrotizing fasciitis (Buchananan et 
al., 2006) and pneumonia (Beiter et al., 2006). Neutrophils have been shown to 
release NETs with antimicrobial functionality into the extracellular environment 
and form ‘traps’ that serve as a physical barrier for microorganisms (Remijsen et 
al., 2011 & Riyapa et al., 2012); preventing their spread and limiting the extent of 
damage to healthy tissues (Esmon et al., 2011). Trapping microbes prevents their 
dissemination and inactivates virulence factors (Hampton et al., 2008). So far 
NETs have been demonstrated to trap bacteria, pathogenic parasites, fungi and 
yeasts (Brinkmann and Zychlinsky, 2012). The ability of NETs to kill microbes is 
hypothesised to be due to the local effects of NET associated proteins which exert 
antimicrobial activity localised in proximity to the pathogen even at low 
concentrations (Riyapa et al., 2012). These include enzymes (lysozyme & 
proteases), antimicrobial peptides (defensins), ion chelators (calgranulin) and 
histones (Brinkmann et al., 2004). These components which are present on NETs 
may be present in combination or in isolation (Bergamo et al., 2012 & Riyapa et 
al., 2012). Increased concentrations of these components found on NETs are 
associated with increased antimicrobial activity (Bergamo et al., 2012).  
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6.2.3.2 Pro-inflammatory role of NETs 
 
In contrast, NET release has also been shown or proposed to exacerbate 
pathological conditions such as periodontitis (Delbosc et al., 2011), streptococcal 
infections (Molloy, 2006), appendicitis (Fuchs et al., 2007), shigellosis 
(Brinkmann et al., 2004), cystic fibrosis (CF), ischemia (Brinkmann et al., 2012), 
pre-eclampsia (Gupta et al., 2005) autoimmune and thrombotic disorders 
(Farquharson et al., 2011) and contribute to the overall inflammatory milieu 
(Remijsen et al., 2011). It has been proposed that the formation of NETs can 
prolong inflammation by concentrating antimicrobial proteins (AMPs) 
(Brinkmann et al., 2012) and serine proteases such as elastase and cathepsin G 
within tissues and therefore increase the risk of tissue damage (Forsyth et al., 
1994). The DNA component of NETs in the extracellular matrix has also been 
suggested to be immunogenic (Lande et al., 2007) and investigators have shown 
initiation and maturation of antigen presenting cells (APCs) such as bone marrow 
and dendritic cells (DCs) by up-regulating the expression of MHC-II, CD40 and 
CD54 (Ishii et al., 2001). In addition, extracellular DNA elicits TLR-9 signalling 
in DCs (Garcia-Romo et al., 2011) and monocytes (Tillack et al., 2012) which 
stimulate the production of interferons (IFNs), thus exacerbating adaptive and 
autoimmune responses (Brinkman et al., 2012). This has been proposed as a 
driver of a type-1 IFN gene expression signature in blood neutrophils from 
periodontitis patients (Wright et al., 2008). 
 
The pro-inflammatory activity of NETs has been observed in the mucolytic 
therapy for CF patients (Manzenreiter et al., 2012) who were treated with 
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recombinant DNases to disintegrate NETs (Segal et al., 2005) with the aim of 
liquefying sputum, reducing its viscosity and facilitating mucus clearance 
(Buchanan et al., 2006). However, this therapeutic approach proved to be 
problematic as disintegrated NETs released neutrophil elastase which further 
processed core histones contributing to tissue damage (Buchanan et al., 2006 & 
Papayannopoulos et al., 2011). Notably studies currently document that histones 
induce a number of pathological effects including collateral damage via toll-like 
receptors (TLR-2/4) (Gupta et al., 2010), kill endothelial cells (Saffarzadeh et al., 
2012) and are implicated in the pathogenesis of sepsis (Xu et al., 2009) and 
systemic lupus erythematosus (SLE) (Garcia-Romo et al., 2011) .  
 
6.2.4 Inducers of NET release 
 
Several inducers of NET release have been identified including bacteria (Fuchs et 
al., 2007), parasites (Guimaraes-Costa et al., 2009), fungi (Brinkmann et al., 
2012), yeast (Urban et al., 2006b), cytokines (Brinkmann et al., 2004), antibody-
antigen complexes (Garcia-Romo et al., 2011 & Lande et al., 2011), microbial 
components such as lipophosphoglycans (Oehmcke et al., 2009) and bacterial 
endotoxins (Brinkmann et al., 2004). Interestingly, antibodies in 
concentrated/aggregated forms e.g. IgG coated beads are also capable of inducing 
NETs, however IgG in free solution does not (Fuchs et al., 2007 & Kessenbrock 
et al., 2009).  
 
The most dominant NET triggers reported are ROS including hydrogen peroxide 
(H2O2) (Fuchs et al., 2007) and hypochlorous acid (HOCl) (Palmer et al., 2012). 
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In-vitro studies have also identified phorbol myristate acetate (PMA) (Guimaraes-
Costa et al., 2009) and lipopolysaccharide (LPS) (Neeli et al., 2009 & Lim et al., 
2011) to be enhancers of NET release. It is clear that, NET release is variable 
according to the nature of the stimulus employed and the processes involved in 
NETosis involve multiple pathways (Fuchs et al., 2007). A whole live bacterium 
has been shown to induce NETs more efficiently than a single TLR-4 activator 
such as LPS (component of outer membrane of gram negative bacteria) alone 
(Clark et al., 2007 & Fuchs et al., 2007).  
 
6.2.5 Mechanism(s) of NET release 
 
Neutrophils are short lived (2-4 days) and therefore current knowledge regarding 
the molecular mechanism(s) by which NETs are produced is limited. One of the 
first reports describing the process of NETosis was identified by employing PMA 
as a stimulus. In this early report, PMA was identified to cause rapid NET release 
(Takei et al., 2006). PMA is lipophilic and therefore able to cross the cell 
membrane quickly bypassing any cell surface receptor interactions (Seligmann et 
al., 1980). PMA in neutrophils is a potent activator of the NADPH oxidase 
(Teufelhofer et al., 2003) and evokes NET release in a relatively prolonged 
activation of protein kinase C (PKC) by replacing the role of the physiological 
activator diacylglycerol (DAG) (Newton, 1995 & Ermert et al., 2009). In addition, 
subsequent in-vitro studies also recognised that PMA enhanced NET release by 
53% in neutrophils in response to the parasite L. amazonensis (Guimaraes-Costa 
et al., 2009) and also up-regulated responses to yeast Candida albicans (Urban et 
al., 2006b) and to Aspergillus nidulans (Bianchi et al., 2009). Findings from the 
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three studies propose that activation upstream of NADPH oxidase complex (also 
known as phagocytic oxidase PHOX/NOX2) and downstream of PKC culminates 
in a NET release cascade involving the Raf-MEK-ERK kinase pathway (Hakim et 
al., 2011) and Rac2 (Neeli et al., 2009 & Lim et al., 2011).  
 
In chapter 5 the traditional role of the NADPH oxidase was described in the 
context of production of ROS species to eliminate pathogens (Sequchi & 
Kobayashi, 2002). However, the oxidase also displays a number of less well 
known roles in neutrophil physiology such as regulation of NET release (Amulic 
et al., 2012). Evidence for this has been observed in chronic granulomatous 
disease (CGD) patients whose NADPH oxidase enzyme complex is compromised 
(Bakri et al., 2009) and therefore fails to elicit NET release when neutrophils are 
stimulated with potent inducers such as PMA or bacteria (Dinauer 2005, 
Brinkmann & Zychlinsky, 2012 & Palmer et al., 2012). However, interestingly 
when the CGD neutrophils were treated with H2O2, a product of dismutation of 
O2
-
 during ROS release (section 5.2.2), the cells resulted in NET release 
(Bergamo, 2012). The same was observed for HOCl treated CGD neutrophils 
(Palmer et al., 2012), HOCl derived from MPO. These findings indicate that 
exogenous H2O2 targets the same molecule as endogenously produced H2O2 
suggesting that overall NET release is regulated by the downstream signaling of 
NADPH oxidase at the HOCl level, even though the NADPH oxidase complex 
itself is not functional (Fuchs et al., 2007). Further evidence that ROS and 
specifically H2O2 regulate NET formation has been reported (Fuchs et al., 2007). 
When neutrophils were exposed to low concentrations of diphenyl- eneiodonium 
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(DPI) (oxidase inhibitor) and catalase (degrades H2O2 to molecular O2 and water 
during ROS formation), ROS and NET release were inhibited in response to 
potent PHOX inducers namely PMA and S. aureus (Fuchs et al., 2007). 
Conversely upon employing the catalase inhibitor, 3-amino-1,2,4 triazole (3-AT), 
both ROS and NET release were evoked (Fuchs et al., 2007). However, the 
precise mechanism(s) underpinning both processes is yet unclear. Furthermore, 
conflicting to the above report, it was recently demonstrated that NET release was 
decreased following 3-AT stimulation (Palmer et al., 2012). Thus it may be 
concluded that ROS species formation (section 5.2.2) contributes to microbe 
killing via two strategies (a) intra-phagosomal killing in live neutrophils and/or 
(b) act as secondary messengers for stimulating NET mediated killing post 
NETosis (Amulic et al., 2012). It is also now known that NET formation is not 
solely dependant on ROS production but specifically HOCl which can directly 
stimulate NET release (Palmer et al., 2012). 
 
The overall process of NET formation is incomplete without chromatin de-
condensation and the association of AMPs (Papayannopoulos et al., 2010 & 
Remijsen et al., 2011). Studies have generalized that MPO and neutrophil elastase 
found on NETs and stored in the azurophilic granules regulate the process 
(Papayannopoulos et al., 2010). It is proposed that upon NADPH oxidase 
activation, both MPO and NE are released through an unknown mechanism 
(Papayanopoulos et al., 2010) and that MPO independent of its enzymatic activity 
acts synergistically with NE causing degradation of the linker histones H1 
(Papayannopoulos et al., 2010). In addition to the above proposed model, 
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experimental evidence has confirmed that both NE and MPO are required for 
chromatin de-condensation (Papayannopoulos et al., 2010 & Parker et al., 2012). 
For example, NE deficient mice fail to secrete NETs (Papayannopoulos et al., 
2010). The role of MPO which yields HOCl during ROS formation was 
investigated by employing HOCl as a stimulus to CGD neutrophils (Palmer et al., 
2012). Studies revealed that when HOCl is directly added to CGD neutrophils, 
NET release was stimulated (Palmer et al., 2012). This observation confirms that 
ROS are essential for NET formation and further substantiates the involvement of 
MPO and MPO derived HOCl displays a regulatory role in NET release (Palmer 
et al., 2012). In addition, Palmer et al., (2012) employed the specific MPO 
inhibitor 4-aminobenzoic acid hydrazide (4-ABAH) which resulted in inhibition 
of NETs confirming data from Papayannopoulos et al., (2010). The current 
evidence supports the fact that superoxides, ROS and the by-products of the 
respiratory burst such as MPO contribute to the activation of NETosis and overall 
the process may be NADPH oxidase dependent (Fuchs et al., 2007) or 
independent (Pilsczek et al., 2010).  
 
6.2.6 NETosis distinct to apoptosis and necrosis 
 
NETosis is distinct to cellular apoptosis (Fadeel, 2009) and necrosis (Fuchs et al., 
2007). Preliminary evidence reports that NETs may form in as little as 10 minutes 
after cell stimulation, a process more rapid than apoptosis (Brinkmann et al., 
2004). During NET formation, the neutrophils flatten, remaining motile and 
phagocytic (Brinkmann et al 2004). Their nuclei lose their characteristic lobular 
morphology and fill the majority of the intracellular cytoplasmic space (Fuchs et 
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al., 2007). Concomitantly, the chromatin begins to decondense so the distinction 
between eu- and hetero-chromatin is lost (Brinkmann et al., 2004). Lastly, both 
the nuclear and granular components homogenise and form web-like structures 
called NETs which are ejected into the extracellular environment (Fuchs et al., 
2007). This indicates that NETs are formed by a controlled extrusion, rather than 
by the random spilling of granule and nuclear contents into the extracellular space 
(Fuchs et al., 2007).  
 
In contrast, during cell necrosis the nuclear membrane remains intact; there is no 
loss of differentiation between eu- and hetero-chromatin and extracellular DNA 
release does not occur (Fuchs et al., 2007). Similarly, during apoptosis there is no 
DNA fragmentation; chromatin is strongly exhibited and is separated into several 
membrane bound apoptotic bodies and no cell contents are released into the 
extracellular space (Fuchs et al., 2007). Apart from the morphological distinctions 
mentioned above, both NETosis and apoptosis are highly regulated processes but 
apoptosis requires proteases known as caspases which are regarded as 
‘executioners of apoptosis’ (Chang & Yang, 2000). In contrast, NETosis process 
is currently understood to be independent of such compounds (Fuchs et al., 2007).  
 
6.2.7 NETs detection and quantification 
 
A number of methods have been adopted to visualise and quantify NET release 
(Grinberg et al., 2008). To date, microscopy (Brinkmann et al., 2004, Hakkim et 
al., 2010, Papayannopoulos et al., 2010 & Metzler et al., 2011), immuno-staining 
(Oklu et al., 2013) and SEM (Brinkmann et al., 2004, Krautgartner & Vitkov, 
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2008 & 2009, Urban et al., 2009 & Manzenreiter et al., 2012) have been 
employed to visualise NET release and NET structures. Previously antibodies to 
detect histone and/or granule components were utilised to detect NET release 
(Fuchs et al., 2007). However, more sensitive immuno-fluorescence visualisation 
techniques involving SYTOX
®
 Green (Martinelli et al., 2004) have been 
developed (Grinberg et al., 2008). SYTOX
®
 Green is a DNA intercalating dye 
which fluoresces upon binding to DNA (Grinberg et al., 2008). The application of 
SYTOX
®
 Green previously has been claimed to possibly inhibit NET formation 
(Brinkmann et al., 2004). However as demonstrated by its application in 
subsequent publications, this was not the case (Ermert et al., 2009) and it now is 
regarded as the ‘gold standard’ to determine NET release (Grinberg et al., 2008). 
 
NET release may also be quantified fluorometrically which is helpful in order to 
make comparisons regarding the potency of stimuli (Meijer, 2012). Initial studies 
involving quantification of NET release were based on images. These included 
counting the number of discrete areas of DNA larger in size than a neutrophil 
(Buchanan et al., 2006) or the number of neutrophil forming NETs as a 
percentage of total cell count (Grinberg et al., 2008). Such attempts however were 
ruled out over time as these techniques were highly biased and unreliable when 
individual cells could not be distinguished. Another limitation of quantifying NET 
release this way was that capturing images was dependent on the entire field being 
visualised (Buchanan et al., 2006 & Grinberg et al., 2008). Subsequent studies, 
successfully developed a robust fluorometric method for quantification of 
extracellular NET-DNA release using SYTOX
® 
Green dye to stain the 
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extracellular NET-DNA (Alghamdi et al., 2005 & Ermert et al., 2009). However, 
this method also presented some limitations in the fluorometric measurement of 
extracellular NET-DNA release. The complicating factor involved was the 
staining of intracellular DNA of dead cells (von Köckritz-Blickwede, 2008). This 
was resolved by the introduction of the MNase assay which is now deemed the 
most appropriate method for the fluorometric quantification of extracellular NET-
DNA release (Fuchs et al., 2007, Ramos-Kichik et al., 2009 & Wang et al., 2009).  
 
Initially, before considering MNase, mammalian DNase was employed but later 
studies demonstrated its capacity to bind to actin causing depolymerisation and 
preventing polymerisation which interferes with the NET release mechanism 
(Hitchcock, 1980). As a consequence MNase has been demonstrated to be suitable 
for the digestion of extracellular genomic DNA as it is a DNase secreted by S. 
aureus (Buchanan et al., 2006) which acts as an endo- and exo-nuclease to yield 
3’mono- or di-nucleotides (Heins et al., 1967). It is relatively non-specific in 
terms of base sequence preference, although preferentially cleaves chromatin at 
the linker region between nucleosomes (Noll, 1974). Another key methodological 
finding has been that following prolonged incubation times such as >4 hrs for 
human neutrophils stimulated with microbes, toxins or drugs the DNA release 
may be caused by other mechanisms in addition to NETosis (Brinkmann & 
Zychlinsky, 2012). Therefore, studies quantifying NET release are reported to be 
conducted within the 4 hr incubation time to avoid false NET-DNA experimental 
readouts (Brinkmann & Zychlinsky, 2012).  
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Chapter 5 demonstrated that Ti nano and micron sized particles can be 
phagocytosed by the human neutrophil and induce dose-dependent ROS release 
(through oxidative burst reactions) (Kumazawa et al., 2002 & Goncalves et al., 
2011). NET release is closely related to the process of respiratory burst and ROS 
production appears to be a crucial process involved in inducing NET release 
(Fuchs et al., 2007 & Papayannopoulos & Zychlinsky, 2009). Therefore, the effect 
of Ti stimulation of neutrophils on NET production is relevant to the overall 
understanding of the inflammatory response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 151 
6.3 METHODS 
 
6.3.1 Ex-vivo determination of NET production  
 
The fluorescent DNA stain, SYTOX
®
 Green was supplied at a concentration of 5 
mM in DMSO (S7020; Invitrogen, Paisley, UK) and has a fluorescence 
excitation/emission maxima of 504/523 nm respectively. SYTOX
®
 Green is a 
high affinity DNA staining dye and used to visualise NETs and to allow 
fluorometric quantification of the magnitude of extracellular NET-DNA release 
from stimulated neutrophils. 1 µL of the stock was further diluted in 999 µL of 
PBS (Appendix I) for it to be used at 10 µM and stored at -20 °C until further use. 
 
6.3.2 Stimuli used to induce NET production in neutrophils  
 
The control (Table 6.1) and experimental stimuli (Table 2.1; section 2.2) were 
prepared by adding high purity reagents to RPMI-1640. Table 6.1 demonstrates 
the working concentration of the prepared solution and stimulation concentration 
once added to the experimental system. 
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Table 6.1 Stimuli used to induce NET formation 
 
 
Stimuli  
(Acronym) 
Supplier 
Cat No. 
Working 
Concentration 
Stimulation 
Concentration 
RPMI-1640 
supplemented with 
glutamine (RPMI) 
Sigma-Aldrich 
R2405 
 
- 
 
- 
Hypochlorous acid 
(HOCl) 
Sigma-Aldrich 
425044 
1% 0.57% 
Phorbol 12-myristate 
13-acetate (PMA) 
Sigma-Aldrich 
P8139 
405 nM in 
RPMI-1640 
50 nM  
Ops S. Aureus  
(Ops Sa) (non-viable) 
LGC Standards 
ATCC 9144 
6x10
8
/mL 
RPMI-1640 
MOI
1
 1:300 
F. Nucleatum  
(FN) (non-viable) 
LGC Standards 
ATCC 10953 
6x10
8
/mL 
RPMI-1640 
MOI
1
 1:100 
 1
MOI Multiplicity of Infection (number of bacteria per neutrophil). 
 
6.3.3 Visualisation of NET release 
 
Neutrophils were extracted (Appendix I) and re-suspended at a concentration of 
1x10
5 
cells/mL in RPMI-1640 media supplemented with 1 U/mL of glutamine 
(Sigma-Aldrich, UK). 300 μL of the cell suspension were added to each well of a 
transparent 24-well sterile plate (CLS3527; Corning Costar, Dorset, UK) which 
had been pre-blocked with 500 μL of 1% PBS-BSA per well and stored overnight 
at 4
 
°C. The blocking buffer was removed by pipetting prior to cell addition. Cells 
were incubated for 30 mins at 30 °C and subsequently stimulated with 75 µL of 
the stimuli summarized in Table 6.1 and Table 2.1 (section 2.2). Overall, two 
replicates for each stimulus were conducted and the entire experiment was 
repeated four times. 
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6.3.4 Image capturing and processing 
 
NET formation was visualised using an epi-fluorescence microscope (Nikon 
Eclipse TE300, Japan) with a 472 nm fluorescent excitation filter and a 520 nm 
emission filter (BrightLine
®
 GFP-3035B, Semrock). 25 μL of 10 μM SYTOX® 
Green in PBS (S7020; Invitrogen, Paisley, UK) was added to the suspended cells 
and images were acquired at 0, 1, 2, 3 and 4 hrs following stimulation, using a 
digital camera (Nikon Coolpix 990, Japan) with a x20 microscope objective lens.  
 
6.3.5 Sensitivity of fluorometric quantification of DNA  
 
NET derived nuclear DNA complexes with different protein components which 
exhibit variability in dye binding and subsequent fluorescence (Saffarzadeh et al., 
2012). In addition, previous work quantifying NETs by fluorescence techniques 
have been reported using white micro-well plates or black micro-well plates 
(Bruns et al., 2010), which introduces further variability to the measured 
fluorescence. Therefore, the sensitivity range for fluorescence detection of 
extracellular NET-DNA release following SYTOX staining was investigated in 
both black (3915; Corning, Lowell, MA, USA) and white micro-well plates 
(Immunolon2, Chantilly, VA, USA) by calibrating the assay with known 
concentrations of calf thymus DNA. The calf thymus DNA (S89370; Sigma-
Aldrich, UK) stock solution was prepared at 1 mg/mL using molecular biology 
grade water and thorough vortexing prior to storage at -20 °C. To calibrate the 
measurement of fluorescence, the stock of calf thymus DNA was diluted further 
to produce concentrations ranging from 0 to 1 µg/mL. 10 µL of the known 
 154 
concentrations of calf thymus DNA with an additional 175 µL of RPMI-1640 
media supplemented with 1 U/mL of glutamine (Sigma-Aldrich, UK) were 
stained with 15 µL of 10 μM SYTOX® Green (S7020; Invitrogen, Paisley, UK) in 
black and white micro-well plates for 10 mins at room temperature allowing the 
DNA to bind. Each DNA standard was performed in triplicate and calibrated three 
times. Readings were obtained in arbitrary fluorescence units (AFU) using a 
fluorometer (Twinkle LB970, Berthold Technologies, Germany) with excitation 
and emission filter wavelengths of 485 and 525 nm, respectively.  
 
6.3.6 Micrococcal nuclease (MNase) assay of NET release   
 
Further neutrophils were prepared (Appendix I) and re-suspended at a 
concentration of 1x10
5 
cells/mL. 100 μL of the cell suspension, with an additional 
75 μL of RPMI-1640 supplemented with 1 U/mL of glutamine (Sigma-Aldrich, 
UK), was added to each well of a sterile 96-well white plate (Immunolon2, 
Dynex, Chantilly, VA, USA) which had been pre-blocked with 200 μL of 1% 
PBS-BSA per well and stored overnight at 4 °C. The blocking buffer was 
removed prior to cell addition. Cells were incubated at 30 °C for 30 mins and then 
stimulated with 25 μL of the control or experimental stimuli (Table 6.1 & Table 
2.1; section 2.2). All stimuli were run in quadruplicate and cells were incubated 
for an additional 3 hrs at 30 °C. Following incubation, to separate extruded NET-
DNA from the cellular debris, 15 μL of MNase (LS004797; Worthington 
Biochemical Corporation, Lakewood, NJ, USA) was added to each well and left 
at room temperature for 20 mins. The plate contents were then centrifuged at 1800 
rcf for 10 mins and 150 μL of the supernatant containing the separated 
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extracellular NET-DNA was then transferred to a 96-well black micro-plate 
(3915; Corning, Lowell, MA, USA) containing 15 μL of 10 μM SYTOX® Green 
in PBS (S7020; Invitrogen, Paisley, UK) per well. Over a period of 5 mins 
fluorometric measurements were acquired five times for each well in order to 
quantify the NET-DNA release. The total fluorescence from each well was 
measured at 37 °C and recorded in arbitrary fluorescence units (AFU) using a 
Twinkle LB970 (Berthold Technologies, Germany) with excitation and emission 
filter wavelengths of 485 and 525 nm, respectively. To investigate the effect of 
well colour on fluorescence measurements NET-DNA release was quantified from 
stimulated neutrophils with the separated supernatant in 96-well white micro-
plates (Immunolon2, Chantilly, VA, USA) (parallel study run simultaneously with 
the black wells using the same neutrophils for each well “pair”) also containing 15 
μL of 10 μM SYTOX® Green in PBS (S7020; Invitrogen, Paisley, UK). The 
experiment was repeated twelve times for black wells (during which eight times 
white wells were also used in parallel using the same neutrophil source). 
 
6.3.7 Ex-vivo detection of NET adherence on Ti implant surfaces 
 
Ti discs Grade IV (Commercially pure; Cp) and Grade V (Ti-6Al-4V) (12 mm 
diameter, 1 mm thickness, Titanium Products Ltd, Birmingham, UK) were used as 
model substrates to investigate the adherence of NETs to Ti implant surfaces in  
the presence and absence of a protein adsorbed layer. 
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6.3.7.1 Ti discs-Ti implant substrate models preparation 
 
Ti discs were prepared by sequential polishing on a grinding and polishing 
machine (DAP-7, Struers, Rotherham, UK) with waterproof silicon carbide grit 
papers (Struers, Solihull, UK) from P220 through P320, P500, P800, P1000, 
P1200, P2400 up to P4000 with distilled water as a lubricant. Twelve Ti discs of 
grade IV and V each were manufactured for each surface finish determined by the 
final SiC abrasive grade. Mirror-like surfaces were created by further polishing 
the P4000 surfaces on a MD chem disc (Struers, Solihull, UK) with colloidal 
silica particles of 0.04 µm using water as a lubricant (Struers, Solihull, UK). To 
create a consistent surface all polished specimens were sonicated for 10 mins each 
in acetone followed by ethanol and distilled water. The samples were then 
autoclaved at 121 °C for 1 hr (Prestige Medical, Minworth, UK) to sterilise them 
prior to use.  
 
6.3.7.2 Fluorometric quantification of NET-DNA release on Ti implant discs-
Ti implant model substrates 
 
NET interaction with Ti implant surfaces in the presence and absence of a protein 
adsorbed layer were investigated. To allow protein adsorption on Ti discs, six 
Grade IV and V discs each were immersed in a sterile 24 well transparent plate 
(CLS3527; Corning Costar, Dorset, UK) containing 500 µL of 1% PBS-BSA per 
well and stored at room temperature for 2 hrs prior to cell addition. A further six 
Grade IV and V Ti discs each were also placed in an additional 24 sterile well  
transparent plate containing none 1% PBS-BSA. Neutrophils were extracted 
(Appendix I) and re-suspended at a concentration of 1x10
5 
cells/mL. 600 μL of the 
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cell suspension were added to each well containing the Ti disc. The 1% PBS-BSA 
buffer was removed prior to cell addition (section 6.3.3). Wells containing Ti 
discs with cells were incubated at 30 °C for 30 mins and then stimulated with 150 
μL of either PMA, HOCl or RPMI. Each stimulus was run in duplicate and the 
cell suspensions with the Ti discs were further incubated at 30 °C for 2 hrs. 
Extracellular NET-DNA release was quantified fluorometrically as detailed in 
section 6.3.6 after the 2 hr incubation period by transferring 400 μL of the cell 
suspension from the 24 well transparent plate (CLS3527; Corning Costar, Dorset, 
UK) to 96-well black micro-plates (3915; Corning, Lowell, MA, USA) containing 
15 μL of 10 μM SYTOX® Green in PBS (S7020; Invitrogen, Paisley, UK) per 
well. The entire experiment was conducted four times and on each occasion 
neutrophils were sourced from different healthy volunteers. 
 
6.3.7.3 Visualisation of NETs adherence on Ti discs-Ti implant model 
substrates 
 
Following NET-DNA quantification in the liquid compartment of wells 
containing Ti discs, the discs were washed with RPMI three times, fixed in 2.5% 
glutaraldehyde fixative for 30 mins and then dehydrated through graded solutions 
of ethanol diluted in distilled water from 10, 20, 30, 40, 50, 60, 70, 80, 90, to 
100% for 10 mins each. Samples were then dried using a critical point drier (Bio-
Rad E3000, Sussex, UK). Samples were initially placed into the critical point 
drier chamber immersed in 100% ethanol. The ethanol was then replaced with 
CO2 in a purging chamber five times. The chamber was then slowly heated to 32 
°C, the critical point of CO2, in order to evaporate all the remaining moisture. The 
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dried sample was then mounted onto 25 mm aluminium stubs and SEM images 
were acquired using a JEOL JSM-840 (JEOL, Japan) at an accelerating voltage of 
20 KeV, at high vacuum. 
 
6.3.8 Statistical analysis 
 
Statistics were performed using SPSS 20 software. The data were initially 
explored for normality using a Shapiro-Wilk test at a 95% significance level. A 
Kruskal-Wallis test was then used to determine significant differences between 
group means at a 95% significance level. Comparisons between individual group 
means were determined by Mann-Whitney tests at a 95% significance level.  
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6.4 RESULTS 
 
6.4.1 Ex-vivo time course fluorescence visualisation of NET release 
 
Fluorescence microscopy of stimulated neutrophils was conducted to identify 
NET release over different time periods following stimulation. HOCl (Palmer, 
2012), PMA (Gupta et al., 2005 & Ermert et al., 2009), periodontal bacteria 
including non-viable Ops Sa (Fc-γ mediated) (Huzinga et al., 1989) and FN (TLR-
4/2 mediated) (Remer et al., 2003) are well characterised inducers of NET release 
and were employed within this study as positive controls. RPMI-1640 was used as 
the negative control stimulus. NET production was visually characterised at 
hourly intervals up to 4 hours. Experimental simulation with Ti oxide as 
nanoparticles and micron sized metallic species dispersed in RPMI-1640 at 
concentrations of 2000 and 200 ppm was also performed (Table 2.1; section 2.2). 
 
Figures 6.1-6.3 are representative fluorescence images taken from four repeat 
experiments and presented on a standardised scale. These images are further 
correlated with the fluorometric quantification of NET-DNA production 
measurements (section 6.4.3).  
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Figure 6.1 Images of NET fluorescence captured at 0, 1, 2, 3 and 4 hours of 
neutrophils stimulated with RPMI, HOCl, PMA, Ops Sa and FN 
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Figure 6.2 Images of NET fluorescence of neutrophils stimulated with Ti 
oxide as nanoparticles and micron sized metallic particles dispersed in RPMI 
at a concentration of 2000 ppm 
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Figure 6.3 Images of NET fluorescence of neutrophils stimulated with Ti 
oxide as nanoparticles and micron sized metallic particles dispersed in RPMI 
at a concentration of 200 ppm 
 
STIMULUS 
 
Hrs      Anatase            Rutile          Mix oxide          Metallic           Metallic 
            (~30 nm)         (~50 nm)        (~66 nm)           (~5 µm)           (~20 µm) 
 
 
 
0   
 
 
 
 
 
1 
 
 
 
 
 
 
2 
 
 
 
 
 
3 
 
 
 
 
 
4 
 
 
 
 
 
 
 
2 µm 
 163 
Prior to stimulation and at 1 hr post stimulation with positive controls and Ti 
stimuli, low levels of fluorescence were detected (Figures 6.1-6.3) for all 
conditions, except when cells were stimulated with HOCl where a NET-like 
morphology was observed. After 2 hrs stimulation NET like structures began to 
be observed for all stimulation conditions (Figures 6.1-6.3). After 3 hrs, 
fluorescence was further increased and structures resembled the more typical 
strand like NET morphology (Figures 6.1-6.3) as described by Brinkmann et al., 
(2004) & Behrendt et al., (2010). At 4 hrs post stimulation, fluorescence levels 
were further increased, however, NET morphology was observed to resemble 
denser web-like strands which were not as distinctive to those observed at 3 hrs. 
Therefore, 3 hrs was chosen as the optimal time point (provided adequate 
fluorescence intensity and NET morphology) for the NET-DNA quantification 
assay. 
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6.4.2 Sensitivity of fluorometric quantification of DNA  
  
The sensitivity range for fluorometric detection of extracellular NET-DNA release 
following SYTOX staining and the comparison of the effect of micro-well colour 
on the fluorescence detected (measured in AFU) was calibrated using known 
concentrations of calf thymus DNA. Results are presented as a logarithmic 
standard calibrated curve of the mean of fluorescence in AFU against known 
concentrations of calf thymus DNA in µg/mL (Figure 6.4). Increased fluorescence 
levels were observed in white wells when compared with black wells (Figure 6.4) 
and this was confirmed upon reading blank white wells without SYTOX
®
 Green 
which produced an excessive baseline reading of 6000 AFU, compared to 10 AFU 
for blank black wells without SYTOX
®
 Green. 
 
Figure 6.4 Fluorometric detection of SYTOX stained calf thymus DNA  
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Fluorometric quantification of a known concentration of calf thymus DNA was 
employed to determine the percentage of neutrophils producing NETs. Studies 
have demonstrated that on average human neutrophils contain 5 pg of DNA (Mee 
& Adelstein, 1981). The total DNA content for 10
5
 neutrophils, used in each well 
for this study, therefore equates to a total DNA content of 0.5 µg. The standard 
curve was used to determine the percentage of
 
stimulated neutrophils in each well 
producing NETs. For example, HOCl employed as a dominant NET inducer 
(Palmer et al., 2012) produced fluorescence values of 25000 AFU in black wells. 
According to the standard curve (Figure 6.5) this corresponds with approximately 
0.25 µg of DNA (indicated by dashed line in Figure 6.5) and it may be concluded 
that [(0.25 µg/0.5 µg)*100] = 50% of the 10
5 
neutrophils in each well are 
producing NETs when stimulated with HOCl. Accordingly, for each stimulated 
condition, the percentage of neutrophils producing NETs quantified in black wells 
is estimated (Table 6.2). 
 
 
Figure 6.5 Ascertaining the percentage of HOCl stimulated neutrophils at a 
concentration of 1x10
5
 cells/mL producing NETs quantified in black wells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25000 
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Table 6.2 Estimated percentage of cells at a concentration of 1x10
5
 cells/mL producing NETs quantified in black wells 
 
 
 
Stimuli Average NET-DNA release 
(AFU) 
Conc. Of DNA 
(µg/mL) 
Estimated percentage of 
neutrophils producing NETs 
(%) 
RPMI 728 - - 
HOCl 25000 0.25 50 
PMA 13519 0.18 36 
Ops Sa 10100 0.16 32 
FN 9259 0.16 32 
Anatase 2000 ppm 5207 0.13 26 
Anatase 200 ppm 4124 0.12 24 
Rutile 2000 ppm 20558 0.22 44 
Rutile 200 ppm 13438 0.18 36 
Mix oxide 2000 ppm 8937 0.15 30 
Mix oxide 200 ppm 5422 0.13 26 
Metallic (~5 µm) 2000 ppm 9024 0.16 32 
Metallic (~5 µm) 200 ppm 7198 0.14 28 
Metallic (~20 µm) 2000 ppm 6968 0.13 26 
Metallic (~20 µm) 200 ppm 6321 0.13 26 
 
 
 
 
 167 
6.4.3 Ex-vivo fluorometric quantification of extracellular NET-DNA release  
 
Extracellular NET-DNA release in the supernatant of stimulated neutrophils of 12 
independent experiments after a 3 hr incubation period in black wells was 
quantified in AFU (Figures 6.6 & 6.8). Extracellular NET-DNA release in the 
supernatant of stimulated neutrophils of 8 independent experiments after a 3 hr 
incubation period in white wells was also quantified in AFU (Figures 6.7 & 6.9). 
Fluorometric measurements are presented in the form of Box/Whisker plots 
(median, inter-quartile range, 10
th
 and 90
th
 percentiles and outliers) (Figures 6.6-
6.9). Significant differences between groups are marked by asterisk(s) (Figures 
6.6-6.9). 
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The extracellular NET-DNA release quantified in black wells (Figures 6.6 & 6.8) 
was explored using a Shapiro-Wilk test at a 95% significance level, which 
identified the data to be not normally distributed. A Kruskal-Wallis test 
demonstrated significant differences between the magnitude of NET formation 
following neutrophil stimulation with positive and negative control stimuli 
(P<0.001). Pair-wise comparisons using Mann-Whitney tests demonstrated that all 
positive control stimuli resulted in significantly increased NET formation when 
compared to the negative control RPMI (P<0.001) (Figure 6.6).  
 
Figure 6.6 Box/Whisker plot of extracellular NET-DNA release quantified in 
black wells of 3 hr control stimulated neutrophils including RPMI, HOCl, 
PMA, Ops Sa and FN 
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The extracellular NET-DNA release quantified in white wells (Figures 6.7 & 6.9) 
was explored using a Shapiro-Wilk test at a 95% significance level, which 
identified the data to be not normally distributed. A Kruskal-Wallis test 
demonstrated significant differences between the magnitude of NET formation 
following neutrophil stimulation with positive and negative control stimuli 
(P<0.001). Pair-wise comparisons using Mann-Whitney tests demonstrated that all 
positive control stimuli (P<0.002) except FN (P=0.074) resulted in significantly 
increased NET formation when compared to the negative control of RPMI (Figure 
6.7).  
 
 
Figure 6.7 Box/Whisker plot of extracellular NET-DNA release quantified in 
white wells of 3 hr control stimulated neutrophils including RPMI, HOCl, 
PMA, Ops Sa and FN  
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Extracellular NET-DNA release in response to the positive control stimulated 
neutrophils in both black (Figure 6.6) and white wells (Figure 6.7) was 
significantly highest from HOCl stimulated neutrophils (P<0.001) followed by 
PMA, Ops Sa and FN exposures.  
 
The magnitude of DNA fluorescence quantified in black wells from neutrophils 
stimulated with Ti oxide as nanoparticles and with micron sized metallic species 
at 2000 and 200 ppm was concentration dependent (Figure 6.8). Pair-wise 
comparisons using Mann-Witney tests demonstrated that all Ti species at 2000 
ppm and 200 ppm resulted in significantly increased extracellular NET-DNA 
release when compared with the negative control RPMI (P<0.001). Exposure to Ti 
oxide as rutile (~50 nm) at 2000 and 200 ppm resulted in significantly increased 
NET-DNA release when compared with all other Ti stimuli (P<0.001) (Figure 
6.8). No significant differences in the magnitude of NET formation were found 
between mixed oxide (~66 nm) and ~20 µm sized metallic species of 2000 ppm 
(P=0.82) (Figure 6.8a), mix oxide and ~5 µm sized metallic species of 2000 and 
200 ppm (P=0.25) (Figure 6.8) and between ~20 µm and ~5 µm sized metallic 
species of 2000 and 200 ppm (P=0.25 & 0.30) (Figure 6.8).  
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Figure 6.8 Box/Whisker plots of extracellular NET-DNA release quantified in 
black wells of 3 hr stimulated neutrophils with Ti oxide as nanoparticles and 
micron sized metallic species dispersed in RPMI at a concentration of (a) 
2000 ppm and (b) 200 ppm  
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Similar to experiments in black wells, a dose-dependent extracellular NET-DNA 
release was observed in white wells from neutrophils stimulated with Ti oxide as 
nanoparticles and micron sized metallic species at concentrations of 2000 and 200 
ppm (Figure 6.9). Pair-wise comparisons using Mann-Witney test demonstrated 
that all Ti oxides at 2000 ppm and 200 ppm (P<0.002) except Ti oxide as anatase 
(~30 nm) (P=0.06) resulted in significantly increased extracellular NET-DNA 
release when compared with the negative control RPMI (Figure 6.9).   
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Figure 6.9 Box/Whisker plots of extracellular NET-DNA release quantified in 
white wells of 3 hr stimulated neutrophils with Ti oxide as nanoparticles and 
micron sized metallic species dispersed in RPMI at a concentration of (a) 
2000 ppm and (b) 200 ppm  
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6.4.4 Ex-vivo visualisation of NET adherence to Ti implant surfaces 
 
SEM of stimulated neutrophils co-incubated with Ti discs was used to detect NET 
adherence to Ti implant surfaces in the presence and absence of a protein 
adsorbed layer (Figure 6.10). HOCl (Palmer et al., 2012) and PMA (Gupta et al., 
2005, Ermert et al., 2009) were employed as positive NET inducers and RPMI-
1640 was used as the negative control stimulus. NETs were observed to adhere to 
Ti implant surfaces in the presence and absence of a protein layer, however 
increased NET adhesion was observed when proteins were present on the Ti 
surface (representative of the clinical situation) (Figure 6.10).  
 
Figure 6.10 Images of NET adherence to protein adsorbed Ti implant 
surfaces (top) vs. non-protein adsorbed Ti implant surfaces (bottom) 
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6.4.5 Ex-vivo quantification of NET-DNA release of stimulated neutrophils on 
Ti implant surfaces 
 
In addition to direct visualisation of NET adherence to Ti implant surfaces, NET-
DNA release was also quantified following neutrophil stimulation in the presence 
of a Ti implant surface with and without a protein adsorbed layer (Figure 6.11). 
Data represents four individual experiments quantifying NET-DNA release in 
black wells using the MNase assay (section 6.3.7.2).  
 
 
The data demonstrates stimulated neutrophils in presence of a protein adsorbed 
layer exhibited statistically increased levels of NET-DNA release (Figure 6.11a) 
relative to a non-protein adsorbed layer (Figure 6.11b) (P<0.005). However, for 
both negative (P<0.001 for RPMI) and positive (P<0.001 for HOCl and PMA) 
stimuli, measurements were proportionally increased by a similar factor 
suggesting that the observed effect attributable to the protein layer may be 
negligible. 
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Figure 6.11 Box/Whisker plot of ex-vivo NET-DNA quantification of 
stimulated neutrophils on Ti implant surfaces (a) in presence of a protein 
adsorbed layer and (b) in absence of a protein adsorbed layer 
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6.5 DISCUSSION 
 
Currently only one study has identified NET release from neutrophils following 
stimulation with Ti. The study reported responses of fish neutrophils, Pimpehales 
promelas (Jovanovic et al., 2011b) to Ti oxide nanoparticles at levels 
representative of environmental exposure. The authors demonstrated that 0.1 ppm 
of Ti oxide as nanoparticles (speciation not defined) was sufficient to stimulate 
NET release (Jovanovic et al., 2011b). However, the underlying functional 
mechanism by which Ti can modulate NET release is not known. In Chapter 5, it 
was demonstrated that Ti implant derivatives representative of debris found in-
vivo as oxide nanoparticles and micron sized metallic species stimulated dose 
dependent and Ti oxide species specific ROS production from human neutrophils. 
It is understood that activation of the respiratory burst in neutrophils may cause 
the cell to either trigger apoptosis or NETosis (Amulic et al., 2012) and the 
generation of reactive oxygen species is known to be important in the induction of 
NET formation (Amulic et al., 2012). Therefore, in the current study, the same Ti 
implant derivatives were used to stimulate neutrophils before ex-vivo fluorometric 
visualisation of NET structures (section 6.4.1) and quantification of extracellular 
NET-DNA release (section 6.4.3). 
 
Observations of Ti (oxide or metallic) stimulated cells after 1 and 2 hrs of 
stimulation demonstrated relatively low levels of fluorescence (Figures 6.1-6.3). 
This suggests that only a small number of non-viable cells were present and NET 
release was minimal at this stage. This was consistent with the positive control 
stimuli with the exception of 0.57% HOCl stimulated neutrophils which exhibited 
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increased fluorescence levels after 1 hr stimulation and clear NET like structures 
were seen to form consistent with Palmer et al., (2012). The remaining control and 
Ti stimulated neutrophils were subsequently observed to produce NETs only after 
3 hrs of stimulation and the resultant morphologies were consistent with previous 
descriptions of NET release appearing as discrete DNA strands (Brinkman et al., 
2004/2007, Urban et al., 2009 & Behrendt et al., 2010). Interestingly, for Ti 
stimulated neutrophils at 3 hrs, the NET-DNA strands were abundant but 
appeared to be aggregated and associated with agglomerates of Ti particles. The 
capacity of the Ti particles to strongly stimulate NETosis may be a consequence 
of the internalised Ti which cannot be digested by neutrophil components 
remaining within the phagosomal compartments and thus chronically stimulating 
the NADPH oxidase (Segal, 2005). Chronic stimulation of the respiratory burst 
had been shown to be associated with a decrease in pH and a flow of K
+
 and Cl
-
 
ions into the phagosomes which may further contribute to release of elastase and 
cathepsin G (antimicrobial proteins found on NETs) (Segal, 2005) (Figure 6.12).  
 
Figure 6.12 Schematic representation of NET signalling pathway of Ti oxide 
as nanoparticles or micron sized metallic particle stimulated neutrophils 
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It is proposed that chronic activation of the NADPH oxidase (respiratory burst) by 
internalised particles may lead to its prolongation which consequently ruptures the 
cell (Papayannopoulos et al., 2010). Moreover, it is known that Ti particles 
possess strong binding affinity towards proteins (Vamanu et al., 2008) and 
therefore when cell rupture occurs the internalised particles possibly complex with 
AMPs which may then be ejected back into the physiological environment and 
continue to contribute to the progression of extracellular damage (Jovanovic, 
2011). The strong binding affinity of the particles to NETs was demonstrated in 
the current study, however, it could not be explicitly determined whether this was 
an association with previously internalised particles or free extracellular particles 
in the medium. 
 
In contrast, micron sized metallic particles which cannot be easily phagocytosed 
by mammalian neutrophils (often larger in size than the cell) (Chapter 5) also 
stimulated NETs. It has been proposed that the neutrophil may attempt and re-
attempt to phagocytose the particle leading to the activation of the oxidase. This 
induced hyperactivity of the neutrophils may also cause the cells to eventually 
enter NETosis. In contrast to the nanoparticles the resulting NETs observed were 
not seen to be associated with the micron sized Ti particles and this difference 
from the nanoparticles may be accounted for by their reduced surface energies 
(Thorek & Tsourkas, 2008).  
 
Visualisation of NET structures at 4 hrs after stimulation with both positive 
controls and Ti stimuli revealed that although the fluorescence levels were 
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increased, the NETs were denser in morphology (less NET-like). Therefore, 3 hrs 
was chosen as an optimal time for extracellular NET-DNA quantification (to 
avoid false NET-DNA experimental readouts). Fluorometric quantification of 
extracellular NET-DNA in both black and white wells was performed to 
determine the effect of well colour and allow correlation with previously reported 
findings. Fluorescence levels measured in AFU for stimulated neutrophils in 
white wells were around 1000 times higher than quantified in black wells, 
however scaling between the measures differed and the white wells were 
considered to be less sensitive. Black wells were therefore used for quantification 
of NET-DNA release in further assays. 
 
The NET quantification data was identified to be not normally distributed varied 
considerably with individual (neutrophil donor) responses, which were assumed to 
vary on a day to day basis. Enhanced responses (in magnitude of NET production) 
suggest increased sensitivity of certain individuals; however this was not 
systemically evaluated. The data coincided with previous findings that HOCl is a 
dominant ROS trigger for NET formation (Palmer et al., 2012) in comparison to 
the other inducers of NET release employed including PMA, Ops Sa and FN. 
Stimulation with Ti oxide as nanoparticles resulted in statistically higher orders of 
dose-dependent extracellular NET-DNA release when compared with micron 
sized metallic particles at the same concentrations and was consistent with the 
fluorescence microscopy.  
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The differences in the biological activity of Ti as nanoparticles and as micron 
sized particles have been attributed primarily to the ability or inability of the 
neutrophil to firstly internalise the particle and secondly attempt to digest the 
particle within the phagosome. However, it is now clear that considerable 
differences in the mechanisms of nanoparticle uptake by neutrophils occur 
including pathways of pinocytosis, endocytosis and/or phagocytosis (Tamura et 
al., 2002, Long et al., 2007 & Pierre, 2010) when compared with larger particles. 
The high surface to volume ratio of nanoparticles and higher surface energies not 
only modify intra-cellularisation potential (Thorek & Tsourkas, 2008), but also 
their subsequent interactions in intra-cellular compartments or within the cytosol. 
Although specific mechanisms cannot be derived from the findings of this study, 
the variability in cell responses to nanoparticles of different size and speciation 
suggests the existence of multiple pathways. Moreover, determining the 
mechanisms underpinning the inconsistencies in the dose-dependent magnitude of 
extracellular NET-DNA release observed is further complicated by inherent 
variability in particulate agglomeration-associated with dispersing different 
concentrations of particles in solution (Tirado-Miranda et al., 2003). Particle 
agglomeration may determine whether the nanoparticles become phagocytosed 
leading to higher orders of respiratory burst and for NET release (Thorek & 
Tsourkas, 2008). 
 
NET release also appeared sensitive to the speciation of the Ti oxide nanoparticles 
with the greatest response observed to Ti oxide as rutile (~50 nm). In comparison 
with other experimental stimuli, these particles were larger than anatase (~30 nm) 
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and smaller than the mix oxide (~66 nm). This observation was not surprising as a 
similar pattern in the magnitude of ROS production was observed (Chapter 5). 
The finding is consistent with the previous reports regarding the dependency of 
NET formation on a ROS-dependent pathway (Fuchs et al., 2007 & Amulic et al., 
2012). However, the correlation between the increased ROS production observed 
for rutile and NET formation (Figures 5.9 & 6.8) cannot be explicitly linked, 
because the molecular mechanism(s) of both ROS and NET release pathways to 
Ti exposures were not considered within the current study. An alternative 
hypothesis whereby there was a morphological sensitivity to rutile itself, or to 
aggregation effects, or responses to surface associated biomolecules cannot be 
excluded (Tirado-Miranda et al., 2003). 
 
In the in-vivo environment, it is known that Ti oxide nanoparticles readily bind to 
combinations of human serum proteins including fibrinogen and immunoglobulin 
(Lundqvist, 1996), and albumin (Vamanu et al., 2008). In the context of the 
progression of inflammation, understanding the role of particulate-protein 
associations is necessary in order to identify the mechanisms determining cell 
entry and cellular activation (Park et al., 2008, Wang et al., 2008 & Jin et al., 
2011). Protein association with Ti particles may further modify agglomeration 
effects through attractive and/or repulsive forces modifying surface energy 
(Tirado-Miranda et al., 2003). The association of particles with NETs is 
previously unreported and may indeed modify their functional activity. 
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The study also demonstrated the adherence of NETs to a model of a Ti implant 
surface in the presence and absence of a protein adsorbed layer (section 6.4.4). 
NET adherence to Ti discs was observed to be increased in the presence of surface 
adsorbed proteins which were representative of the in-vivo conditions. 
Fluorometric quantification of extracellular NET-DNA release of PMA and 
HOCl-stimulated neutrophils incubated on protein adsorbed Ti implant surfaces 
resulted in significantly increased NET release in comparison to PMA and HOCl 
stimulated neutrophils incubated on Ti implant surfaces in absence of a protein 
adsorbed layer. The retention of NET like structures on biomaterial surfaces is 
interesting particularly if anti-microbial activity is retained as they may interact 
with surface pathogens. The retention of NETs in a site of inflammation has also 
been proposed to be pro-inflammatory (Remijsen et al., 2011) and further studies 
are required to ascertain their functionality and impact on peri-implant 
inflammation.  
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6.6 CONCLUSION 
 
The findings demonstrate that Ti implant derivatives as oxide nanoparticles and 
micron sized metallic particles, both representative of products observed in peri-
implant tissues, can be potent stimulators of NETs. It is suggested that there is a 
strong correlation with ROS production; however, further mechanisms sensitive to 
particle size and speciation also appear to be active. NETs have been 
demonstrated for the first time to bind to Ti surfaces and may impact on the peri-
implant inflammatory response. Further studies are required to determine the 
dependency of NET formation upon the pathways of particle internalisation and 
on the subsequent distribution of the particles within the neutrophil. 
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CHAPTER 7 
 
THE EFFECT OF NEUTROPHIL PRIMING WITH 
TITANIUM IMPLANT DERIVATIVES UPON 
SUBSEQUENT MICROBIAL STIMULATION 
 
 
7.1 PREFACE 
 
It is possible that neutrophils may be primed by Ti implant derivatives within 
peri-implant tissues, which may then alter neutrophil responses to bacterial 
challenge. Therefore, enhanced chemiluminescence and Micrococcal Nuclease 
(MNase) assays were used to determine the impact of priming selected Ti 
derivatives (oxide or metallic) upon NADPH oxidase stimulation and Neutrophil 
Extracellular Trap (NET) formation by neutrophils. Responses following priming 
with Ti derivatives to peri-implant pathogens including opsonised S. aureus (Ops 
Sa) (Fc-γ receptor mediated) and F. nucleatum (FN) (TLR-4 receptor mediated); 
and/or physiological agonists such as phorbol myristate acetate (PMA) were 
investigated. The Ti species were representative of products of mechanically 
assisted crevice corrosion (Ti oxide as nanoparticles) or larger debris generated 
through tribiological processes (micron sized metallic Ti). Neutrophils primed 
with Ti at minimal stimulatory concentrations (50 ppm) produced a significant 
decrease in the release of ROS and NETs in response to Ops Sa exposure (Fc-γ 
receptor mediated), but the response to FN (TLR-4 receptor mediated) was 
unaffected. In contrast, Ti primed neutrophils (at 50 ppm) exposed to PMA 
exhibited increased NET release.  
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7.2 INTRODUCTION 
 
7.2.1 Neutrophil priming 
 
Priming of neutrophils arises in-vivo at sites of inflammation (Edwards, 1994 & 
Brown et al., 2004) and has been shown to significantly affect the nature of the 
cell response (Dias et al., 2010). The induction of a state of pre-activation of 
neutrophils by agents such as eicosanoids and/or cytokines (e.g. IL-6, IL-8 & 
TNF-α) (Gainet et al., 1999) at low concentrations, followed by subsequent 
stimulation with physiological agonists resulting in the generation of a more 
powerful inflammatory response (Smith, 1994 & Hatanaka et al., 2003) is known 
as priming. A variety of neutrophil priming agents have been recognised (Table 
7.1), with variable efficiencies and kinetics. 
 
Table 7.1 Priming agents (Shalaby et al., 1987, Koenderman et al., 1989 & 
Edwards, 1994) 
 
Primer Type Priming Agent 
Cytokines IL-1β, IL-6, IL-8, IL-18, TNF-α, GM-CSF, GCSF and 
IFN-α/γ 
Lipids PAF, PMA, lysophosphatidylcholine, arachinoid acid, 
leukotrienes (LTB1) and ceramide (C2 and C6) 
Bacterial LPS and opsonised zymosan 
Others Angiotensin II, homocysteine, C5a, Ca
2+ 
and immune 
complexes  
 
 
Neutrophil priming with such agents may enhance respiratory burst reactions and 
effect phagocytosis and bacterial killing processes (Edwards, 1994). In contrast, 
priming agents have also been shown to cause inhibition of the respiratory burst 
(Guichard et al., 2005) and/or fail to induce superoxide production in neutrophils 
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(Koenderman et al., 1989). These functional changes in the neutrophil are 
typically observed within 15-60 mins following exposure to the priming agent and 
are caused by mobilisation of intracellular granules which form pre-formed 
receptors on the plasma membrane (Edwards, 1994). Priming can affect the 
number and the binding affinity of the receptors to their ligand (Edwards, 1994) 
which is independent of down-stream effects. 
 
Among the prominent neutrophil priming agents are inteferons (IFNs) (IFN-α/γ) 
(2-50 U/mL) (Berton et al., 1986 & Atzeni et al., 2002) which are reported to be 
produced during infection (Koyama et al., 2008). These are released by helper T-
cells during cell activation and by natural killer cells in response to species such 
as IL-2 and H2O2 (Wright et al., 2008). The importance of IFN-α and its influence 
on the hyperactivity and hyper-reactivity of neutrophils in periodontitis patients 
has been acknowledged (Wright et al., 2008 & Dias et al., 2010). Studies indicate 
that IFN-α causes inhibition of neutrophil apoptosis through Phosphatidylinositide 
3-Kinases (PI3K), Protein Kinase C-δ (PKC-δ), Nuclear Factor-kB (NF-kB) and 
Signal Transducers and Activators of Transcription (STAT) signalling pathways 
(Wang et al., 2003 & Sakamoto et al., 2005). In addition, previous priming studies 
with IFN-α suggest prolongation of the neutrophil lifespan (Wright et al., 2008) 
and are reported to enhance respiratory burst reactions upon exposure to 
secondary stimuli (Gyllenhammar et al., 1988 & Little et al., 1994). 
 
Therefore, priming agents in combination with secondary stimuli have been 
shown to affect the assembly and activation of the NADPH oxidase (NOX) 
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complex and influence the magnitude of the immunological response (Guichard et 
al., 2005). However, the priming agent is not directly involved in the activation of 
the NOX complex itself (Edwards, 1994). In contrast, priming agents can manifest 
their impact through modulation of the activation of different receptors and 
therefore may influence more than one signalling pathway (Edwards, 1994).  
 
7.2.2 Receptor expression in neutrophils for recognition of foreign material 
 
Initial recognition of foreign material and/or pathogens and pathogen associated 
molecular patterns (PAMPs) (Mogensen, 2009) involves activation of pattern 
recognition receptors (PRRs) which induce an inflammatory response 
(Medzhitov, 2001). Neutrophils express toll-like receptors (TLRs) which are a 
major class of PRRs that recognise a variety of specific PAMPs including 
bacterial lipopolysaccharides (LPS), peptidoglycans (PGNs), lipoteichoic acids 
from gram positive bacteria and viral nucleic acids (Madianos et al., 2005). 
Activation of such receptors enables identification and enables transduction of 
signals to various intracellular adaptor molecules that elicit the pathogen-specific 
destruction (Witko-Sarsat, 2000). 
 
In addition to TLR, Fc-γ receptors (Fc-γR) are another class of specific receptor 
which are extensively expressed in neutrophils (100,000-200,000 receptors per 
cell) and are important in neutrophil mediated damage (Pierre, 2010). There are 
three different Fc-γR classes recognised in neutrophils including Fc-γRI (CD64), 
Fc-γRII (CD32) and Fc-γRIII (CD16) with different binding affinity to IgG and 
different functionality (Quayle et al., 1997). Fc-γRI is a high-affinity IgG receptor 
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that binds to monomeric IgG (Quayle et al., 1997) which is induced by activated 
neutrophils in the presence of cytokines such as IFNs (Wright et al., 2010). In 
contrast, Fc-γRII is constitutively expressed in neutrophils in two isoforms 
including Fc-γRIIa and Fc-γRIIb which also bind to monomeric IgG however 
with low affinity; yet display higher affinity towards dimers or aggregates of IgG 
(Quayle et al., 1997). Both isoforms of Fc-γRII initiate different functional 
responses in neutrophils (Wright et al., 2010) where Fc-γRIIa is an activating 
receptor (Belostocki et al., 2005) and Fc-γRIIb generates an inhibitory signal 
(Radstake et al., 2006). Evidence suggests that neutrophils challenged with 
opsonised bacteria initiate chemotaxis, phagocytosis and killing via Fc-γRIIa 
(Belostocki et al., 2005). However, Fc-γRIII which binds complexes of IgG with 
low affinity displays a pivotal role in ROS secretion in response to immune 
complexes (Fossati et al., 2002). Moreover, priming causes intracellular stores of 
Fc-γRIII to be mobilized to maintain expression (Fossati et al., 2002). 
 
7.2.3 Neutrophil phagocytosis 
 
Priming of cells also confers morphological changes and cytoskeletal alterations 
(Edwards, 1994) which are remodelling phenomena most prominently observed 
when cells undergo phagocytosis (Metchnikoff, 1893). The understanding of the 
underlying mechanism(s) by which professional phagocytes e.g. neutrophils serve 
to internalise and/or remove particulate material from the extracellular space is of 
immense value (Pierre, 2010).  
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Phagocytosis which is a specialised actin dependent process is known to be 
mediated through different signalling pathways (Kwiatkowska & Sobota, 1999). 
The phagocytic route which has been suggested for Ti particulate uptake involves 
Fc-γR engagement and activation (Dobrovolskaia and McNeil, 2007). Fc-γR 
mediated internalisation is characterised by dramatic extension of the plasma 
membrane around the particle (May & Machesky, 1997) and is associated with 
activation of superoxide production and/or the release of pro-inflammatory 
cytokines (Roitt, 1994). Activation of Fc-γR in response to particles coated with 
Igs (mainly IgG) (Yokota et al., 1992) which act as opsonins has been shown to 
render the particle more susceptible to phagocytosis (May & Machesky, 1997). In 
contrast, other studies have proposed that nanoparticles are internalised by 
neutrophils via caveolae-mediated endocytosis; clathrin mediated endocytosis (da 
Rosa, 2013) and/or receptor mediated phagocytosis including the mannose 
receptor, complement receptor, and scavenger receptor (Pierre, 2010). 
 
The impact of direct exposure of Ti implant derivatives on neutrophil morphology 
and activation (ROS and NET release) has been demonstrated (Chapters 5 & 6). 
However, the potential of Ti oxide as nanoparticles and micron sized metallic 
particles to interfere or perturb responses (ROS and NET release) to a bacterial 
challenge and/or to exogenous agents has not been established. Moreover, the 
understanding and morphological characteristics of neutrophil phagocytosis of Ti 
nanoparticles via Fc-γR (IgG opsonised) route is limited. Investigation of these 
effects will enable better understanding regarding the potential mechanism(s) by 
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which Ti implant derivatives contribute to the progression of the peri-implant 
inflammatory response.  
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7.3 METHODS 
 
7.3.1 Ex-vivo determination of Ti implant derivatives capacity to perturb 
neutrophil responses 
 
Neutrophil priming was performed to determine the capacity of Ti implant 
derivatives to perturb neutrophil ROS release and NET formation responses to 
either peri-implant pathogens including Ops Sa and FN; and/or a physiological 
agonist-PMA. Enhanced chemiluminescence assays and MNase assays were 
employed to quantify ROS and NET production respectively, from primed 
neutrophils.  
 
7.3.2 Preparation of primers to perturb neutrophil ROS and NET responses 
 
Control and experimental primers were prepared by adding high purity reagents to 
PBS (Appendix I) for enhanced chemiluminescence assays and to RPMI-1640 for 
MNase assays. Table 7.2 demonstrates the working concentration of the prepared 
solution and the stimulation concentration once added to the experimental system. 
 
Table 7.2 Primers employed to perturb neutrophil ROS and NET responses 
 
Primer 
 
Supplier 
Cat Number 
Working 
Concentration 
Stimulation 
Concentration 
Inteferon-alpha 
(IFN-α) 
R & D Systems 
11200-2 
250 U/mL 2.5 U/mL 
Ti-anatase 
(~30 nm) 
Alfa-Aesar 
039953 
100 ppm 50 ppm 
Ti-rutile 
 (~50 nm) 
Sigma-Aldrich 
1317802 
100 ppm 50 ppm 
Ti-metallic 
 (~5 µm) 
Produced in house 
(section 2.2.2) 
100 ppm 50 ppm 
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7.3.3 Ex-vivo enhanced chemiluminescence assay quantifying ROS release 
from primed and/or unprimed neutrophils  
 
A 96-well white plate (Immunolon2, Dynex, Chantilly, VA, USA) was pre-
blocked with 200 µL of 1% PBS-BSA per well and stored overnight at 4 °C. All 
assays were performed at 37 °C using a Berthold microplate luminometer (LB96, 
EG and G Berthold UK Ltd., Milton Keynes, Bucks, UK) where light output was 
recorded for 1 sec per well in relative light per units (RLU). Each well contained 
45 μL of glucose supplemented PBS (GPBS) (section 5.3.5) with 30 μL of 
luminol (3 mmol/L) (section 5.3.1), or 60 μL of isoluminol (3 mmol/L) (section 
5.3.1) with 15 μL horseradish peroxidise (HRP) (section 5.3.6). 100 μL of isolated 
cells (Appendix I) at a concentration of 1x10
5
 cells/mL suspended in PBS were 
added per well and light output was monitored for 30 mins to establish baseline 
signal. At 30 mins, selected cells were primed with 10 μL of either IFN-α 
(positive control primer) or Ti oxide nanoparticles as anatase (~30 nm) or rutile 
(~50 nm) (experimental primers) (Table 7.2) and light output was monitored again 
for a further 30 mins. At 1 hr, primed and unprimed cells were stimulated with 25 
μL of either PBS (negative control), opsonised S. aureus (Ops Sa) (MOI: 300-
bacteria/neutrophil) or F. nucleatum (FN) (MOI: 100-1) (Appendix II) and light 
output was monitored for a further 2 hrs. All samples were run in quadruplicate. 
The assay was performed twelve times with neutrophils sourced from different 
healthy volunteers. 
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7.3.4 Quantification of ROS release from neutrophils co-stimulated with Ti 
and Ops Sa (IgG opsonised) with primed or unprimed neutrophils 
 
To identify whether Ti implant derivatives mediate an Fc-γR mediated pathway, a 
further set of isolated cells (Appendix I) at a concentration of 1x10
5
 cells/mL were 
re-suspended in PBS. The assay was performed as detailed in section 7.3.2 where 
100 μL of suspended cells in PBS were added per well and light output was 
monitored for 30 min to establish a baseline signal. At 30 min, selected cells were 
primed with 10 μL of either IFN-α (control primer) or Ti oxide nanoparticles as 
rutile (~50 nm) or ~5 μm sized metallic particles (experimental primers) and light 
output was monitored for a further 30 mins. At 1 hr, primed cells were 
subsequently stimulated with 25 μL of Ops Sa, whereas selected unprimed cells 
were either (a) co-stimulated with 25 μL of Ti oxide nanoparticles as rutile (~50 
nm) or ~5 μm sized metallic particles with Ops Sa (Fc-γR mediated) or 
alternatively (b) stimulated with 25 μL of either PBS, Ops Sa, FN or Ti oxide 
nanoparticles as rutile (~50 nm) or ~5 μm sized metallic particles (controls), 
following which light output was monitored for a further 2 hrs. All samples were 
run in quadruplicate. The assay was performed thirteen times with neutrophils 
sourced from different healthy volunteers. 
 
7.3.5 Micrococcal nuclease (MNase) assay quantifying NET release from 
primed and/or unprimed neutrophils  
 
Isolated neutrophils at a concentration of 1x10
5 
cells/mL were re-suspended in 
RPMI-1640 supplemented with 1 U/mL of glutamine (Sigma-Aldrich, UK) 
(section 6.3.6). 100 μL of the cell suspension with an additional 65 μL of RPMI 
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was added to each well of a sterile 96-well white plate (Immunolon2, Dynex, 
Chantilly, VA, USA) which had been pre-blocked with 200 μL of 1% PBS-BSA 
per well and stored overnight at 4 °C. The blocking buffer was removed by 
pipetting prior to cell addition. Cells were incubated at 30 °C for 30 mins and then 
selected cells were primed with either 10 μL of control primer (IFN-α) or 
experimental primer (Ti oxide as nanoparticles or micron sized metallic particles) 
(Table 7.2). At 1hr, incubated primed and unprimed cells were subsequently 
stimulated with 25 μL of either RPMI, Ops Sa, FN or PMA (Appendix II). All 
samples were run in quadruplicate and cells were incubated for an additional 2 hrs 
at 30 °C. Following incubation (pre-primed, primed and after stimulation period), 
to separate extruded NET-DNA from the cellular debris, 15 μL of MNase 
(LS004797 Worthington Biochemical Corporation, Lakewood, NJ, USA) was 
added to each well and left at room temperature for 20 mins. The plate was then 
centrifuged at 1800 rcf for 10 mins and 150 μL of the supernatant containing the 
separated extracellular NET-DNA was then transferred to 96-well black micro-
plates (3915; Corning, Lowell, MA, USA) containing 15 μL of 10 μM SYTOX® 
Green in PBS (S7020; Invitrogen, Paisley, UK) per well. Over a period of 5 mins 
fluorometric measurements were acquired five times for each well in order to 
quantify the NET-DNA release. The total fluorescence from each well was 
measured at 37 °C and recorded in arbitrary fluorescent units (AFU) using a 
Twinkle LB970 (Berthold Technologies, Germany) with excitation/emission filter 
wavelengths of 485/525 nm, respectively. The experiment was repeated twelve 
times with neutrophils sourced from different healthy volunteers. 
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7.3.6 Ex-vivo imaging of cellular interactions of neutrophils co-stimulated 
with Ti nanoparticles and Ops Sa (IgG opsonised) 
 
To investigate the cellular interactions of Ti species with Ops Sa (Fc-γR 
mediated), 700 µL of isolated neutrophils at a concentration of 1x10
5
 cells/mL 
were re-suspended in 175 µL of Ti oxide as rutile (~50 nm) dispersed in PBS at a 
concentration of 200 ppm (Table 2.1; section 2.2). The suspended cells in Ti rutile 
(~50 nm) were immediately stimulated with 175 µL of Ops Sa (IgG opsonised) 
and then incubated for 1hr at 37 °C. At 1 hr the co-stimulated cells were 
repeatedly (x10) centrifuged and washed in PBS. The suspension was 
immediately fixed with 2.5% glutaraldehyde (1hr) and then 1% osmium tetroxide 
(1hr). Post-fixation samples were dehydrated through a series of alcohol solutions 
(50-100%). After ethanol treatment, cells were embedded in propylene oxide 
resin. Thin sections were cut with a diamond knife-microtome and stained with 
3% uranyl acetate and lead citrate. The sections were examined using a JEOL 
1200 TEM. 
 
7.3.7 Statistical analysis  
 
Statistics were performed using SPSS 20 software. The data were initially 
explored for normality using a Shapiro-Wilk test at a 95% significance level. 
Comparison between individual group means was performed using Wilcoxon 
Sign Rank tests at a 95% significance level. 
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7.4 RESULTS 
 
7.4.1 Ex-vivo chemiluminescence quantification of ROS release from primed 
and/or unprimed neutrophils  
 
Chemiluminescence measurements of ROS release from unprimed and primed 
neutrophils sourced from 12 different healthy volunteers at 2 hrs following 
stimulation with periodontal pathogens (Ops Sa and FN) is presented in the form 
of Box/Whisker plots (median, inter-quartile range, 10
th
 and 90
th
 percentiles and 
outliers) (Figure 7.1). The plots demonstrate the maximum RLU at 2 hrs against 
the condition (unprimed and/or primed) and stimulus employed. 
 
The chemiluminescence data was explored using the Shapiro-Wilk test at a 95% 
significance level where the data was identified to be not normally distributed 
(Figure 7.1). Pair-wise comparisons using Wilcoxon Sign rank tests demonstrated 
that all unprimed and/or primed cells exposed to periodontal pathogens resulted in 
significantly increased total and extracellular ROS release in comparison with 
cells exposed to the negative control stimulus (PBS) (P<0.005 for each 
comparison) (Figure 7.1).  
 
No significant difference in the magnitude of total and extracellular ROS 
production was observed between unprimed cells exposed to either Ops Sa or FN 
(positive controls) (P=0.94) (Figure 7.1). Similarly, no significant difference in 
the magnitude of total and extracellular ROS production was observed between 
IFN-α primed cells exposed to Ops Sa or FN (control primer) (P>0.05) (Figure 
7.1). A significantly increased magnitude in total ROS production was observed 
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when IFN-α primed cells exposed to Ops Sa when compared with unprimed cells 
exposed to the same stimulus (P=0.01) (Figure 7.1a). In contrast, no significant 
difference in extracellular ROS production was observed when IFN-α primed cells 
exposed to Ops Sa when compared with unprimed cells exposed to the same 
stimulus (P=0.07) (Figure 7.1b). However, IFN-α primed cells exposed to FN 
exhibited no significant change in total or extracellular ROS release when 
compared with unprimed cells (P>0.05) (Figure 7.1). 
 
Cells primed with anatase (~30 nm) or rutile (~50 nm) resulted in significantly 
decreased total and extracellular ROS production when compared with IFN-α 
primed cells and unprimed cells when stimulated with Ops Sa (P<0.05) (Figure 
7.1). In contrast, no significant difference in ROS production was observed 
between anatase (~30 nm) or rutile (~50 nm) primed cells when compared with 
IFN-α primed cells and unprimed cells exposed to FN (P>0.05) (Figure 7.1).  
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Figure 7.1 Box/Whisker plots demonstrating (a) total (luminol dependent) 
and (b) extracellular (isoluminol dependent) ROS production of unprimed 
and/or primed neutrophils. Scales are not common for plots displayed 
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7.4.2 Quantification of ROS release from neutrophils co-stimulated with Ti 
and Ops Sa (IgG opsonised) with unprimed or primed neutrophils 
 
To further help determine whether Ti implant derivatives mediate an Fc-γR 
mediated pathway, neutrophil ROS release was measured from 13 different 
healthy volunteers where selected cells have been either (i) unprimed but exposed 
to either PBS, Ops Sa, FN or Ti (rutile and metallic) (controls) (ii) primed with Ti 
(rutile or metallic) or IFN-α then stimulated with Ops Sa and/or (iii) co-stimulated 
with Ti (rutile or metallic) and Ops Sa (IgG opsonised) together. Data is presented 
in the form of Box/Whisker plots demonstrating maximum RLU at 2 hrs against 
condition (unprimed, primed and/or co-stimulated) employed (Figure 7.2). 
 
The chemiluminescence data was explored using the Shapiro-Wilk test at a 95% 
significance level where the data was identified to be not normally distributed 
(Figure 7.2). Pair-wise comparisons using Wilcoxon Sign rank tests demonstrated 
that all tested conditions (co-stimulated, primed and/or unprimed cells) resulted in 
significantly increased total and extracellular ROS release in comparison with 
unprimed cells exposed to PBS (P<0.002 for each comparison) (Figure 7.2).  
 
A similar pattern of total and extracellular ROS production was observed for cells 
unprimed and primed with either IFN-α or Ti oxide as rutile (~50 nm) as detailed 
in sections 5.4.3 and 7.4.1 respectively. In addition, cells primed with metallic Ti 
(~5 μm) then stimulated with Ops Sa resulted in a significantly lower magnitude 
of ROS production when compared with IFN-α primed cells and unprimed cells 
exposed to the same stimulus (P<0.002 for each comparison) (Figure 7.2).   
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The highest magnitude of ROS production was observed from cells co-stimulated 
with Ti oxide nanoparticles as rutile (~50 nm) and Ops Sa (IgG opsonised) 
together when compared to all other tested unprimed and primed cell conditions 
(P<0.05) (Figure 7.2). In contrast, ROS production from metallic Ti (~5 μm) and 
Ops Sa (IgG opsonised) co-stimulated cells were significantly reduced when 
compared with IFN-α primed and unprimed cells exposed to Ops Sa (P<0.02 for 
each comparison) (Figure 7.2). However, metallic Ti (~5 μm) and Ops Sa (IgG 
opsonised) co-stimulated cells resulted in significantly increased ROS release 
when compared with responses from unprimed cells exposed to metallic Ti (~5 
μm) species and metallic Ti (~5 μm) primed cells exposed to Ops Sa (P<0.004) 
(Figure 7.2). 
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Figure 7.2 Box/Whisker plots demonstrating (a) total (luminol dependent) 
and (b) extracellular (isoluminol dependent) ROS production from 
neutrophils co-stimulated with Ti (rutile or metallic) and Ops Sa (IgG 
opsonised) together with unprimed or primed neutrophils. Scales are not 
common for plots displayed 
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7.4.3 Ex-vivo fluorometric quantification of NET release from unprimed and 
primed neutrophils  
 
Fluorometric measurements of extracellular NET-DNA release in the supernatant 
of unprimed and primed neutrophils sourced from 12 different volunteers exposed 
to periodontal pathogens (Ops Sa or FN) and physiological agonists (PMA) after a 
3 hr incubation period in black wells was quantified in AFU (Figure 7.3). The 
fluorometric measurements are presented in the form of Box/Whisker plots 
demonstrating maximum AFU quantified against condition (unprimed and/or 
primed) employed. 
 
The extracellular NET-DNA release data was explored using a Shapiro-Wilk test 
at a 95% significance level, which identified the data to be not normally 
distributed (Figure 7.3). Pair-wise comparisons using Wilcoxon-Sign Rank test 
demonstrated that all tested conditions (unprimed and primed) resulted in 
significantly increased NET formation when compared to the negative control 
RPMI (P<0.004 for each comparison) (Figures 7.3).  
 
No significant difference in extracellular NET-DNA release was observed 
between unprimed cells exposed to Ops Sa or FN (positive controls) (P=0.11) 
and/or between IFN-α primed cells exposed to Ops Sa or FN (control primer) 
(P=0.51). In contrast, significantly increased NET release was observed for 
unprimed and IFN-α primed cells exposed to PMA when compared with 
unprimed and IFN-α primed cells exposed to Ops Sa or FN (P=0.005 for each 
comparison) (Figure 7.3).  
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Figure 7.3 Box/Whisker plots of extracellular NET-DNA release quantified in 
black wells after 3 hr incubation period for unprimed and primed 
neutrophils. Scales are not common for the plots displayed  
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IFN-α primed cells resulted in significantly decreased NET release when 
compared with unprimed cells when exposed to Ops Sa (P=0.007) (Figure 7.3). 
When cells were primed with Ti oxide as nanoparticles or micron sized metallic 
particles a significantly decreased extracellular NET-DNA release was observed 
when compared with unprimed and/or IFN-α primed cells exposed to Ops Sa 
(P=0.007 for each comparison) (Figure 7.3).  
 
In contrast, no significant difference in NET production was observed between 
IFN-α primed cells and unprimed cells exposed to FN (P=0.88). In addition, no 
significant difference in NET production was observed between Ti oxide as 
nanoparticles primed cells when compared with unprimed and/or IFN-α primed 
cells exposed to FN (P>0.05). In contrast, Ti as micron sized metallic (~5 & 20 
μm) primed cells resulted in significantly reduced NET release when compared 
with unprimed and/or IFN-α primed cells exposed to FN (P<0.007) (Figure 7.3).     
 
The highest magnitude of extracellular NET-DNA release was observed from 
unprimed and primed cells exposed to PMA when compared to all other tested 
unprimed and primed cell conditions exposed to either Ops Sa or FN (Figure 7.3). 
However, no significant differences in NET release were observed between IFN-α 
primed cells when compared with unprimed cells exposed to PMA (P=0.05). In 
addition, no significant difference in NET production was observed between 
anatase (~30 nm) or rutile (~50 nm) primed cells exposed to PMA when 
compared with unprimed and/or IFN-α primed cells exposed to PMA (P>0.05). 
However, significant differences in NET production were observed for mix oxide 
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(~66 nm) and micron sized metallic (~5 & ~20 μm) primed cells exposed to PMA 
with compared with unprimed and/or IFN-α primed cells exposed to PMA 
(P<0.009 for each comparison) (Figure 7.3). 
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7.4.4 Ex-vivo imaging of cellular interactions of neutrophils co-stimulated 
with Ti nanoparticles and Ops Sa (IgG opsonised) 
 
TEM was performed on neutrophils which had been co-stimulated for 1 hr with 
rutile (~50 nm) at a concentration of 200 ppm and Ops Sa (IgG opsonised) (Figure 
7.4). The TEM images indicated cellular uptake of large numbers of Sa. The 
surface of the phagocytosed Sa were themselves associated with nanoparticles as 
agglomerates (black and white features) (Figure 7.4). 
 
Figure 7.4 TEM image (JEOL 1200, Japan) acquired at 10,000 magnification 
of an isolated neutrophil post 1 hr co-stimulation with Ti oxide as rutile (~50 
nm) dispersed in PBS at a concentration of 200 ppm and Ops Sa (IgG 
opsonised)  
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7.5 DISCUSSION 
 
The capacity of Ti as oxide nanoparticles or micron sized metallic particles to 
modify neutrophil ROS and NET responses to periodontal pathogens has not been 
previously investigated. In peri-implant disease bacterial colonisation of the 
implant surface by pathogens including Ops Sa (gram positive) and FN (gram 
negative) are known to contribute to peri-implant inflammation (Remer et al., 
2001 & Huzinga et al., 1997). The phagocytosis of Ops Sa and FN by human 
neutrophils involves Fc-γR and TLR-4 activation respectively and these pathways 
are well characterised. In the current study, findings were compared with a PMA 
stimulus which is a non-physiological diester responsible for enhancing 
inflammatory reactions (ROS and NET) via activation of Protein Kinase C (PKC). 
Previous studies on the priming of neutrophils have used IFN-α as control primer 
which has been shown to enhance ROS responses to periodontal pathogens (Ops 
Sa or FN). 
 
Interestingly, Ti oxide primed neutrophils reduced ROS release when the cells 
were exposed to Ops Sa but did not affect responses to FN. Similarly, metallic Ti 
primed cells also reduced ROS release when the cells were exposed to Ops Sa. 
Differential inhibition of neutrophil ROS activity in Ti (oxide or metallic) primed 
neutrophils suggests specific effects on Fc-γR pathways whereas TLR-4 
activation appeared to be unaffected. The inhibition of ROS activity may possibly 
result from Ti implant derivatives becoming associated with blocking Fc-γR sites 
which reduce the concentration of Fc-γR ligand interactions. The ROS activity 
was less inhibited when neutrophils were primed with the ~5 µm sized metallic Ti 
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particles when compared with oxide nanoparticles and the latter have been shown 
to have greater affinity for the cell surface membrane. The consequences of such 
modulation of ROS release will be a failure to induce an adequate inflammatory 
response to the pathogen. Decreased activity and reactivity of Ti (oxide or 
metallic) primed neutrophils to further respond to other inflammatory mediators 
needs further evaluation.  
 
To further identify whether Ti implant derivatives modify ROS activity through 
Fc-γR activity, neutrophils were co-stimulated with Ti implant derivatives (oxide 
or metallic) and Ops Sa. The data demonstrated that co-stimulated cells exhibited 
the highest magnitude of ROS release which is contradictory to previous 
observations that Ti priming reduces the response to Ops Sa. This observation is 
possibly a consequence of exposing neutrophils with a stimulatory concentration 
of both Ops Sa and the Ti nanoparticles, in contrast to exposing the neutrophils to 
priming concentrations. Moreover, imaging of Ti and Ops Sa co-stimulated cells 
demonstrated a strong surface interaction of the Sa with the Ti nanoparticles and 
high levels of phagocytosis (Figure 7.4). The Ti surface association with Ops Sa 
may also cause masking or blocking of the surface opsonins and therefore a 
decrease in neutrophil activation but this was not observed. 
 
A higher magnitude of ROS release was observed for metallic Ti (~5 μm) and Ops 
Sa co-stimulated cells when compared with ~5 μm metallic Ti primed cells 
exposed to Ops Sa and/or unprimed cells stimulated with ~5 μm metallic Ti 
conditions. However, the magnitude of ROS release was still observed to be less 
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than IFN-α primed and unprimed cells exposed to Ops Sa (Figure 7.2). This 
suggests that the effects are mediated by particle size. Differential responses are 
possibly a consequence of neutrophils co-activated by Ti implant derivatives and 
Sa behaving differently when compared with pre-activated cells exposed with Ti 
implant derivatives following subsequent exposure to Ops Sa. This suggests 
neutrophils exposed to Ti are activated and thus possess enhanced ROS release, in 
contrast to inactivated cells exposed to Ti. This observation was supported, in 
chapter 5 where phagocytosis and subsequent ROS production processes by 
neutrophils exposed to micron sized metallic Ti particles was demonstrated to be 
lower than nanoparticles. 
 
As discussed in Chapter 6, the mechanism of NET release is dependent on the 
ROS release pathway. Therefore, the capacity of Ti implant derivatives (oxide or 
metallic) to possibly modify NET production in response to Ops Sa and FN was 
also investigated. Similar to the inhibition of ROS activity by Ti (oxide or 
metallic) primed neutrophils that was observed following exposure to Ops Sa, 
inhibition of NET release was also demonstrated upon exposure to the same 
stimuli. However, in contrast to the effects of priming on ROS release, priming 
with micron sized metallic Ti particles also reduced the magnitude of NET release 
to FN. This down regulation of NET release may possibly be attributed to cell 
death or decreased stimulatory activity which is consistent with the ROS release 
data.  
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In contrast, Ti (oxide or metallic) primed neutrophils exposed to PMA exhibited 
the highest orders of NET release. This enhanced activity of the cell is possibly as 
a consequence of the hydrophilic nature of PMA which by-passes cell surface 
membranes and therefore readily interacts with the cell which has already entered 
into a pre-activated state due to the exposure to Ti implant derivatives. Therefore, 
it may be concluded that the capacity of Ti (oxide or metallic) primed neutrophils 
to inhibit NET responses to periodontal pathogens or to enhance NET responses 
to PMA is dependent upon the Ti implant derivatives interaction with the surface 
receptors and the magnitude of the response is governed by the nature of the Ti 
stimulus. 
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7.6 CONCLUSION 
 
These findings suggest that Ti (oxide or metallic) implant derivatives can modify 
the response of neutrophils to periodontal pathogens and pro-inflammatory 
molecules (PMA). The modification of the response involves to some extent the 
Fc-γR pathway which was differentially down-regulated by exposure to low levels 
of Ti (either as oxide or metallic particles). The consequence of the observations 
would be an inadequate response to certain periodontal pathogens, leading to their 
persistence in the tissues and inducing a perpetuation of the chronic inflammation.  
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CHAPTER 8 
 
THE EFFECT OF TITANIUM IMPLANT DERIVATIVES 
ON NEUTROPHIL CHEMOTAXIS 
 
 
8.1 PREFACE 
 
 
This chapter explores the effect(s) of the exposure of selected Ti implant 
derivatives (oxide or metallic) on the chemotactic response of neutrophils using 
the Insall bridge chamber. To date, there are no studies which demonstrate 
whether Ti implant derivatives act as chemoattractants promoting neutrophil 
migration into the peri-implant tissues. Furthermore, it is currently not known 
whether neutrophil exposure to Ti implant derivatives modifies the cell’s 
chemotactic behaviour. The chemotactic responses to Ti derivatives presented as 
oxide (rutile) (~50 nm) and as metallic (~5 µm) species were initially studied. The 
species were representative of products of mechanically assisted crevice corrosion 
(Ti as oxide nanoparticles) or larger debris generated through tribiological 
processes (micron sized metallic Ti). Subsequently, the chemotactic response of 
neutrophils previously exposed to Ti as rutile (~50 nm) and metallic (~5 µm) 
species to physiological chemoattractants fMLP (strong chemoattractant) and IL-8 
(moderate chemoattractant) was investigated. 
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8.2 INTRODUCTION 
  
8.2.1 Neutrophil motility 
 
 
The migration of neutrophils into peri-implant tissues (Van Dyke, 1985) and their 
subsequent accumulation is a histological characteristic of peri-implant disease 
(Itakura et al., 2011 & Tong et al., 2012). Neutrophils have been demonstrated to 
migrate into pathological sites at speeds of up to 20 µm min
-1 
following 
chemoattractant gradient(s) which may include bacterial derived peptides such as 
N-Formyl-Methionyl-Leucyl-Phenylalanine (fMLP) (Witko-Sarsat et al., 2000); 
proteolytic fragments of the extracellular matrix (Senior et al., 1980) and 
chemokines such as Interleukin-8 (IL-8) (Leonard & Yoshimura, 1990). 
  
Cell motility may be defined as chemotaxis or chemokinesis (Pfeffer, 1884). 
Chemotaxis is the directional migration of cells along a chemical concentration 
gradient (Zachariae, 1993 & Insall, 2010) which contributes to cell accumulation 
at specific sites (Devreotes and Zigmond, 1988). In contrast, chemokinesis is the 
random movement of cells (Wells, 2000) in response to an extracellular signal 
(Lippincott Schwartz, 2005 & Insall, 2010). Cell motility itself is governed by a 
complex series of cellular processes including cell protrusion/pseudopod 
formation, adhesion, de-adhesion and contraction of the cell (Muinonen-Martin et 
al., 2012). In neutrophils, motility is controlled by cell surface receptor activation 
which leads to the re-organisation of the actin cytoskeleton framework (Glogauer 
et al., 2000 & Ciccheti, 2002). Activated neutrophils undergo a sequence of 
structural changes (Zigmond, 1977 & Seveau et al., 2001) resulting in a polarised 
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morphology with a distinct actin rich front lamella and tail-like uropod at the 
dorsal end which forms an axis that is orientated in the field of the 
chemoattractant (Benard et al., 1999 & Larmonier et al., 2011). Chemoattractants 
induce F-actin polymerisation of the leading edge of the cell causing it to move 
directionally within the concentration gradient of the chemoattractant species 
(Larmonier et al., 2012). 
 
8.2.2 Role of chemoattractants in cell motility 
 
The speed, frequency and directionality of cell migration are influenced by the 
chemoattractant species (Lippincott-Schwartz, 2005). Neutrophils are understood 
to have multiple receptors for the recognition of chemoattractants (Wagner & 
Roth, 2000). One of the predominant chemotactic receptors expressed on the 
plasma membrane of a neutrophil (Edwards, 1994) is the 32-kDa heterotrimeric 
G-protein-coupled, pertussis-toxin-sensitive fMLP receptor (~50,000/cell) 
(Williams et al., 1977). This receptor recognises bacterial and mitochondrial 
proteins that are formylated at their amino terminal (De Nardin et al., 1991 & 
Ciccheti, 2002). Activation of the fMLP receptor stimulates multiple processes 
including degranulation, oxidative burst, cytoskeletal changes, priming for 
enhanced response to other activators in addition to chemotaxis (Wagner & Roth, 
2000); fMLP being a potent chemoattractant. The most comprehensively studied 
neutrophil receptors are the chemokine receptors (mainly CXCR1 & CXCR2) for 
IL-8 (Premack & Schall, 1996). Chemokines are a group of approximately forty 
small proteins (6-15 KDa) (Nickel et al., 1999) with similar cysteinyl containing 
structures (Wagner & Roth, 2000). IL-8 also known as the neutrophil attractant 
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protein-1 (NAP-1) (Edwards, 1994) is an 8 KDa protein (Nickel et al., 1999) 
which is a moderately potent activator for neutrophils inducing chemotaxis 
(Wagner & Roth, 2000), exocytosis (Baggiolini & Clark-Lewis, 1992) and the 
respiratory burst (Guichard et al., 2005). It is expressed in neutrophils in response 
to lipopolysaccharides (LPS) (Edwards, 1994), inflammatory cytokines (e.g. TNF-
α & IL-1) (Deforge et al., 1992) and after exposure to priming agents such as 
granulocyte macrophage colony-stimulating factor (GM-CSF) (Witko-Sarsat, 
2000).  
 
8.2.3  Parameters influencing the outcome of the chemotactic response and 
its implications for inflammation 
 
In the absence of inflammation, neutrophils are partitioned in the bloodstream 
(Witko-Sarsat, 2000). However, at sites of tissue inflammation and infection, an 
array of inflammatory mediators (e.g. IL-8, IFN-α, TNF-α) behave as either 
attractants or repellents and act to regulate neutrophil chemotaxis (Herlihy et al., 
2013). The cell’s speed (a measure of random movement in any direction), 
velocity (speed in a consistent direction towards or away from the inflammatory 
mediator) and the chemotactic index (the accuracy of migration measured as the 
angled movement in the direction of the chemoattractant) are three important 
parameters involved in predicting the outcome of the chemotactic response to the 
inflammatory mediator (Sapey et al., 2011). Moreover, the ability of the cell to 
migrate and the speed of migration are dependent upon the availability of cell 
surface receptors and their attachment to the chemoattractant (Lippincott-
Schwartz, 2005). This in turn depends on the concentration of the ligand, the 
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concentration of the ligand receptor and the ligand receptor binding affinity 
(Palecek et al., 1997). 
 
In certain cases, the magnitude of the chemotactic response of the cell may be 
slow and/or repulsive (restricted or away) to a specific inflammatory mediator 
which consequently inhibits cell migration and accumulation in the tissues 
(Herlihy et al., 2013). The inhibition of the neutrophil chemotactic response at 
inflamed tissue sites by chemorepellents promotes pathological tissue damage and 
delays the inflammatory resolution processes (Brubaker et al., 2013). Likewise, an 
excessively increased and/or directed cell movement towards the inflammatory 
mediator may also contribute to the perpetuation of the inflammatory response. 
This may lead to tissue destruction via oxidative damage and the release of 
proteases (Larmonier et al., 2011) due to the disproportionate accumulation of 
neutrophils at the inflamed site. Therefore, it is useful to measure the magnitude 
of a cell’s chemotactic response (speed, velocity and chemotactic index) to 
determine potential implications for inflammation. This functional assay would 
provide greater insights into the expected impacts from the stimulation of the 
NADPH oxidase complex by Ti implant derivatives. 
 
8.2.4 Cell motility assays 
 
In-vivo techniques for direct observation of cell locomotion in humans and 
animals have been reported, however these sophisticated microscopy techniques 
are technically challenging, expensive and often lack reproducibility (Condeelis & 
Segall, 2003, Cavanagh & Weninger, 2008 & Tong et al., 2012). As a result, a 
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number of in-vitro cell motility assays have been developed to investigate 
biological cell migration mechanism(s). The Insall chamber (Insall, 2010) is a 
novel but well characterised method developed for direct and real-time 
visualisation of both population scale and single cell chemotaxis behaviour at a 
high resolution (Muinonen-Martin et al., 2012 & Tong et al., 2012). The device is 
simple, inexpensive to fabricate and allows reproducible measurements. Most 
importantly, these bridge shaped chambers allow chemotaxis to be accurately 
distinguished from (random) chemokinesis behaviour (Muinonen-Martin et al., 
2012). 
 
8.2.5 The Insall bridge chamber geometrical design and assay principle 
 
The Insall chamber (Insall, 2010) consists of a square closed central chamber 
separated from a square outer chamber by two bridges on opposite sides (Figure 
8.1). The outer chamber is utilised as a chemoattractant reservoir where direct 
administration of the chemoattractant is conducted (indicated by red arrows on 
Figure 8.1) (Muinonen-Martin et al., 2012 & Tong et al., 2012). The bridges 
measure 3 mm in length with widths of 0.5 mm and 1 mm respectively. The 
narrow and wide bridges produce two different gradients of the chemoattractant 
within the one assay system (Figure 8.1) (Muinonen-Martin et al., 2012).  
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Figure 8.1 Schematic representation of Insall bridge chamber 
 
 
 
 
 
 
 
 
Cells are plated onto a glass cover slip which is then inverted over the central 
chamber leaving a small gap of 20-30 µm between the bridge and the cover slip 
(Insall, 2010). The gap is too small for fluid movement to occur, but large enough 
to allow diffusion of the chemoattractant (Figure 8.1) (Muinonen-Martin et al., 
2012 & Tong et al., 2012). Cells centrally located on the wide bridge, between the 
outer and inner square chambers are then observed using an inverted time lapse 
microscope (indicated by green box on Figure 8.1) (Zigmond et al., 1998, 
Muinonen-Martin et al., 2012 & Tong et al., 2012) recording multiple image 
frames over the time course of the experiment. 
 
 
 
 
 
 
 
 
 
Narrow Bridge 
0.5 mm 
Wide 
Bridge 
1 mm 
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8.3 METHODS 
 
8.3.1 Preparation of neutrophils for chemotaxis assay 
 
The chemotaxis assay was conducted within four hrs of neutrophil isolation 
(Appendix I). Isolated cells at a concentration of 1x10
6
 cells/mL were re-
suspended in RPMI-1640 media and incubated at 37 °C and 5% CO2 in a 
humidified atmosphere until use.  
 
8.3.2 Cover slip preparation 
 
22 mm x 22 mm (0.16-0.18 mm thick) cover slips were washed in 0.1 M HCl for 
1 min followed by further washing with distilled water twice for 1 min each. The 
cover slips were then coated with 500 µL of 7.5% BSA for 2 min. Excess coating 
was carefully tipped off and replaced with 300 µL of the prepared cell suspension 
at 37 °C for 20 mins allowing cells to adhere to the cover slip. 
 
8.3.3 Chemoattractant preparation 
 
Control and experimental chemoattractants were prepared by adding high purity 
reagents to RPMI-1640. Table 8.1 demonstrates the working concentration of the 
prepared solution and final stimulation concentration once added to the 
experimental system. 
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Table 8.1 Chemoattractants used to induce chemotaxis 
 
Chemoattractant 
 
Supplier/Cat 
No. 
Working 
Concentration 
Stimulation 
Concentration 
RPMI-1640 Sigma-Aldrich 
R0883 
 
- 
 
- 
N-Formyl-Met-Leu-
Phe (fMLP) 
Sigma-Aldrich 
F3506 
400 µg/mL 4 ng/mL 
Interleukin-8  
(IL-8) 
Sigma-Aldrich 
SRP3098 
200 ng/mL 10 ng/mL 
Ti oxide-rutile  
(~50 nm) 
Sigma-Aldrich 
1317802 
100 ppm 50 ppm 
Metallic-Ti  
(~5 µm) 
Prepared in 
house (section 
2.2.2) 
100 ppm 50 ppm 
 
8.3.4 Insall chamber preparation 
 
The inner and outer wells of the Insall chamber (Beatson Institute, Glasgow, UK) 
were washed three times with RPMI-1640 buffer followed by leaving a droplet of 
the buffer in the inner well to entirely cover the surface (Figure 8.1). The prepared 
cover slip with adherent cells was then inverted onto the prepared chamber so that 
cells were overlying the inner chamber and bridge areas avoiding air bubbles. 
Excess buffer was subsequently blotted from the edges of the cover slip taking 
care to avoid movement of the cover slip, which could result in shearing of the 
cells over the bridge. Fluid that had been displaced into the outer well was 
carefully removed using absorbent filter paper. 70 µL of a specified 
chemoattractant was then pipetted into the chemotactic reservoir (outer chamber) 
(Figure 8.1) developing a gradient across the bridge. The entire Insall chamber 
was then inverted and mounted onto a slide holder prior to time lapse microscopy. 
All measurements were conducted at 22 ± 1 °C. The assay was repeated three 
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times for each chemoattractant where neutrophils were sourced from different 
donors each time. 
 
8.3.5 Time lapse microscopy 
 
A Nikon TE2000-E (TE2000-E, Japan) inverted time lapse microscope was used 
to capture images. The microscope was configured with an auto-focus to ensure 
the quality of the image. Overlapping images across an area at the mid-point of 
the width of the bridge were captured using an x20 objective. Images were 
acquired every 10 secs for up to 20 mins. 
 
8.3.6 Preparation of Ti pre-treated neutrophils for chemotaxis assay 
 
To determine if Ti implant derivatives modify neutrophil ‘chemotactic behaviour’, 
a further set of 600 µL of isolated cells (Appendix I) at a concentration of 1x10
6
 
cells/mL suspended in RPMI-1640 were pre-treated with 150 µL of Ti as oxide-
rutile (~50 nm) or metallic (~5 µm) species at a concentration of 50 ppm. The pre-
treated cells were incubated at 37 
o
C and 5% CO2 in a humidified atmosphere for 
20 mins prior to exposure to known chemoattractants including RPMI (negative 
control), fMLP and IL-8 (section 8.3.3) using the Insall chamber. The experiment 
was repeated three times with neutrophils isolated from different healthy donors. 
Cell from each donor were used for all aspects of the experiment i.e. were 
exposed to all three chemoattractants. 
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8.3.7 Cell tracking and quantitative data analysis 
 
The manual tracking plug-in for Image J was used to track 15 individual cells 
migrating on the wider bridge of the chamber within the overlapping fields of 
view created by the time-lapse images. In addition, the chemotaxis plug-in was 
quantified using MATLAB (MathWorks, Natick, MA, USA) to analyse cell 
behaviour. The magnitude of a cell’s chemotactic response including speed, 
velocity and chemotactic index (Table 8.2) were calculated as a measure of shift in 
the cosine θ angle (Figure 8.2) of a migrating cell.  
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Table 8.2 Dynamic parameters calculated   
 
 
Chemotaxis Parameter Measure of Formula Units 
 
Speed (Chemokinesis) 
total movement distance 
Time 
δ 
Time 
 
μm.min-1 
 
Velocity (Chemotaxis) 
distance moved in the direction 
of the chemoattractant 
Time 
 
Δcosθ  
Time 
 
μm.min-1 
Chemotactic Index 
(Chemotactic accuracy) 
Extent of migration in the 
direction of the chemoattractant 
 
Δcosθ 
 
µm 
 
 
Figure 8.2 The direction of neutrophil migration calculated as a measure of 
shift in the angle θ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.3.8 Statistical analysis 
 
Wilcoxon Sign Rank test was conducted to determine whether the circular 
distribution of 45 tracked cells was random or non-random. Subsequently, a one-
way analysis of variance (ANOVA) followed by post-hoc Tukey test were used to 
compare group means of speed, velocity and chemotactic index at a 95% 
Δ 
 
δ
δ 
 
1 
0 
-1 
0 
Neutrophil 
Chemoattractant 
θ 
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significance level. Statistics were performed using Graphpad Prism version 3.02 
statistical software. 
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8.4 RESULTS 
 
8.4.1 Change of neutrophil morphology in response to chemoattractants 
 
Neutrophils go through a sequence of morphological changes following activation 
(Zigmond & Sullivan, 1979). Time lapse images taken every 10 secs for 20 mins 
were assessed at 10 mins to define the morphology of the cells. Positive control 
chemoattractants included fMLP (strong) and IL-8 (moderate) and a negative 
control chemoattractant as RPMI-1640. Experimental chemoattractants employed 
were Ti as rutile (oxide; ~50 nm) and metallic (~5 µm) species prepared as 
dispersions in RPMI-1640 at a concentration of 50 ppm.  
 
RPMI exposed cells were round and spherical indicating the cells were not 
activated (Figure 8.3). In contrast, fMLP, IL-8 and Ti (oxide or metallic) species 
exposed cells acquired the morphology of a stimulated cell with the cell periphery 
becoming irregular exhibiting small membrane protrusions and retractions (Figure 
8.3). 
 
Figure 8.3 Morphology of human neutrophils at 10 mins post exposure to 
RPMI (negative control chemoattractant), fMLP or IL-8 (positive control 
chemoattractants) and Ti implant derivatives (experimental 
chemoattractants) 
 
RPMI                                 fMLP/IL-8                     Ti (oxide or metallic) 
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8.4.2 Modulation of induced neutrophil direction of movement in response to 
the chemoattractants 
 
Cell tracks of 15 individual cells migrating on the central area of the wider (1.0 
mm) bridge of the chamber (indicated by green box on Figure 8.1) were assessed 
to determine the directional migration of neutrophils to the chemoattractants 
employed (section 8.3.4). Data is presented in the form of spider plots which 
indicate the paths of 15 individual cells (Figure 8.4).  
 
The spider plot of RPMI (negative control chemoattractant) exposed cells 
indicated none or minimal migration (Figure 8.4). In contrast, spider plots of cells 
exposed to fMLP and IL-8 (positive control chemoattractants) exhibited 
directional (upwards) movement towards the chemoattractant gradient (Figure 
8.4). Notably, cells migrating to fMLP chemoattractant exhibited increased 
movement when compared with IL-8 moving a distance of between 80 and 100 
µm (towards the chemoattractant gradient) for fMLP within the 20 min measured 
assay time compared with <80 µm for IL-8 (Figure 8.4). 
 
Spider plot of cells exposed to Ti as rutile (oxide; ~50 nm) and metallic (~5µm) 
species (experimental chemoattractants) at a concentration of 50 ppm exhibited no 
significant directional migration (Figure 8.4). Ti implant derivatives (oxide or 
metallic) exhibited none or limited chemoattractant properties.  
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Figure 8.4 Spider plots indicating individual cell paths to chemoattractants 
including RPMI, fMLP, IL-8 and Ti oxide as rutile (~50 nm) and metallic (~5 
µm) species at concentration of 50 ppm dispersed in RPMI-1640  
 
                
                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RPMI fMLP 
IL-8 Rutile (~50 nm) 
Metallic  (~5 µm) 
Key 
      = Chemoattractant 
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8.4.3 Modulation of the direction and magnitude of the chemotactic response 
induced by neutrophils in response to the chemoattractants 
 
Quantification of the chemotactic response was performed and displayed as rose 
plots (Figures 8.5 & 8.6). Rose plots use end point data to plot points on a unit 
circle showing a red line indicating the direction and magnitude of the mean 
resultant vector (Figure 8.5 & 8.6; Left) and angular histograms associated with 
the trajectories (Figure 8.5 & 8.6; Right). Circles dotted on the edge of the circle 
represent the 45 individual cells tracked (Figures 8.5 & 8.6; Left). The dotted blue 
lines from the centre of the circle represent the confidence intervals (Figures 8.5 
& 8.6; Left). 
 
The mean resultant vector length of cells exposed to RPMI was of a low 
magnitude (0.2556) with wide 95% confidence intervals consistent with the 
random movement of cells (Figure 8.5; Left). The evidence for non-directed 
migration was further supported by a Wilcoxon Sign Rank test for non-random 
movement (P>0.05) (Figure 8.5). In comparison to RPMI exposed cells, the mean 
resultant vector length for fMLP and IL-8 was increased to 0.8988 and 0.9183, 
respectively with corresponding narrow 95% confidence intervals in the direction 
of the chemoattractants (Figure 8.5). The evidence for directed migration of cells 
to fMLP and IL-8 chemoattractants was supported by a significant Wilcoxon Sign 
Rank test (P=0.001) respectively, demonstrating cell chemotaxis (directed 
migration) towards the chemoattractant gradient (Figure 8.5). 
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Figure 8.5 Rose plots quantifying the neutrophil chemotactic response to 
chemoattractants including RPMI, fMLP and IL-8  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemoattractant was situated at 90
o
, uppermost point in the rose plots. 
 
 
RPMI RPMI 
fMLP fMLP 
IL-8 IL-8 
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When Ti oxide as rutile (~50 nm) and metallic (~5 µm) species at a concentration 
of 50 ppm were used as experimental chemoattractants, the mean resultant vector 
lengths were 0.2263 and 0.2481 respectively (Figure 8.6). The magnitude of the 
mean resultant vector length for Ti (oxide or metallic) species was significantly 
decreased when compared with fMLP and IL-8 (positive control 
chemoattractants) (P<0.05) (Figure 8.5) but similar to RPMI (negative control 
chemoattractant). The rose plot of rutile (~50 nm) as a chemoattractant indicated 
wide 95% confidence intervals and the predominant direction was in the opposite 
direction of the chemoattractant gradient (Figure 8.6). The apparent repulsive 
behaviour exhibited by cells when Ti-rutile (~50 nm) was used as a 
chemoattractant was supported by a significant Wilcoxon Sign Rank test 
(P=0.0091) (Figure 8.6). The rose plot for the metallic (~5 µm) stimulus indicated 
a similar wide 95% confidence interval. No evidence for directed migration of 
cells to metallic (~5 µm) species was observed, confirmed by an insignificant 
Wilcoxon Sign Rank test (P=0.07) and resulting chemokinesis (from the uniform 
angular distribution of cells) (Figure 8.6).  
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Figure 8.6 Rose plots quantifying the neutrophil chemotactic response to Ti 
oxide as rutile (~50 nm) and metallic (~5 µm) species at concentration of 50 
ppm dispersed in RPMI-1640 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemoattractant was situated at 90
o
, uppermost point in the rose plots. 
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8.4.4 Modulation of direction induced by Ti pre-treated neutrophils in 
response to known chemoattractants 
 
The chemotactic response of neutrophils pre-exposed to Ti as rutile (~50 nm) and 
metallic (~5 µm) species at a concentration of 50 ppm to known chemoattractants 
RPMI, fMLP and IL-8 was also investigated. Spider plots indicated minimal 
directional migration for Ti (rutile or metallic) pre-treated neutrophils toward the 
negative control chemoattractant gradient RPMI (Figure 8.7). However, 
directional migration was observed for Ti (rutile or metallic) pre-treated cells 
towards the chemoattractant gradients fMLP and IL-8 (Figure 8.7). Notably, Ti as 
rutile (~50 nm) and metallic (~5 µm) pre-treated cells travelled distances up to 
100 µm and 200 µm, respectively towards the fMLP chemoattractant gradient 
(Figure 8.7) and this was significantly increased when compared to the untreated 
cells (Figure 8.4) (P<0.005). However, Ti as rutile (~50 nm) and metallic (~5 µm) 
pre-treated cells travelled <60 µm towards the IL-8 chemoattractant gradient 
(Figure 8.7) which was significantly less than untreated cells (Figure 8.4). 
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Figure 8.7 Spider plots indicating individual cell paths of pre-treated cells 
with Ti as rutile (~50 nm) and metallic (~5 µm) species at a concentration of 
50 ppm dispersed in RPMI-1640 to known chemoattractants RPMI, fMLP 
and IL-8. Scales are not common between chemoattractants used 
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      = Chemoattractant 
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Rutile (~50 µm) fMLP Metallic (~5 µm) fMLP 
Rutile (~50 m) IL-8 Metallic (~5 µm) IL-8 
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8.4.5 Modulation of the direction and magnitude of the chemotactic response 
induced by Ti pre-treated neutrophils in response to known 
chemoattractants 
 
Analysis of chemotaxis using rose plots demonstrated that Ti (rutile or metallic) 
pre-exposed neutrophils were unaffected in their response to RPMI (Figure 8.8). 
Random movement was observed with a mean resultant vector length of 0.2790 
(rutile; ~50 nm) and 0.2364 (metallic; ~5 µm) with wide 95% confidence intervals 
and little directionality towards the RPMI chemoattractant was shown (Figure 
8.8).  
 
Figure 8.8 Rose plots quantifying the chemotactic response of Ti oxide as 
rutile (~50 nm) and metallic (~5 µm) species of 50 ppm pre-treated cells in 
response RPMI chemoattractant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rutile (~50 nm) RPMI Rutile (~50 nm) RPMI 
Metallic (~5 µm) RPMI Metallic (~5 µm) RPMI 
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For cells pre-treated with rutile (~50 nm) at a concentration of 50 ppm and then 
exposed to chemoattractants fMLP and IL-8 (Figure 8.9), the magnitude of the 
mean resultant vector length of fMLP treated cells (0.6810) was reduced in 
comparison with IL-8 treated cells (0.7180) with a narrow 95% confidence 
interval in the direction of the chemoattractant gradient (Figure 8.9). Wilcoxon 
Sign Rank test demonstrated a significant chemotaxis behaviour for both fMLP 
and IL-8 chemoattractant (P<0.001). 
 
Figure 8.9 Rose plots quantifying the chemotactic response of Ti oxide as 
rutile (~50 nm) of 50 ppm pre-treated cells in response to fMLP and IL-8 
chemoattractants 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Rutile (~50 nm) fMLP Rutile (~50 nm) fMLP 
Rutile (~50 nm) IL-8 Rutile (~50 nm) IL-8 
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Rose plots for cells pre-treated with Ti-metallic (~5 µm) at a concentration of 50 
ppm exposed to chemoattractants fMLP and IL-8 demonstrated modified 
behaviour (Figure 8.10). The magnitude of the mean resultant vector length of 
metallic fMLP treated cells (0.6593) was significantly increased in comparison 
with metallic IL-8 treated cells (0.3697) (P<0.005) (Figure 8.10). However, Ti-
metallic fMLP treated cells exhibited a narrower 95% confidence interval in the 
direction of the fMLP chemoattractant when compared with Ti-metallic IL-8 
(Figure 8.10). The evidence for Ti-metallic (~5 µm) pre-treated cells exhibiting 
chemotaxis (directed migration) to chemoattractants fMLP and IL-8 was 
supported by a significant Wilcoxon Sign Rank test (P<0.002).  
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Figure 8.10 Rose plots quantifying the chemotactic response of Ti-metallic 
(~5 µm) at 50 ppm pre-treated cells in response to fMLP and IL-8 
chemoattractants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemoattractant was situated at 90
o
, uppermost point in the rose plots. 
 
 
 
 
 
 
Metallic (~5 µm) fMLP Metallic (~5 µm) fMLP 
Metallic (~5 µm) IL-8 Metallic (~5 µm) IL-8 
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8.4.6 Parameters including speed, velocity and chemotactic index influencing 
the outcome of the chemotactic response 
 
 
The speed (Figure 8.11), velocity (Figure 8.12) and chemotactic index (Figure 
8.13) are measurements of a cell’s chemotactic response to the chemoattractants 
employed (Table 8.1). Data is presented in the form of box plots identifying the 
magnitude of the cells’ chemotactic response on the y-axis vs. the 
chemoattractants employed on the x-axis [mean ± standard deviation (S.D) and 
full data range] (Figures 8.11-8.13). 
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The cell speed was significantly lowest following exposure to RPMI (negative 
control chemoattractant) for both untreated and Ti pre-treated cells (P<0.05) 
(Figure 8.11). For all other tested conditions including Ti (rutile; ~50 nm or 
metallic; ~5 µm) as the chemoattractant; fMLP & IL-8 (positive control 
chemoattractants) and Ti (rutile; ~50 nm or metallic; ~5 µm) pre-treated cells 
exposed to fMLP and IL-8, a significantly increased magnitude of cell speed was 
observed (P<0.05) (Figure 8.11). However, no significant difference in the 
magnitude of cell speed was observed between all tested conditions other than Ti-
metallic pre-treated cells exposed to fMLP and IL-8 chemoattractants (P<0.05) 
(Figure 8.11). Pre-treatment of neutrophils with metallic particles (~5 µm) 
significantly increased speed in response to a positive chemoattractant when 
compared with all other stimulations.  
 
Figure 8.11 Measure of cells’ speed 
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The velocity of cell movement (in the direction of the chemoattractant) was 
significantly lowest for cells exposed to RPMI (negative control chemoattractant) 
for both untreated and Ti pre-treated cells (P<0.05) (Figure 8.12); and for cells 
when Ti (rutile; ~50 nm or metallic; ~5 µm) was used as an experimental 
chemoattractant (P<0.05) (Figure 8.12). Significantly increased velocities were 
observed for cells exposed to fMLP and IL-8 (positive control chemoattractants) 
for both untreated and Ti pre-treated cells when compared to all other tested 
conditions (P<0.005) (Figure 8.12). However, cell velocity was significantly 
reduced for Ti-rutile (~50 nm) pre-treated cells when compared with untreated 
cells exposed to the same chemoattractants (P<0.005) (Figure 8.12). In contrast, 
cell velocity significantly increased for Ti-metallic (~5 µm) pre-treated cells 
exposed to both fMLP and IL-8 chemoattractants (P<0.05) (Figure 8.12). 
 
Figure 8.12 Measure of cells’ velocity   
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The chemotactic index when RPMI was used as the negative control 
chemoattractant for both untreated and Ti pre-treated cells was significantly lower 
than all other tested conditions (P<0.05), however an exception were rutile (~50 
nm) RPMI treated cells (P=0.12) (Figure 8.13). The magnitude of the chemotactic 
index was significantly increased for fMLP as a chemoattractant when compared 
with IL-8 (P<0.05) (Figure 8.13). A significant decrease in the magnitude of the 
chemotactic index was observed for Ti (rutile; ~50 nm and metallic; ~5 µm) pre-
treated cells exposed to both fMLP and IL-8 chemoattractants (P<0.05) (Figure 
8.13).  
 
Figure 8.13 Measure of cells’ chemotactic index 
 
 
 
 243 
8.5 DISCUSSION 
 
The current study used the Insall chamber (a novel in-vitro system) for the first 
time to observe chemotaxis of neutrophil populations exposed to Ti implant 
derivatives (oxide nanoparticles or micron sized metallic particles) at a single cell 
resolution. The assay was designed to determine if selected Ti implant derivatives 
such as rutile (~50 nm) or metallic (~5 µm) act as neutrophil chemoattractants and 
if cells exposed to Ti (oxide or metallic) subsequently modify chemotactic 
responses to known chemoattractants (fMLP and IL-8).  
 
The findings of this study demonstrated that Ti as both oxide nanoparticles and 
micron sized metallic particles forms do not directly act as chemoattractants 
(Figures 8.4 & 8.6). This is unsurprising given the chemical stability of both 
forms of Ti in the pseudophysiological conditions of the Insall chamber. Analysis 
of cell movement parameters (speed, velocity and chemotactic index) of 
neutrophils when Ti was used as the experimental stimulus suggested some 
chemokinesis properties (Figures 8.11-8.13). Due to the insolubility of TiO2 (as 
particles or as the passive surface of metallic particles) no concentration gradient 
of Ti can be established. However, when rutile (~50 nm) nanoparticles were used 
as a chemoattractant, minimal but significant directional movement away from the 
stimulus was observed (Figure 8.6). Although, this may be an experimental 
artefact, it may also be explained by the adsorption of components e.g. proteins 
(BSA) from the liquid media in the Insall chamber onto the surfaces of the 
nanoparticles creating small localised (negative) gradients within the experimental 
setup. 
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The exposure of neutrophils to Ti (as either oxide-rutile nanoparticles or micron 
sized metallic particles) resulted in modified chemotactic behaviour to known 
chemoattractants (fMLP and IL-8) (Figures 8.7, 8.9 & 8.10). However, the effects 
on chemotaxis are best considered as discrete components, speed, velocity and 
chemotactic index which differed significantly with the type of Ti exposure and 
the type of chemoattractant (Figures 8.11-8.13). 
 
Pre-exposure to rutile (~50 nm) nanoparticles significantly reduced the speed of 
neutrophils whereas pre-exposure to metallic (~5 µm) particles, dramatically 
increased cell speed (Figure 8.11). An increase in cell speed may be associated 
with cell activation following e.g. phagocytosis or attempted phagocytosis of the 
particulate debris. Although internalisation of oxide nanoparticles has been 
demonstrated in this study, it has also been observed that nanoparticles 
accumulate on the cell membrane. This may act to inhibit cell motility (through 
interruption or modification of the actin cytoskeleton framework) or by possibly 
blocking the active site for F-actin polymerisation (Larmonier et al., 2011) on the 
neutrophil surface. The nanoparticles may also act to block (mask) surface 
receptors to the chemoattractants. In the current study exposure to oxide 
nanoparticles also resulted in a decrease in cell velocity (Figure 8.12) and 
chemotactic index (Figure 8.13) indicating that not only do cells move less but the 
directionality towards the chemoattractants is disturbed. It is hypothesized that 
cell surface interactions of nanoparticles masking receptor sites may lead to a 
modification in the chemical gradient that the cell can sense leading to 
disorientated movement. However, for cells pre-exposed to larger particles which 
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are not observed to aggregate at the cell membrane, both a significant increase in 
cell movement and a reduction in the chemotactic index was observed and is 
possibly accounted for by the cells unsuccessful attempts to phagocytose the 
associated particle (Figure 8.13). Of particular note was a significant decreased 
chemotactic index associated with IL-8 as a chemoattractant when compared with 
fMLP (Figure 8.13). This interesting finding may be explained by the likely 
production of IL-8 (or other chemoattractants) by the active neutrophils (via the 
NF-kB and MAPK mediated pathway) (Ryu et al., 2004) in response to larger 
particles which leads to modification of the chemoattractant gradient in the local 
environment and hence a modification of cell movement.  
 
The recruitment and activation of neutrophils to sites of peri-implantation may be 
driven by responses to microbial stimuli (e.g. LPS) (Edwards, 1994). However, 
the current study demonstrates that Ti debris (in forms encountered in the tissues) 
(Chapters 3 & 4) may significantly modify neutrophil chemotaxis within the 
tissues, reducing chemotactic accuracy and velocity potentially leading to the 
progression of peri-implant inflammation. The results suggest that Ti may 
influence the existing chemical concentration gradient, reducing or significantly 
increasing cell speed depending on the nature of the Ti stimulus and reducing the 
chemotactic index in the presence of inflammatory mediators (Figures 8.11 & 
8.13). The mechanisms underlying the process appear complex but seemingly are 
sensitive to cell membrane association with particles and cell activation (likely 
through phagocytosis) (Pierre, 2010). The data suggests that in the presence of 
significant quantities of Ti implant derivatives neutrophils are more likely to 
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cause host tissue damage due to their disrupted movement through the inflamed 
tissue and simulataneously activation of ROS and NET release. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 247 
8.6 CONCLUSION 
 
Neutrophils are key mediators of inflammation and their recruitment, activation 
and migration is regulated by range of chemoattractants at inflammatory sites 
(Witko-Sarsat, 2000). Results indicate that although Ti implant derivatives do not 
act as chemoattractants, following previous exposure to Ti the cells chemotactic 
response to e.g. inflammatory cytokines may be significantly modified. This may 
result in an inability for the neutrophil to adequately migrate to sites of bacterial 
invasion or may result in the cells persistence in areas of non-inflamed tissue 
contributing to host tissue damage.  
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CHAPTER 9 
 
GENERAL DISCUSSION 
 
 
9.1 Discussion 
  
In the current thesis it was demonstrated using synchrotron X-ray micro-focus 
spectroscopy that a scattered and heterogeneous (concentration, size and chemical 
species) distribution of Ti can be present in inflamed peri-implant soft tissues 
adjacent to both indwelling and skin/mucosal penetrating Ti implants (Chapters 3 
& 4). For mixed connective tissues associated with indwelling orthopaedic 
implants where wear and/or loading processes are a major factor for the 
deterioration of the implanted device, the presence of large quantities of Ti were 
not surprising. However, the accumulation of significant levels of Ti in thin 
sections (6 µm thick) of tissues excised from adjacent to skin penetrating Ti 
implants cannot be explained by the action of macroscopic wear processes. 
Findings suggest that previous investigations have lacked the pre-requisite 
detection sensitivity to identify Ti in such tissues and that Ti debris may indeed 
play some vital role in determining the clinical outcomes of these devices.  
 
Using XANES the Ti distribution identified in the inflamed skin penetrating peri-
implant tissues was characterised to exist in a variety of Ti co-ordinations 
including oxide, metallic and peroxy-complexes and Ti soluble products ranged in 
size (Chapter 4). The heterogeneity of the Ti debris and the predominance of 
oxide species are unlikely to be accounted for debris resulting from implant 
insertion (where metallic particles would be unexpected). In contrast, the findings 
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suggested that the Ti implant derivatives accumulated within skin penetrating 
peri-implant tissues result from mechanically assisted crevice corrosion (MACC) 
processes occurring in-vivo (Adya et al., 2005 & Addison et al., 2012). These 
findings are of significant concern and suggest that the passive oxide layer on Ti 
implants responsible for maintaining the biocompatibility of the biomaterial is 
transiently disrupted in service (Adya et al., 2005). To confirm the hypothesis 
electrochemical studies were performed in which an artificial pit of Ti was 
corroded at pitting potential of 7 V. XANES analysis of the Ti corrosion products 
formed within the artificial pit (Chapter 4) identified the same Ti species that were 
previously shown to be accumulated within peri-implant inflamed tissues 
(Chapters 3 & 4). The findings are strongly indicative that passive Ti medical 
device surfaces are subjected to MACC processes in-vivo. MACC of Ti surfaces 
results in the release of Ti ions which subsequently oxidise forming insoluble 
particles from nano-scale to micron sized or complex with biomolecules in the 
peri-implant environment (Thomas et al., 2004 & Vamanu et al., 2004). 
 
Within the tissues where XRF mapping confirmed Ti distributions, neutrophils 
were observed. This is unsurprising given that these cells are the predominant 
acute inflammatory cells in the peri-implant site (Chapter 3). Neutrophils are 
known to be having a significant impact on the progression of periodontal disease 
(Kantarci et al., 2003 & Nussbaum et al., 2011) and are thought to similarly 
influence the progression of peri-implantitis (Klinge et al., 2005 & Berglundh et 
al., 2011). The role of a pathogenic biofilm in the failure of skin and mucosal 
penetrating Ti implants is increasingly studied (Gitto et al., 1994 & Ahmed et al., 
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2012). However, there is almost no research on the role of Ti, and its potential to 
influence inflammatory outcomes despite the known importance in aseptic Ti 
prosthesis failure in an orthopaedic context (Ratner, 2001). Therefore, a range of 
neutrophil responses including phagocytosis, respiratory burst, NET release, 
priming, cytokine release and chemotaxis were studied to determine the potential 
impact of Ti implant derivatives on neutrophil function (Chapters 5-8 & Appendix 
IV). Ti species representative of crevice corrosion products as identified within 
peri-implant tissues were studied and neutrophil responses were correlated to 
particle size, speciation and concentration.  
 
The current investigation demonstrated that the Ti implant derivatives in all forms 
observed in tissues (either oxide nanoparticles or micron sized metallic particles) 
in-vivo do not act as chemoattractants for neutrophil chemotaxis (Chapter 8) into 
inflamed peri-implant tissue sites. This suggests that in the absence of other 
chemoattractants (microbial products or cellular signalling molecules) the 
presence of Ti in the peri-implant tissues from a neutrophil response perspective is 
largely unimportant. However, in the presence of another stressor the prior 
accumulation of Ti can become important if it modifies neutrophil activity at the 
site (Chapters 7 & 8).  
 
In this study it was demonstrated that Ti particles are readily internalised by the 
neutrophil dependent on particle size. Large particle > 3 µm were less readily 
internalised (Kumazawa et al., 2001, Tamura et al., 2002, Jovanović et al., 2011) 
and the smallest particle size were suggested to enter the cell by a combination of 
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phagocytosis and endocytosis mechanisms (Pierre, 2010). The strong association 
of nanoparticles with cell membranes is particularly interesting given their 
apparent interactions with cell surface receptors (Tamura et al., 2002). This was 
highlighted by the differential priming effects observed on neutrophils and the 
subsequent effects on pathways involving Fc-γR and TLR receptors (Chapter 7). 
Importantly, all Ti species were demonstrated to be inducers of ROS and NET 
release but with a dependence on particle size, species and dose (Chapters 5 & 6). 
Moreover, simulation of oxidative burst in neutrophils exposed to nano and 
micron sized Ti species was consistent with NET release in neutrophils exposed to 
similar assay conditions. This observation further supports the growing evidence 
that NETosis is closely related to the process of respiratory burst and ROS 
production appears to be crucial signal in initiating NET release (Bruns et al., 
2010 & Remijsen et al., 2011).  
 
The differential magnitude of ROS and NET release observed between Ti oxide 
nanoparticles (of different size and speciation) and micron sized metallic particles 
is difficult to interpret. However, the results demonstrate that Ti oxide 
nanoparticles have greater pro-inflammatory potential and this has been attributed 
to their increased surface energies (Nel et al., 2006 & Hussain et al., 2009) and 
intra-cellularisation mechanisms (Kumazawa et al., 2001, Tamura et al., 2002 & 
Pierre, 2010). Phagocytosis of Ti oxide nanoparticles was demonstrated to be 
more feasible in comparison with larger particulate debris. However presence of 
non-membrane bound particles in the cytosol demonstrates non-phagocytosis 
mechanisms do occur. Nanoparticles were shown to have strong affinity to cell 
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membranes (Chapter 5) and were suggested to effect cell motility, cell chemotaxis 
(Chapter 8) and activation of cell surface receptors (Chapter 7). 
 
Inhibition of ROS and NET release was demonstrated to periodontal pathogens 
Ops Sa and it was proposed that Ti implant derivatives may block or mask Fc-γR 
sites which then fail to recognise exogenous pathogens (Chapter 7). This 
observation is of significant concern as demonstrates pre-exposed cell may 
modify the peri-implant inflammatory response in sites of infection. Similarly, 
inhibition of the normal chemotactic response by Ti pre-exposed cells stimulated 
to known chemoattractants including fMLP and IL-8 was observed (Chapter 8). 
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CHAPTER 10  
 
CONCLUSIONS AND FUTURE WORK 
 
 
10.1 Conclusions 
 
Chronic inflammation associated with Ti implants leads to bone loss and 
ultimately failure of the device (Cobelli et al., 2011). The current study developed 
from evidence generated in an orthopaedic context that metal ions and particles 
released from an implant can be pro-inflammatory and/or modify inflammatory 
pathways (Chapter 4). In the context of mucosa penetrating (dental), or skin 
penetrating (craniofacial) implants chronic inflammatory peri-implant disease till 
date has been attributed to characteristics of the surface biofilm (Klinge et al., 
2005 & Berglundh et al., 2011) and to the host response (Flatebø et al., 2006). 
This study has demonstrated for the first time that extensive distributions of Ti 
particles (likely nano in scale) are found within the peri-implant tissues (Chapters 
3 & 4) and Ti in ionic forms bound to biomolecules is likely. The study further 
demonstrated that mechanically assisted crevice corrosion (MACC) can account 
for the Ti species observed in tissues (Chapter 4). It is noted however that ‘free-
Ti’ is likely to be further modified by interaction with cellular and extracellular 
components of the tissues (Lange et al., 2002 & Neumann et al., 2003). 
Neutrophils are highly significant in periodontal disease (Kantarci et al., 2003 & 
Nussbaum et al., 2011) and are found in high numbers in percutaenous and 
transmucosal implant sites (Chapter 3) (Klinge et al., 2005 & Berglundh et al., 
2011). It was therefore assumed that these professional phagocytes will interact 
with Ti in the tissues. A series of experiments demonstrated that Ti-oxide, 
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metallic Ti and Ti-peroxy compounds all demonstrated a dose related ability to 
stimulate the release of ROS from human neutrophils and the magnitude of ROS 
release was sensitive to Ti-species and particle size (Chapter 5). In addition to 
ROS stimulation Ti debris was a potent stimulator of NETosis and the pattern of 
the stimulatory magnitude was highly consistent with the stimulation of 
respiratory burst (Chapter 5 & 6). Differences between responses were identified 
to be related to particle size but at the nano-scale Ti-O co-ordination also appeared 
to be important in determining cell-entry routes and membrane interactions. In 
addition, to the direct pro-inflammatory activity of the Ti debris, Ti exposure also 
resulted in modified responses of neutrophils to periodontal pathogens (Chapter 7) 
which may reduce the effectiveness of neutrophils to clear pathogens at the peri-
implant site. These findings in combination with observations of modification of 
neutrophil chemotaxis behaviour suggest that that Ti implant derivatives will 
modify the progression of inflammation within peri-implant tissues. 
 
10.2 Future work 
 
The current study raises a large number of questions which yet have not been 
addressed within the current study and will contribute to enhancing our 
understanding of the underlying role of Ti corrosion products in tissues in-vivo: 
 
 Evaluate the potential of Ti corrosion products to cause activation of NLRP3 
inflammasome and provide insights regarding its significance which is known 
to cause further release of inflammatory cytokines such as IL-1 contributing to 
the inflammation present. 
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 Study the gene expression following Ti corrosion products exposure upon 
neutrophils which differentiates between (a) the possible receptor pathways 
such as PKC and inflammatory cytokines released (b) the positive or negative 
expression levels between the PHOX and PAD4 subunits of the NADPH 
complex responsible for the release of ROS and NET release mechanisms and 
(c) differentiate the expression levels between the three FC-γR classes. 
 
 Investigate the impact on neutrophil chemotaxis and/or ROS responses of 
exposure of Ti products which have been associated with endotoxin LPS in 
direct stimulatory and priming assays. 
 
 Identify the components comprised within NET structures released from 
neutrophils challenged with Ti implant derivatives. This will contribute in the 
understanding of possible interaction of Ti implant derivatives with neutrophil 
granular components and provide further insights regarding the functionality of 
the NET structures in the peri-implant environment. 
 
 Investigate further neutrophil pathways which are possibly up-regulated or 
down-regulated for the induction of respiratory burst and NET release from Ti 
stimulated neutrophils by Ti exposure of different sizes.  
 
 Investigate the effects on the release of pro-inflammatory cytokines and cell 
motility from neutrophils challenged with Ti implant derivatives which are 
blocked by SOD (ROS release inhibitor). 
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 Investigate interactions of Ti derivatives with the actin and cytoskeleton 
proteins which form the cytoplasmic framework of neutrophils influencing 
neutrophil chemotaxis and phagocytosis processes. 
 
 Investigate the cellular effects of Ti peroxy compounds on neutrophil NET 
release and chemotaxis. Ti peroxy compounds are potential product of previous 
Ti interactions with neutrophils and hence their continued functionality is of 
great significance. 
 
 Investigate the potential impact of neutrophils challenged with Ti implant 
derivatives on the activity of caspase 1 which is crucially involved in cell 
apoptosis. This investigation will provide insights regarding the induction of 
apoptosis by neutrophils challenged with Ti particles and compared to cell 
NETosis. 
 
 Due to the interference of Ti nanoparticles in various assays, it would be 
interesting to investigate the biological responses to neutrophils via non-
colourimetic/ fluorimetric methods e.g through gene expression or proteomic 
studies. 
 
 It has been proposed that pre-activated cells with Ti oxide derivatives inhibit 
release of pro-inflammatory cytokine IL-1β. Therefore, it would be interesting 
to compare the cellular effects of IL-1β release from neutrophils stimulated 
with Ti implant derivatives that are producing ROS and from those that are not. 
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 To study whether the response of neutrophils to Ti products is influenced by an 
existing state of hyper-reactivity and hyper-activity as seen in chronic 
periodontitis.  
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APPENDIX I 
 
11.1 Selection of volunteers 
 
Healthy volunteers were recruited from Birmingham Dental School, University of 
Birmingham, UK. Ethical approval was obtained from School of Medicine and 
Dentistry, University of Birmingham Dental Hospital, UK and donors gave their 
informed consent. Exclusion criteria included volunteers were non-diabetic, non-
smokers, no special dietary requirements, did not consume or use any recreational 
drugs and did not have any course of non-steroidal anti-inflammatory drugs 
(NSAID’s) in the past 24 hours prior to blood collection.  
 
11.2 Collection and isolation of peripheral blood neutrophils (PBN) 
 
The following section details the isolation of peripheral blood neutrophils (PBN) 
from whole blood. At least 18 mL or more blood was collected from the ante-
cubital fossa into lithium heparin coated tubes (171 U/mL) through a vacutainer 
(Greiner, Bio-one Ltd, Stonehouse, UK). PBN were extracted using discontinuous 
Percoll
® 
(1.13 g/mL) (17-0891-01; GE Healthcare, Buckinghamshire, UK) density 
centrifugation (Matthews et al., 2007) (section 11.3).   
 
11.3 Percoll
®
 density gradients preparation 
 
The isolation of cells of interest by Percoll
®
 density gradient is based on the 
differences in size or buoyant density existing in a population of cells. Therefore, 
two Percoll
® densities (δ=1.079 and 1.098 g/mL) were prepared (Table 11.1).  
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Table 11.1 Reagents and volumes used to prepare Percoll
® 
densities (δ=1.07  
and 1.098 g/mL) 
 
Density Volume in mL for Percoll
®
 
density 1.079 g/mL 
Volume in mL for Percoll
®
 
density 1.098 g/mL 
Percoll
®
 19.708 24.823 
Water 11.792 6.677 
1.5 M NaCl 3.500 3.500 
 
Discontinuous Percoll
® 
gradient was prepared by layering 8 mL of 1.098 Percoll
® 
density underneath 8 mL of 1.079 Percoll
® 
density in a 25 mL centrifuge tube. 
These were stored at 4 °C until use.  
 
Percoll
® 
forms self-generated gradients with centrifugation in 1.5 M NaCl (S9625; 
Sigma-Aldrich, UK) as consists of colloidal silica particles of 15-30 nm diameter 
(23% w/w in water) that are coated with polyvinylpyrrolidone (PVP) (Sigma-
Aldrich, Chemical Company, Poole, UK). Also another advantage of using 
Percoll
®
 is that its inert nature prevents interfering with downstream assays in 
comparison to dextran/ficoll method which can pre-activate neutrophils. 
  
11.4 Lysis buffer 
 
1 L of lysis buffer was made by adding 8.3 g NH4Cl (A9434; Sigma-Aldrich), 1 g 
KHCO3 (P9144; Sigma-Aldrich), 0.04 g C10H14N2Na2O8
.
2H2O (E5134; Sigma-
Aldrich) and 2.5 g Bovine Serum Albumin (BSA) (A4530 Sigma-Aldrich) to 1 L 
of water (Versol, Somerset, UK) and stored at 4 °C until use. Buffer was 
replenished after 30 days as degradable. 
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11.5 Phosphate buffered saline (PBS)  
 
1 L of PBS was made by combining 7.75 g NaCl (S9625; Sigma-Aldrich), 0.2 g 
KH2PO4 (P5379; Sigma-Aldrich) and 1.5 g K2HPO4 (P8281; Sigma-Aldrich) in 1 
L distilled water. The buffer pH was adjusted to 7.3, autoclaved and stored at 4 
°C. 
 
11.6 Neutrophil isolation  
 
Whole blood (~6 mL) was layered on top of percoll gradients (section 11.3) and 
centrifuged for 8 mins at 150 rcf, followed by 10 mins at 1200 rcf. The plasma, 
lymphocyte and monocyte layers separated were carefully removed and discarded 
by manual aspiration using a plastic pasteur pipette. The neutrophil layer located 
at the top of the red blood cell layer was transferred, again using a plastic pasteur 
pipette, to a 50 mL centrifuge tube containing 15 mL lysis buffer (section 11.4). 
The tube was gently inverted to mix, and incubated at room temperature for 5 
mins until red blood cells had lysed. This was then centrifuged for 6 mins at 500 
rcf to pellet the neutrophils. The supernatant was discarded and the pellet was re-
suspended in 3 mLs of lysis buffer and incubated for 5 mins at room temperature 
prior to re-centrifugation at 500 rcf for 6 mins. The supernatant was removed; the 
pellet was washed in 3 mLs of PBS (section 11.5), and centrifuged once more for 
6 mins at 500 rcf before re-suspension in 3 mLs of PBS.  
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11.7 Cell viability 
 
Cells were counted using a light microscope (LeitzLaborlux s, Germany) and 
haemocytometer (Neubauer, Reichart, Germany). Cell viability was determined 
by trypan blue exclusion (1:1 mix of cells with trypan blue) (T8154; Sigma-
Aldrich, UK) immediately prior to assay and was typically >98%.  
 
Neutrophils of interest were used immediately by re-suspending in either PBS or 
RPMI-1640 for ex-vivo neutrophil functional assays (Chapters 5-8). 
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APPENDIX II 
 
12.1 Bacterial stimuli preparation 
 
Bacteria were used as control stimuli for neutrophil functional assays (Chapters 5-
8). Bacteria were grown in broth cultures and rinsed twice by centrifugation at 
1087 rcf for 40 mins. The supernatant was removed and the pellet was then re-
suspended in sterile PBS (Appendix I) following bacterial number estimation 
using spectrophotometry (section 12.11). Bacterial suspensions were then diluted 
in sterile PBS and stored at -30 °C/- 80 °C respectively until further use. 
 
12.2 Mannitol salt agar (MSA) 
 
MSA (ThermoFisher Scientific, Oxford, UK) contains 7.5% NaCl which inhibits 
growth of gram negative bacteria. Therefore gram positive bacteria were grown 
according to manufacturer’s instructions. Briefly, 55.5 g of MSA was dissolved in 
500 mL of distilled water. Post autoclaving at 121 °C for 15 mins the agar was 
cooled to 50 °C in a water bath. Agar was poured into Petri dishes (101VR20; 
Sterilin, Newport, UK) allowing around 25 mins settling time and then stored at 4 
°C until further use. 
 
12.3 Horse blood agar 
 
5% defibrinated horse blood (SR0050B; Oxoid) was aseptically added to tryptone 
soya agar (CM0131; Oxoid) prepared according to manufacturer’s instructions. 40 
g of tryptone soya agar was dissolved in 1 L of distilled water and autoclaved at 
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121 °C for 15 mins. The agar was then cooled to 50 °C in a water bath. Agar was 
pored into petri dishes (101VR20; Sterilin, Newport, UK) allowing to equilibrate 
at room temperature for 1 hr and then stored at 4 °C until further use. 
 
12.4 Tryptone soya broth 
 
Tryptone soya broth (ThermoFisher Scientific, Oxford, UK) was prepared 
according to the manufactures instructions. 111 g of tryptone soya broth was 
dissolved in 1 L of distilled water and autoclaved.  
 
12.5 Opsonisation of S. aureus (Ops Sa) 
 
Staphylococcus aureus (ATCC 9144) was cultured on MSA (section 12.2). Sterile 
tryptone soya broth (section 12.4) was inoculated by transfer of bacterial growth 
from agar plate (section 12.2) using a flame sterilised loop. Cultures were grown 
in an anaerobic chamber comprised of CO2 9.97%, hydrogen 9.92% with nitrogen 
balance at 37 °C (Don Whitley Scientific, Molecular Atmosphere Controlled 
System, CAL-3200, Shipley UK). After overnight growth, bacteria were pelleted 
by centrifugation at 3800 rcf for 5 mins, the supernatant was removed and the 
pellet was re-suspended in sterile PBS. This was repeated three times. After the 
third centrifugation step the bacterial pellet was re-suspended in 3% formaldehyde 
(P6148; SigmaAldrich, UK) in PBS and incubated at room temperature for 1 hr to 
fix. The bacteria were again washed three times by centrifugation and re-
suspended in sterile PBS. Bacterial concentration was then estimated by 
spectrophotometry (section 12.11) and diluted in additional sterile PBS to give a 
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suspension of 1x10
9 
bacteria per mL. The bacteria were then heat killed by 
incubating at 80 °C for 20 mins. This bacterial suspension was then treated with 
33 μL of Vigam liquid (5 mg/mL IgG; Bio Products Laboratory, Hertfordshire, 
UK) per mL of bacteria and incubated overnight at room temperature with 
constant agitation to allow opsonization. Staphylococcus aureus is a gram positive 
bacterium and was opsonised with IgG to enable stimulation of cellular Fc-γ 
receptors (Fc-γR). Finally, bacteria were again rinsed twice in sterile PBS by 
centrifugation and stored at -80 
°
C. Bacterial numbers were again estimated by 
spectrophotometry to re-suspend in PBS to give 6x10
8
 bacteria/mL. 
 
12.6 Fusobacterium Nucleatum (FN) 
 
The periodontopathogen F. Nucleatum (ATCC 10953; LGC Standards, Germany) 
supplied as freeze dried bacterial powder was dissolved in 3 mL brain heart 
infusion broth supplemented with 10% serum (BO0129E; Oxoid). 100 µL of the 
above suspension was streaked onto horse blood agar plates (section 12.3) and 
incubated for 48 hrs in an anaerobic chamber of CO2 9.97%, hydrogen 9.92% 
with nitrogen balance at 37 °C (Don Whitley Scientific, Molecular Atmosphere 
Controlled System, CAL-3200, Shipley UK). In addition, another plate was 
inoculated to be left at aerobic conditions at 37 °C to determine purity.  
 
After growth of bacterial cultures on agar plates, a single bacterial colony was 
inoculated in 1 L sterile brain infusion broth using a flame sterilised loop and 
again grown in anaerobic chamber for 48 hrs as described above. After 
incubation, 1 mL of this bacterial suspension was further diluted in 1 L broth and 
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streaked in new agar plates for bacterial quantification. The number of bacteria 
present on the agar plates was used to approximate the number of bacteria present 
in the broth culture. Subsequently then bacteria was isolated from broth cultures 
by centrifugation, washed three times in PBS and heat treated at 80 °C for 20 mins 
prior to dilution with additional sterile PBS to give a final stock suspension of 
4x10
8
 cells/mL, which was stored at -30 °C until further use. 
 
12.7 Identification of bacteria  
 
The identification of bacteria was verified by streak plating out to single colonies 
which were primarily gram stained later to observe microscopic cell morphology. 
This method aided in distinguishing between Streptococci and Staphylococci 
species. The reference system used for identification was Bergey’s manual of 
determinative bacteriology.  
 
12.8 Crystal violet solution  
 
10 g of crystal violet (C0775; Sigma-Aldrich) was dissolved in 100 mL of 95% 
ethanol. 20 mL of this was mixed with 80 mL of 1% ammonium oxalate (A8545; 
Sigma-Aldrich) in distilled water and allowed to stand for several weeks prior to 
use.  
 
12.9 Carbol fuchsin 
 
Strong carbol fuchsin (351874U; Birmingham Dental Hospital) was diluted 1:9 in 
distilled water.  
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12.10 Gram staining procedure  
 
Gram staining was performed by placing a drop of sterile 85% saline on a 
microscope slide. A sterile loop was used to transfer bacterial colonies and is 
further emulsified in this saline drop. This bacterial suspension was dried by 
passing the slide several times through a flame to fix the bacteria. The bacteria 
were then covered with crystal violet for 30 secs, rinsed under tap water, Lugols 
iodine (L6146; Sigma-Aldrich) was applied for 15 secs, rinsed, flooded with 
acetone and washed immediately, then treated with carbol fuchsin (section 12.9) 
for 15 secs and rinsed. The slide was blotted dry and viewed under oil immersion 
microscope (LeitzDialux 22, Germany). This procedure distinguishes between 
gram positive and negative bacteria as gram staining using crystal violet stains 
gram positive bacteria species purple as rich in peptidoglycan outer layer. 
Whereas gram negative bacteria are counter stained pink with carbol fuchsin as 
these species have an outer lipid membrane which is further removed by acetone.  
 
12.11 Determination of bacterial growth by spectrophotometry  
 
Cell growth was estimated using a spectrophotometer (Jenway 6300) by 
measuring the optical density at 600 nm (OD600nm). Non-inoculated samples of 
media were used to correct for media changes in absorbance at OD600nm not due to 
bacterial growth. The OD600nm values that were used to estimate bacterial growth 
were calculated by the Forysth Institute, Boston.  
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Appendix III 
 
Raman spectra of the Ti oxide powders used in the current study are displayed. 
Spectra were obtained using a Renishaw inVia Raman microscope (Renishaw Plc, 
Wotton-under-Edge, UK) with an excitation wavelength of λ=633 nm. Anatase 
(~30 nm) and rutile (~50 nm) powders matched standard spectra and the mixed 
oxide (~66 nm) species contains peak assignments consistent with an admix of 
rutile and anatase (anatase fraction is likely to be larger). 
 
(a) Rutile (~50 nm) powder 
 
 
 
 
 
(b) Anatase (~30 nm) powder 
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(c) Mixed oxide (~66 nm) species 
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Appendix IV 
 
INFLAMMATORY CYTOKINE RELEASE FROM 
HUMAN NEUTROPHILS EXPOSED TO TITANIUM 
IMPLANT DERIVATIVES  
 
 
13.1 PREFACE 
 
 
An Enzyme Linked Immunosorbant Assay (ELISA) was employed for ex-vivo 
measurement of inflammatory cytokines (IL-1β and IL-6) release in supernatants 
collected at 0, 8, 16, and 24 hrs from neutrophils challenged with micron and nano 
sized Ti implant derivatives (oxide or metallic) at concentrations of 2000, 200, 20 
and 2 ppm and compared with control conditions. Given the evidence of a 
significant decrease in ROS and NET production from neutrophils co-stimulated 
with Ops Sa (Fc-γR mediated) and Ti (oxide or metallic), the impact on the 
release of IL-1β and IL-6 cytokines was also measured from cells exposed to 
similar stimuli and compared with stimulated controls. 
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13.2 INTRODUCTION 
 
13.2.1 Neutrophil cytokine release 
 
Alongside phagocytosis and reactive oxygen species (ROS) production (Amulic et 
al., 2012), neutrophils have the capacity to produce and cause a cascade release of 
a variety of pro- and anti-inflammatory mediators which possess a broad spectrum 
of biological activities. Cytokines are amongst the most well studied 
inflammatory signalling molecules involved in acute and chronic inflammatory 
responses (Edwards, 1994 & Hatanaka et al., 2006). A cytokine is a small protein 
less than 20kDa which serves with a hormone like function which enables 
immune cells to communicate with each other (Luster, 1998). During an 
inflammatory response numerous cytokines are generated which influence the 
release of other cytokines and also affect neutrophil functions (such as respiratory 
burst, degranulation and expression of plasma membrane receptors) (Cassatella, 
1995). 
 
It is accepted that the cytokine cascade is highly complex involving expression of 
integrins on leukocytes and activation of numerous pathways (Cassatella, 1995). 
The release of any specific cytokine has a variety of roles in the inflammatory 
processes (Edwards, 1994) and with this respect, IL-1β cytokine which is an 
integral unit of the IL-1 family is one of the most widely studied inflammatory 
cytokines (Hatanaka et al., 2006, Miller et al., 2007, Wright et al., 2010 & Yazdi 
et al., 2010). It’s secretion through the NLRP3 inflammasome pathway in 
neutrophils is recognised as potent mediators of inflammation (Yazdi et al., 2010). 
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In addition, IL-1β is reported to be specifically involved in neutrophil activation 
and recruitment against S. aureus infection in-vivo (Miller et al., 2007). 
 
In addition to IL-1β function in neutrophils, IL-6 is another ubiquitous pro-
inflammatory cytokine released by the neutrophil via the STAT3 pathway 
(Fielding et al., 2008). The biological mechnisms of IL-6 release are complex, 
although its release at inflammatory sites is recognised to regulate transition of 
neutrophils infiltrates to monocyte recruitment which is a hallmark of acute 
inflammation (Kaplanski et al., 2003). In addition, the precise functionality of IL-
6 in neutrophils is still not categorised although it has been reported to modulate 
neutrophil function and is shown to delay neutrophil apoptosis thus resulting in 
prolonged ROS release (Biffi et al., 1996).  
 
13.2.2 Measurement of cytokine release 
 
ELISA is a valuable tool which enables simple and accurate quantification of 
inflammatory cytokines in cell culture supernatants through antibodies and 
enzymatic detection reactions (Edwards, 1994 & Kobayashi et al., 2002). Limited 
studies have been performed to detect the release of various cytokines from Ti 
oxide stimulated neutrophils (Tamura et al., 2002, Goncalves et al., 2010 & 
Pierre, 2010). However, recently some investigators have also reported the 
interference of nanoparticles with enzymatic immunoassays such as ELISA (Kroll 
et al., 2008). 
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The impact Ti stimulation (oxide or metallic) on the release of both IL-1β and IL-
6 cytokines is poorly established (Yazdi et al., 2010). Therefore, these findings 
would provide further insights into understanding the pro-inflammatory potential 
of Ti interactions with neutrophils in the peri-implant environment and will help 
to elucidate mechanistic pathways determining the influence of Ti exposure on 
neutrophil function. 
 
13.3 METHODS 
 
13.3.1 Lipopolysaccharide (LPS) preparation  
 
A component of gram negative bacteria cell wall are LPS, which activate TLR-4/2 
in conjunction with CD14, MD-2 and LPS binding protein. LPS (L4654; Sigma-
Aldrich) provided in lyophilized powder was suspended in PBS for use at a 
concentration of 10 μg/mL.  
 
13.3.2 Cell purification and culture conditions 
 
Isolated neutrophils (2.5 x 10
6 
cells/mL) (Appendix I) were re-suspended in 
RPMI-1640 supplemented with 0.3 g/L glutamine, 2.32 g/L HEPES, 2 g/L sodium 
bicarbonate, 100 µg/mL streptomycin, 100 U/mL penicillin. Cells were 
subsequently cultured in 37 °C in a 5% CO2 atmosphere for up to 24 hrs with and 
without opsonised S.aureus, F.nucleatum and LPS (10 µg/mL) as control stimuli. 
Ti (oxide or metallic) at concentrations of 2000, 200, 20 and 2 ppm dispersed in 
RPMI were employed as experimental stimuli. In addition, neutrophils were co-
stimulated with Ops-Sa and Ti stimuli. Supernatants were removed at 0, 8, 20 and 
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24 hrs following centrifugation at 5000 rcf for 5 mins and stored at -80 °C. IL-1β 
and IL-6 release in the collected supernatants was determined by ELISA kits 
specific for humans -( IL-1β, Ebiosciences, Australia and IL-6 2bscientific, USA). 
The experiment was repeated five times with neutrophils sourced from different 
healthy volunteers. 
 
13.3.3 Measurement of Pro-Inflammatory Cytokine IL-1β Release 
 
The assay was performed in 96-well transparent plate (Corning Costar 9018,UK) 
strictly according to the manufacture’s instructions. Plates were coated with 100 
µL of the capture antibody and stored overnight at 4 °C. Prior to addition of the 
analyte to be tested, the plate was washed with PBS-Tween20 five times 
following subsequent addition of 200 µL of 5% PBS-BSA per well for 1 hr at 
room temperature. Liquid from the wells was then aspirated and the plate was 
washed again five times. 100 µL of the analyte to be tested and known 
concentrations IL-1β analyte were added per well and stored overnight at -4 °C 
for maximal sensitivity. After overnight incubation, aspiration and repeated 
washing was conducted five times. 100 µL of IL-1β detection antibody was added 
to the wells and incubated at room temperature for 1 hr. Liquid from the plate was 
aspirated and washed again five times with PBS-Tween20 to remove any unbound 
antibody-enzyme reagent. 100 µL of HRP was added per well for 30 mins 
following subsequent aspiration and wash with PBS-Tween20 seven times. 100 
µL of substrate TMB solution (provided in the kit) was added per well and 
incubated at room temperature for 15 mins (protected from light). Immediately, 
50 µL of 1 M H2SO4 solution was added per well and the plate was read using a 
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microplate reader set at optical density of 450 nm (Bio-rad 550, UK) and 
corrected at 570 nm respectively. The detection limit was less than 4 pg/ml. All 
samples were assayed in duplicate. 
 
13.3.4 Measurement of Pro-Inflammatory Cytokine IL-6 Release 
 
The assay was performed in 96-well plate (Corning Costar 9018, UK) strictly 
according to the manufacture’s instructions. Plates were coated with 100 µL of 
capture antibody and stored overnight at 4 
o
C followed by washing twice with 
PBS-Tween followed by adding 250 µL of 5% PBS-BSA to the wells for two hrs 
at room temperature. Plates were then aspirated and left at room temperature to 
dry for at least 24 hrs. Post coating with the capture antibody and 5% BSA, 100 
µL of the standard, control, or sample were added per well. The tested samples for 
IL-6 were incubated for at least 1 hr with 50 µL of IL-6 detection antibody. Post 
one hr incubation, the plate was aspirated and washed at least three times with 
PBS-Tween 20 to remove any unbound antibody-enzyme reagent. 100 µL of HRP 
was added to the wells for 20 min at room temperature and again aspirated and 
washed with PBS-Tween as above. Then 100 µL of substrate TMB solution 
(provided in the kit) was added to each well and then incubated and protected 
from light at room temperature for 15 mins. 100 µL of 1M H2SO4 solution was 
added to each well immediately after 15 mins to stop the reaction. The optical 
density of each well was immediately read using a microplate reader set to read at 
450 nm (Bio-rad 550, UK) respectively. The detection limit for IL-6 assay was 2 
pg/mL. All samples were assayed in duplicates. 
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13.4 RESULTS 
 
 
13.4.1 Ex-vivo cytokine (IL-1β and IL-6) release quantification from 
stimulated neutrophils  
 
The maximum release of pro-inflammatory cytokines IL-1β and IL-6 in 
supernatants collected from stimulated neutrophils at 0, 8, 16 and 24 hrs is 
presented in the form of histogram plots (Figure 13.1).    
 
Increased release of IL-1β and IL-6 was observed from neutrophils stimulated 
with the positive controls, Ops Sa (Fc R mediated), LPS and FN (TLR4 mediated) 
when compared with unstimulated neutrophils. The magnitude of cytokine release 
increased with time. In addition, a higher order of magnitude of IL-6 
inflammatory cytokine release was observed from all stimulated conditions in 
comparison to IL-1β release. Amongst, the positive controls employed the highest 
order of magnitude cytokine release was observed in response to Ops Sa. 
 
Following Ti stimulation neutrophils released IL-1β and IL-6 in a dose dependent 
pattern however, the magnitude of the cytokine release was observed to be much 
lower than positive control stimulated neutrophils. In addition, similar to control 
stimulated cells, the orders of IL-6 cytokine release were also observed to be 
higher than IL-1β. A series of experiments were conducted to identify the impact 
of the Ti stimuli on the ELISA assay. The findings (not shown) demonstrated that 
the Ti stimuli interrupted the assay significantly (presumed to bind to the 
antibody) leading to aberrant results which could not be safely interpreted. This 
 306 
phenomenon is rarely reported but has recently been acknowledged in the 
literature.  
 
 
Figure 13.1 Representative histogram plots demonstrating maximum release 
of IL-1β and IL-6 cytokines in supernatants collected from stimulated 
neutrophils at various time points 
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